<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Phytoestrogens for menopausal vasomotor symptoms - Lethaby, A - 2013 | Cochrane Library</title> <meta content="Phytoestrogens for menopausal vasomotor symptoms - Lethaby, A - 2013 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001395.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Phytoestrogens for menopausal vasomotor symptoms - Lethaby, A - 2013 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001395.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001395.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Phytoestrogens for menopausal vasomotor symptoms" name="citation_title"/> <meta content="Anne Lethaby" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="a.lethaby@auckland.ac.nz" name="citation_author_email"/> <meta content="Jane Marjoribanks" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="Fredi Kronenberg" name="citation_author"/> <meta content="College of Physicians &amp; Surgeons, Columbia University in the City of New York" name="citation_author_institution"/> <meta content="Helen Roberts" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="John Eden" name="citation_author"/> <meta content="Royal Hospital for Women" name="citation_author_institution"/> <meta content="Julie Brown" name="citation_author"/> <meta content="University of Auckland" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD001395.pub4" name="citation_doi"/> <meta content="2013" name="citation_date"/> <meta content="2013/12/10" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001395.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001395.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001395.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Glycine max; Hot Flashes [*drug therapy]; Isoflavones [therapeutic use]; Phytoestrogens [*therapeutic use]; Randomized Controlled Trials as Topic; Sweating [*drug effects]; Trifolium" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001395.pub4&amp;doi=10.1002/14651858.CD001395.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="QzbxnhyM";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001395\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001395\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ko","ja","hr","fr","fa","ms"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001395.pub4",title:"Phytoestrogens for menopausal vasomotor symptoms",firstPublishedDate:"Dec 10, 2013 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Gynaecology and Fertility Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=QzbxnhyM&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001395.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001395.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001395.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001395.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001395.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001395.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;アブストラクト&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001395.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001395.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001395.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001395.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>15756 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001395.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#CD001395-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#CD001395-sec-0132"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#CD001395-sec-0043"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#CD001395-sec-0048"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#CD001395-sec-0049"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#CD001395-sec-0073"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#CD001395-sec-0113"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/appendices#CD001395-sec-0137"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/table_n/CD001395StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/table_n/CD001395StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2013 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Phytoestrogens for menopausal vasomotor symptoms</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/information#CD001395-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Anne Lethaby</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/information#CD001395-cr-0003">Jane Marjoribanks</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/information#CD001395-cr-0004">Fredi Kronenberg</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/information#CD001395-cr-0005">Helen Roberts</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/information#CD001395-cr-0006">John Eden</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001395.pub4/information#CD001395-cr-0007">Julie Brown</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/information/en#CD001395-sec-0147">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 10 December 2013 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001395.pub4">https://doi.org/10.1002/14651858.CD001395.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001395-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001395-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001395-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001395-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001395-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD001395-abs-0003">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD001395-abs-0002">한국어</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001395-abs-0001" lang="en"> <section id="CD001395-sec-0001"> <h3 class="title" id="CD001395-sec-0001">Background</h3> <p>Vasomotor symptoms, such as hot flushes and night sweats, are very common during the menopausal transition. Hormone therapy has traditionally been used as a highly effective treatment, but concerns about increased risk of some chronic diseases have markedly increased the interest of women in alternative treatments. Some of the most popular of these treatments are foods or supplements enriched with phytoestrogens—plant‐derived chemicals that have estrogenic action. </p> </section> <section id="CD001395-sec-0002"> <h3 class="title" id="CD001395-sec-0002">Objectives</h3> <p>To assess the efficacy, safety and acceptability of food products, extracts and dietary supplements containing high levels of phytoestrogens when compared with no treatment, placebo or hormone therapy for the amelioration of vasomotor menopausal symptoms (such as hot flushes and night sweats) in perimenopausal and postmenopausal women. </p> </section> <section id="CD001395-sec-0003"> <h3 class="title" id="CD001395-sec-0003">Search methods</h3> <p>Searches targeted the following electronic databases: the Cochrane Menstrual Disorders and Subfertility Group Specialised Register of randomised trials (29 July 2013), the Cochrane Register of Controlled Trials (CENTRAL; 29 July 2013), MEDLINE (inception to 29 July 2013), EMBASE (inception to 29 July 2013), AMED (1985 to 29 July 2013), PsycINFO (inception to 29 July 2013) and CINAHL (inception to 29 July 2013). Attempts were made to access grey literature by sending letters to pharmaceutical companies and performing searches of ongoing trial registers. Reference lists of included trials were also searched. </p> </section> <section id="CD001395-sec-0004"> <h3 class="title" id="CD001395-sec-0004">Selection criteria</h3> <p>Studies were included if they were randomised, included perimenopausal or postmenopausal participants with vasomotor symptoms (hot flushes or night sweats), lasted at least 12 weeks and provided interventions such as foods or supplements with high levels of phytoestrogens (not combined with other herbal treatments). Trials that included women who had breast cancer or a history of breast cancer were excluded. </p> </section> <section id="CD001395-sec-0005"> <h3 class="title" id="CD001395-sec-0005">Data collection and analysis</h3> <p>Selection of trials, extraction of data and assessment of quality were undertaken by at least two review authors. Most trials were too dissimilar for their results to be combined in a meta‐analysis, so these findings are provided in narrative 'Summary of results' tables. Studies were grouped into broad categories: dietary soy, soy extracts, red clover extracts, genistein extracts and other types of phytoestrogens. Five trials used Promensil, a red clover extract; results of these trials were combined in a meta‐analysis, and summary effect measures were calculated. </p> </section> <section id="CD001395-sec-0006"> <h3 class="title" id="CD001395-sec-0006">Main results</h3> <p>A total of 43 randomised controlled trials (4,364 participants) were included in this review. Very few trials provided data suitable for inclusion in a meta‐analysis. Among the five trials that yielded data assessing the daily frequency of hot flushes suitable for pooling, no significant difference overall was noted in the incidence of hot flushes between participants taking Promensil (a red clover extract) and those given placebo (mean difference (MD) ‐0.93, 95% confidence interval (CI) ‐1.95 to 0.10, I<sup>2</sup> = 31%). No evidence indicated a difference in percentage reduction in hot flushes in two trials between Promensil and placebo (MD 20.15, 95% CI ‐12.08 to 52.38, I<sup>2</sup> = 82%). Four trials that were not combined in meta‐analyses suggested that extracts with high (&gt; 30 mg/d) levels of genistein consistently reduced the frequency of hot flushes. Individual results from the remaining trials were compared in broad subgroups such as dietary soy, soy extracts and other types of phytoestrogens that could not be combined. Some of these trials found that phytoestrogen treatments alleviated the frequency and severity of hot flushes and night sweats when compared with placebo, but many trials were small and were determined to be at high risk of bias. A strong placebo effect was noted in most trials, with a reduction in frequency ranging from 1% to 59% with placebo. No indication suggested that discrepant results were due to the amount of isoflavone in the active treatment arm, the severity of vasomotor symptoms or trial quality factors. Also, no evidence indicated that these treatments caused oestrogenic stimulation of the endometrium or the vagina or other adverse effects when used for up to two years. </p> </section> <section id="CD001395-sec-0007"> <h3 class="title" id="CD001395-sec-0007">Authors' conclusions</h3> <p>No conclusive evidence shows that phytoestrogen supplements effectively reduce the frequency or severity of hot flushes and night sweats in perimenopausal or postmenopausal women, although benefits derived from concentrates of genistein should be further investigated. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001395-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001395-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD001395-abs-0007">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD001395-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001395-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD001395-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD001395-abs-0011">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD001395-abs-0010">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD001395-abs-0009">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001395-abs-0016">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/ru#CD001395-abs-0008">Русский</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001395-abs-0006" lang="en"> <h3>Phytoestrogens for vasomotor menopausal symptoms</h3> <p><b>Review question:</b> This Cochrane review has evaluated whether phytoestrogen treatments reduce the number and severity of hot flushes and whether they are safe and acceptable. </p> <p><b>Background:</b> Hormone therapy is an effective treatment for controlling the most common menopausal symptoms—hot flushes and night sweats. However, it is now recommended only in low doses given for the shortest possible time because of concerns about increased risk of some chronic diseases. Many women have started to use therapies that they perceive as 'natural' and safe, but they often do not have good information about the potential benefits and risks. Some of these therapies contain phytoestrogens—a group of plant‐derived chemicals that are thought to prevent or treat disease. Phytoestrogens are found in a wide variety of plants, some of which are foods, particularly soy, alfalfa and red clover. </p> <p><b>Study characteristics:</b> This review found 43 RCTs conducted up to July 2013 that included 4,084 participants with hot flushes who were close to the menopause or were menopausal. Evidence obtained is current to July 2013. </p> <p><b>Key results:</b> Some trials reported a slight reduction in hot flushes and night sweats with phytoestrogen‐based treatment. Extracts containing high levels of genistein (a substance derived from soy) appeared to reduce the number of daily hot flushes and need to be investigated further. Overall no indication suggested that other types of phytoestrogens work any better than no treatment. No evidence was found of harmful effects on the lining of the womb, stimulation of the vagina or other adverse effects with short‐term use. </p> <p><b>Quality of the evidence:</b> Many of the trials in this review were small, of short duration and of poor quality, and the types of phytoestrogens used varied substantially. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001395-sec-0132" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001395-sec-0132"></div> <h3 class="title" id="CD001395-sec-0133">Implications for practice</h3> <section id="CD001395-sec-0133"> <p>No conclusive evidence shows that phytoestrogen supplements effectively reduce the frequency or severity of hot flushes and night sweats in perimenopausal or postmenopausal women, although benefits reported with concentrates of genistein may be beneficial and should be further investigated. Many of the included studies were of poor quality, and results were inconsistent, providing no guidance on which type of product is likely to be more beneficial. Women need to be reassured that these symptoms usually abate over time. When therapy is desired or required, the use of unspecified phytoestrogen supplements is not based on good quality evidence of benefit, although it is possible that high doses of genistein may offer relief. No evidence shows harmful side effects in the short term resulting from the use of these supplements. </p> </section> <h3 class="title" id="CD001395-sec-0134">Implications for research</h3> <section id="CD001395-sec-0134"> <p>More research is required to test the following hypotheses.</p> <p> <ul id="CD001395-list-0019"> <li> <p>Supplements containing at least 15 mg of genistein are more effective than supplements containing less than 15 mg of genistein. </p> </li> <li> <p>Phytoestrogen supplements are more effective in women with more than five moderate to severe hot flushes per day than in those with mild symptoms. </p> </li> <li> <p>Phytoestrogen supplements are more effective in women who are equol producers.</p> </li> </ul> </p> <p>In addition, to enhance comparability, future trials should be based on phytoestrogen products that are well characterised; they should provide strict monitoring of participants throughout the trial, should be well powered and of adequate duration and should use validated measurements of outcome. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001395-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001395-sec-0043"></div> <section id="CD001395-sec-0044"> <h3 class="title" id="CD001395-sec-0044">Description of the condition</h3> <p>Menopause is a significant event in the lives of most women, as it marks the end of a woman's natural reproductive life. The perimenopausal and early postmenopausal years are typically characterised by falling levels of endogenous oestrogen, which can give rise to vasomotor symptoms that are severe and disruptive, particularly in the early and late menopausal transition and in early postmenopause, as categorised by the STRAW (STages of Reproductive Aging Workshop) criteria (<a href="./references#CD001395-bbs2-0145" title="HarlowSD , GassM , HallJE , LoboR , MakiP , RebarRW , et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Fertility and Sterility2012;97(4):843‐51. ">Harlow 2012</a>). These vasomotor symptoms include hot flushes (also known as 'hot flashes'), sweating and sleep disturbances. </p> <p>Hot flushes are described as sudden feelings of heat in the face, neck and chest (<a href="./references#CD001395-bbs2-0188" title="World Health Organisation Scientific Group. Menopause. WHO Technical Report Series 866,1996; Vol. 7, issue 4:236‐42. ">WHO 1996</a>). Hot flushes are frequently accompanied by skin flushing and perspiration, followed by a chill as core body temperature drops (<a href="./references#CD001395-bbs2-0136" title="FreedmanRR . Physiology of hot flashes. American Journal of Human Biology2001;13(4):453‐64. ">Freedman 2001</a>; <a href="./references#CD001395-bbs2-0154" title="KronenbergF . Hot flashes: epidemiology and physiology. Annals of the New York Academy of Sciences1990;592:52‐86. ">Kronenberg 1990</a>). Flushes vary in frequency, duration and severity and may be spontaneous and unpredictable (<a href="./references#CD001395-bbs2-0135" title="FreedmanRR , NortonD , WoodwardS , CornelissenG . Core body temperature and circadian rhythm of hot flashes in menopausal women. Clinical Endocrinology and Metabolism1995;80(8):2354‐8. ">Freedman 1995</a>). Hot flushes that occur during the night are typically referred to as night sweats. Flushes and night sweats are events of concern in themselves because they can disrupt sleep patterns and alter daily activities, which can lead to fatigue and decreased quality of life (<a href="./references#CD001395-bbs2-0119" title="AyersB , HunterMS . Health‐related quality of life of women with menopausal hot flushes and night sweats. Climacteric2013;16:235‐9. ">Ayers 2013</a>; <a href="./references#CD001395-bbs2-0164" title="North American Menopause Society. Treatment of menopause‐associated vasomotor symptoms: position statement of the North American Menopause Society. Menopause2004;11(1):11‐33. ">NAMS 2004</a>). Hot flushes are thought to result from both the brain's response to diminished hormones and hormonal fluctuations that occur during the menopausal transition, which leads to instability of thermoregulatory mechanisms (that regulate temperature) in the hypothalamus (<a href="./references#CD001395-bbs2-0133" title="DeecherDC , DorriesK . Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Archives of Women's Mental Health2007;10(6):247‐57. ">Deecher 2007</a>; <a href="./references#CD001395-bbs2-0136" title="FreedmanRR . Physiology of hot flashes. American Journal of Human Biology2001;13(4):453‐64. ">Freedman 2001</a>; <a href="./references#CD001395-bbs2-0153" title="KronenbergF , DowneyJA . Thermoregulatory physiology of menopausal hot flashes: a review. Canadian Journal of Physiology and Pharmacology1987;65(6):1312‐24. ">Kronenberg 1987</a>). </p> <p>The prevalence of vasomotor symptoms varies with ethnicity. Flushes are less common among East Asian women (median 16%) than among American and European women (median 55%) (<a href="./references#CD001395-bbs2-0137" title="FreemanEW , SherifK . Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric2007;10:197‐214. ">Freeman 2007</a>). Up to 40% of Western women are affected severely enough to seek medical help (<a href="./references#CD001395-bbs2-0137" title="FreemanEW , SherifK . Prevalence of hot flushes and night sweats around the world: a systematic review. Climacteric2007;10:197‐214. ">Freeman 2007</a>; <a href="./references#CD001395-bbs2-0140" title="GoldEB , ColvinA , AvisN , BrombergerJ , GreendateGA , PowellL , et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. American Journal of Public Health2006;96(7):1226‐35. ">Gold 2006</a>). An Australian prospective study with 13‐year follow‐up reported that the mean duration of troublesome vasomotor symptoms was 5.5 years (<a href="./references#CD001395-bbs2-0130" title="ColNF , GuthrieJR , PolitiM , DennersteinL . Duration of vasomotor symptoms in middle aged women: a longitudinal study. Menopause2009;16:453‐7. ">Col 2009</a>). A study of more than 10,000 British women 54 to 65 years of age found that more than half (54%) were currently experiencing vasomotor symptoms (averaging 34 hot flushes or night sweats per week), which were problematic in 40% of cases and were fairly stable across the age range (<a href="./references#CD001395-bbs2-0148" title="HunterMS , Gentry‐MaharajA , RyanA , BurnellM , LanceleyA , FraserL , et al. Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross‐sectional cohort study of 10 418 British women aged 54–65. BJOG2012;119:40‐50. ">Hunter 2012</a>). Although hot flushes are reported as more prevalent and intense in the perimenopausal and early postmenopausal years, they continue to be important in up to 14.6% of women in their sixties and in 8.6% of women in their seventies (<a href="./references#CD001395-bbs2-0170" title="RoussouwJE , PrenticeRL , MansonJE . Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA2007;297:1465‐77. ">Roussouw 2007</a>). </p> </section> <section id="CD001395-sec-0045"> <h3 class="title" id="CD001395-sec-0045">Description of the intervention</h3> <p>Most therapies designed to combat menopausal vasomotor symptoms aim to supplement levels of circulating oestrogen (<a href="./references#CD001395-bbs2-0179" title="SikonA , ThackerHL . Treatment options for menopausal hot flashes. Seminars in Reproductive Medicine2004;71:578‐82. ">Sikon 2004</a>). The treatment of choice has traditionally been hormone therapy (HT), but, despite its effectiveness for symptom reduction, a marked and global decline has occurred in the prescription and use of HT because of concerns about long‐term use, particularly worry about increased risk of chronic diseases (<a href="./references#CD001395-bbs2-0124" title="BestulMB , McCollumM , HansenLB , SaseenJJ . Impact of the women's health initiative trial results on hormone replacement therapy. Pharmacotherapy2004;24(4):495‐9. ">Bestul 2004</a>; <a href="./references#CD001395-bbs2-0143" title="HaasJS , KaplanCP , GerstenbergerEP , KerlikowskeK . Changes in the use of postmenopausal hormone therapy after the publication of clinical trial results. Annals of Internal Medicine2004;140(3):184‐8. ">Haas 2004</a>; <a href="./references#CD001395-bbs2-0184" title="TraversC , O'NeillSM , KhooS‐K , KingR . Hormones down under. Hormone therapy use after the Women's Health Initiative. Australian and New Zealand Journal of Obstetrics and Gynaecology2006;46:330‐5. ">Travers 2006</a>). Although the combination of HT and unopposed oestrogen therapy was previously prescribed to prevent the onset of cardiovascular events as women grew older, a report of the Women's Health Initiative (WHI) trial, in 2002, indicated that the risks of this treatment outweighed the benefits (<a href="./references#CD001395-bbs2-0169" title="RoussouwJE , AndersonGL , PrenticeRL , LaCroixAZ , KooperbergC , StefanickML , et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized trial. JAMA 288;3:321‐33. ">Roussouw 2002</a>). Combined therapy was linked with increased risk of breast cancer, stroke, thromboembolism (blood clots), gallbladder disease and dementia. Unopposed oestrogen therapy increased the risk of stroke, thromboembolism and gallbladder disease, and other studies reported an increase in the incidence of breast cancer (<a href="./references#CD001395-bbs2-0123" title="BeralV . Breast cancer and hormone replacement therapy in the Million Women Study. Lancet2003;362(9382):419‐27. ">Beral 2003</a>). Data now available from 11 years of follow‐up provided by WHI show that risks are influenced by the age of the woman, the time since menopause and whether the HT was combined or consisted of oestrogen only (<a href="./references#CD001395-bbs2-0166" title="North American Menopause Society. The 2012 hormone therapy position statement of the North American Menopause Society. Menopause2012;19(3):257‐71. ">NAMS 2012</a>). Contraindications to HT include a family history or increased risk of cardiovascular disease, blood clotting disorders, venous thromboembolism or certain hormone‐sensitive cancers (<a href="./references#CD001395-bbs2-0118" title="AndersonGL , JuddHL , KaunitzAM , BaradDH , BeresfordSA , PettingerM , et al. Effects of estrogen plus progestin on gynecologic cancers and associated diagnostic procedures: the Women's Health Initiative randomized trial. JAMA2003;290(13):1739‐48. ">Anderson 2003</a>; <a href="./references#CD001395-bbs2-0142" title="GradyD , WengerNK , HerringtonD , KhanS , FurbergC , HunninghakeD , et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/Progestin Replacement Study. Annals of Internal Medicine2000;132(9):689‐96. ">Grady 2000</a>). Some women report adverse effects when taking HT (<a href="./references#CD001395-bbs2-0121" title="BakkenK , EggenAE , LundE . Side‐effects of hormone replacement therapy and influence in pattern of use among women aged 45‐64 years. The Norwegian Women and Cancer (NOWAC) study 1997. Acta Obstetrica Gynecologica Scandinavica2004;83(9):850‐6. ">Bakken 2004</a>; <a href="./references#CD001395-bbs2-0125" title="BjornI , BacksromT . Drug related negative side‐effects is a common reason for poor compliance in hormone replacement therapy. Maturitas1999;32(2):77‐86. ">Bjorn 1999</a>); potential side effects include breast tenderness, bloating and genital bleeding. Regulatory bodies around the world are now advocating that HT should be prescribed only in the smallest dose and for the shortest possible time (<a href="./references#CD001395-bbs2-0134" title="European Medicines Agency. Evaluation of medicines for human use: guidelines for hormone replacement therapy. www.emea.eu.int (accessed on 20 January 2006). ">Europ Med Ag 2006</a>; <a href="./references#CD001395-bbs2-0185" title="Medicines and Healthcare Products Regulatory Agency. Hormone‐replacement therapy: safety update—UK Public Assessment Report. http://www.mhra.gov.uk/Safetyinformation/Generalsafetyinformationandadvice/Product‐specificinformationandadvice/Product‐specificinformationandadvice‐G‐L/Hormonereplacementtherapy%28HRT%29/ (accessed 26 June 2013). ">UK MHRA 2007</a>). </p> <p>Potential health risks associated with HT and further uncertainty surrounding actual benefits to be gained from it have caused many women to seek non‐medical alternatives (<a href="./references#CD001395-bbs2-0120" title="BairYA , GoldEB , AzariRA , et al. Use of conventional and complementary health care during the transition to menopause: longitudinal results from the Study of Women's Health Across the Nation (SWAN). Menopause2005;12:31‐9. ">Bair 2005</a>; <a href="./references#CD001395-bbs2-0168" title="NewtonKM , BuistDSM , KeenanNL , AndersonLA , LaCroixAZ . Use of alternative therapies for menopause symptoms: results of a population‐based survey. Obstetrics and Gynecology2002;100:18‐25. ">Newton 2002</a>). 'Natural' therapies appear to be very popular among women; a survey of 866 women 45 to 65 years of age reported that 61% agreed or strongly agreed with the statement that natural approaches are better than hormone pills for menopausal symptoms (<a href="./references#CD001395-bbs2-0168" title="NewtonKM , BuistDSM , KeenanNL , AndersonLA , LaCroixAZ . Use of alternative therapies for menopause symptoms: results of a population‐based survey. Obstetrics and Gynecology2002;100:18‐25. ">Newton 2002</a>). In a national survey on women's use of complementary alternative medicine (CAM), more than 50% of CAM users indicated that such use was consistent with their beliefs, and 55% said that they wanted a natural approach to treatment (<a href="./references#CD001395-bbs2-0129" title="ChaoMT , WadeC , KronenbergF , KalmussD , CushmanLF . Women's reasons for complementary and alternative medicine use: racial/ethnic differences. Journal of Alternative and Complementary Medicine2006;12(8):719‐22. ">Chao 2006</a>). </p> <p>However, sufficient research on the risks and benefits of these approaches is lacking. A survey of women seen at a university clinic reported that 70% of women taking dietary supplements did not inform their doctors about their use, and only 4% had received information about such supplements from a healthcare provider (<a href="./references#CD001395-bbs2-0158" title="MahadyGB , ParrotJ , LeeC , YunGS , DanA . Botanical dietary supplement use in peri‐ and postmenopausal women. Menopause2003;10:65‐72. ">Mahady 2003</a>). In a national survey, when women using CAM for menopausal symptoms consulted a doctor, their disclosure rate (of CAM) was much higher, with only 36% of women reporting that they did not disclose their self treatment with CAM to their doctors (<a href="./references#CD001395-bbs2-0187" title="WadeC , ChaoM , KronenbergF , CushmanL , KalmussD . Medical pluralism among American women: results of a national survey. Journal of Women's Health2008;17(5):829‐40. ">Wade 2008</a>). </p> <p>Therapies based on phytoestrogens are among the most common alternatives to HT. Phytoestrogens are nonsteroidal plant compounds of diverse structure that are found in many fruits, vegetables and grains (<a href="./references#CD001395-bbs2-0151" title="KnightD , EdenJA . A review of the clinical effects of phytoestrogens. Obstetrics and Gynecology1996;87:897‐904. ">Knight 1996</a>; <a href="./references#CD001395-bbs2-0183" title="ThompsonLU , RobbP , SerrainoM . Mammalian lignan production from various foods. Nutrition and Cancer1991;16:43‐52. ">Thompson 1991</a>). The most common types of phytoestrogens are coumestans, lignans and isoflavones. These compounds structurally resemble oestradiol (E2) and are shown to have weak oestrogenic activity (<a href="./references#CD001395-bbs2-0159" title="MakelaS , DavisVL , TallyWC . Dietary estrogens act through estrogen‐receptor mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environmental Health Perspectives1994;102:572‐8. ">Makela 1994</a>; <a href="./references#CD001395-bbs2-0176" title="SetchellKDR . Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. American Journal of Clinical Nutrition1998;68(Suppl):1333‐46. ">Setchell 1998</a>). When ingested in relatively large quantities, dietary phytoestrogens have been shown to have significant biological effects in several animal species (<a href="./references#CD001395-bbs2-0116" title="AdlercreutzH . Phytoestrogens: epidemiology and a possible role in cancer protection. Environmental Health Perspectectives1995;103(Suppl 7):103‐12. ">Adlercreutz 1995</a>) and in humans (<a href="./references#CD001395-bbs2-0189" title="WilcoxG , WahlqvistML , BurgerHG , MedleyG . Oestrogenic effects of plant foods in postmenopausal women. BMJ1990;301:905‐6. ">Wilcox 1990</a>). In humans, they appear to have both oestrogenic and anti‐oestrogenic effects, depending on the concentrations of circulating endogenous oestrogens and oestrogen receptors (<a href="./references#CD001395-bbs2-0127" title="BolegoC , PoliA , CignarellaA , PaolettiR . Phytoestrogens: pharmacological and therapeutic perspectives. Current Drug Targets2003;4:77‐87. ">Bolego 2003</a>). </p> <p>Isoflavones are among the most oestrogenically potent phytoestrogens; the major dietary isoflavones, genistein and daidzein, are found almost exclusively in legumes such as soy, chick peas, lentils and beans (<a href="./references#CD001395-bbs2-0128" title="CassidyA , BinghamS , CarlsonJ , SetchellKDR . Biological effects of plant estrogens in premenopausal women. FASEB J1993;A:866. ">Cassidy 1993</a>). Urinary excretion of equol, a weak oestrogen, in humans eating soy‐supplemented diets can greatly exceed the concentration of urinary endogenous oestrogens; this enhances the plausibility of human physiological health effects (<a href="./references#CD001395-bbs2-0174" title="SetchellKDR , BorrielloSP , HulmeP , KirkDN , AxelsonM . Nonsteroidal oestrogens of dietary origin: possible role in hormone dependent disease. American Journal of Clinical Nutrition1984;2:49‐56. ">Setchell 1984</a>). Other classes of phytoestrogens—lignans and prenylated flavonoids—also have potent oestrogenic activity but are not as well studied (<a href="./references#CD001395-bbs2-0114" title="AdlercreutzH , HockerstedtK , BannwartC , BloiguS , HamalainenE , FotsisT , et al. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone blinding globulin (SHBG). Journal of Steroids and Biochemistry1987;27:1135‐44. ">Adlercreutz 1987</a>; <a href="./references#CD001395-bbs2-0161" title="MilliganSR , KalitaJC , HeyerickA , RongH , DeCoomanL , DeKeukeleireD . Identification of a potent phytoestrogen in hops (Humulus luputus L.) and beer. Journal of Clinical Endocrinology and Metabolism1999;84:2249‐52. ">Milligan 1999</a>). Soy, a particularly abundant source of isoflavones, is a staple ingredient in the traditional Asian diet. It is postulated that high intake of soy among Asian women may account for lower rates of some menopausal symptoms in this group. Asian populations, such as those in Japan, Taiwan and Korea, are estimated to consume 20 to 150 mg per day of isoflavones, with a mean of about 40 mg from tofu (soy bean curd) and miso (soy bean paste). Soy includes such products as tofu, miso, aburage (fried thin tofu) and fermented or boiled soy beans. Further evidence that soy might be beneficial is suggested by a cohort study of Japanese women (<a href="./references#CD001395-bbs2-0163" title="NagataC , TakatsukaN , KawakamiN , ShimizuH . Soy product intake and hot flashes in Japanese women: results from a community‐based prospective study. American Journal of Epidemiology2001;153:790‐3. ">Nagata 2001</a>), which found a significant inverse association between frequency of flushes and higher levels of soy consumption. However, the findings of this study are contradicted by data from a cross‐sectional study, which found that women who frequently consumed soy products were not less likely to report hot flushes or night sweats than women who never consumed soy products (<a href="./references#CD001395-bbs2-0178" title="SievertLL , MorrisonL , BrownDE , RezaAM . Vasomotor symptoms among Japanese‐American and European‐American women living in Hilo, Hawaii. Menopause2007;14(2):261‐9. ">Sievert 2007</a>). Thus it is not clear whether frequent soy consumption explains the lower rate of hot flushes among different ethnic groups. Red clover (<i>Trifolium pratense</i>), another source of isoflavones, contains compounds that are metabolised to genistein and daidzein after consumption. The most studied red clover product is Promensil. </p> <p>Potential adverse effects of phytoestrogens have included deficits in sexual behaviour in rats and impaired fertility in livestock (<a href="./references#CD001395-bbs2-0122" title="BennettsHW , UnderwoodEJ , ShierFL . A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Australian Vetinary Journal1946;22:2‐12. ">Bennetts 1946</a>). No specific examples of toxicity among humans have been noted in countries in which soy is consumed regularly (<a href="./references#CD001395-bbs2-0175" title="SetchellKDR , Zimmer‐NechemiasL , CaiJ , HeubiJE . Exposure of infants to phytoestrogens from soy‐based infant formula. Lancet1997;350:23‐7. ">Setchell 1997</a>). It is generally considered difficult for humans to consume the quantity of isoflavones from natural soy foods needed to reach toxicological levels that induce pathological effects, as recorded in animals. </p> </section> <section id="CD001395-sec-0046"> <h3 class="title" id="CD001395-sec-0046">How the intervention might work</h3> <p>No clear explanation is known for how phytoestrogens might work in reducing hot flushes among perimenopausal and postmenopausal women. </p> <p>It has been suggested that phytoestrogens act as selective oestrogen receptor modulators (SERMs), exerting anti‐oestrogenic effects in the high‐oestrogen environment of premenopause and oestrogenic effects in the low‐oestrogen environment of postmenopause, where they act as weak agonists by stimulating oestrogen receptors (<a href="./references#CD001395-bbs2-0173" title="SeibelMM . Treating hot flushes without hormone replacement therapy. Journal of Family Practice2003;52(4):291‐6. ">Seibel 2003</a>). Phytoestrogens appear to show greater affinity for the oestrogen receptor beta (ERβ) than for the classical oestrogen receptor alpha (ERα). As a result, they preferentially express oestrogenic effects in the central nervous system, blood vessels, bone and skin without causing stimulation of the breast or uterus (<a href="./references#CD001395-bbs2-0155" title="KuiperG , CarlssonB , GrandienK , et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology1997;138:863‐70. ">Kuiper 1997</a>). Thus, phytoestrogens may reduce vasomotor symptoms through their action on the vascular system without causing unwanted oestrogenic effects on other body systems. </p> </section> <section id="CD001395-sec-0047"> <h3 class="title" id="CD001395-sec-0047">Why it is important to do this review</h3> <p>Current use of phytoestrogen products among perimenopausal and postmenopausal women with vasomotor symptoms is high; an American cross‐sectional analysis of more than 2,000 women (Study of Women's Health Across the Nation (SWAN)) reported that 11% of women with vasomotor symptoms used flaxseed products and 19% used soy products (<a href="./references#CD001395-bbs2-0141" title="GoldEB , BairY , ZhangG , UttsJ , GreendateGA , UpchurchD , et al. Cross‐sectional analysis of specific complementary and alternative medicine (CAM) use by racial/ethnic group and menopausal status: the Study of Women's Health Across the Nation (SWAN). Menopause2007;14(4):612‐23. ">Gold 2007</a>). Several reviews have examined the efficacy of phytoestogen products in alleviating menopausal symptoms, but most have found no benefit or a very slight reduction in the frequency of daily hot flushes compared with placebo. Government agencies and healthcare organisations have also scrutinised the effects of phytoestrogens, particularly isoflavones (<a href="./references#CD001395-bbs2-0117" title="AFSSA Working Group. Safety and benefit of phytoestrogens—recommendations. INSERM‐CRLC M France2005:1‐8. ">AFSSA 2005</a>; <a href="./references#CD001395-bbs2-0131" title="Committee on Toxicity. Phytoestrogens and health. London, 2003:1‐444. ">Com Tox 2003</a>). The North American Menopause Society (NAMS) position statement on the treatment of menopause‐associated vasomotor symptoms suggests that women should consider isoflavone supplementation if their menopausal flushing does not respond to other interventions (<a href="./references#CD001395-bbs2-0164" title="North American Menopause Society. Treatment of menopause‐associated vasomotor symptoms: position statement of the North American Menopause Society. Menopause2004;11(1):11‐33. ">NAMS 2004</a>; <a href="./references#CD001395-bbs2-0165" title="North American Menopause Society. The role of soy isoflavones in menopausal health: report of the North American Menopause Society. Menopause2011;18(7):732‐53. ">NAMS 2011</a>). However, NAMS acknowledges that the evidence base for this recommendation is poor. </p> <p>Thus, the aim of this review is to synthesise all available evidence on the efficacy, safety and acceptability of products containing phytoestrogens to assist women with vasomotor menopausal symptoms to reduce their symptoms by making good evidence‐based treatment decisions. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001395-sec-0048" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001395-sec-0048"></div> <p>To determine the efficacy, safety and acceptability of food products, extracts and dietary supplements containing high levels of phytoestrogens when compared with no treatment, placebo or hormone therapy for the amelioration of vasomotor menopausal symptoms (such as hot flushes and night sweats) in perimenopausal and postmenopausal women. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001395-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001395-sec-0049"></div> <section id="CD001395-sec-0050"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001395-sec-0051"> <h4 class="title">Types of studies</h4> <p>All randomised controlled comparisons of food products, extracts or dietary supplements containing high levels of phytoestrogens (e.g. at least 30 mg/d of isoflavones) versus placebo, HT, no treatment or products containing low levels of phytoestrogens for the alleviation of vasomotor menopausal symptoms. </p> </section> <section id="CD001395-sec-0052"> <h4 class="title">Types of participants</h4> <p><b><i>Inclusion criteria</i> </b> </p> <p> <ul id="CD001395-list-0001"> <li> <p>Perimenopausal women, defined as women in the 45‐ to 55‐year age range, who have menstruated within the past 12 months and are seeking treatment for menopausal vasomotor symptoms </p> </li> <li> <p>Postmenopausal women, defined as women who are older than 45 years of age, who have not menstruated for longer than 12 months and are seeking treatment for menopausal symptoms </p> </li> </ul> </p> <p>Women experiencing spontaneous or surgical menopause (bilateral oophorectomy (removal of both ovaries)) were eligible. Trials were eligible only when most women had vasomotor symptoms. </p> <p><b><i>Source of recruitment</i> </b><br/> Any healthcare setting or the community </p> <p><b><i>Exclusion criteria</i> </b> </p> <p> <ul id="CD001395-list-0002"> <li> <p>Intercurrent major disease</p> </li> <li> <p>Previous HT (hormone therapy) within one month of commencement of the study or an oestrogen implant within the past year </p> </li> <li> <p>Women with breast cancer or a history of breast cancer</p> </li> <li> <p>Women with no or inconsequential vasomotor symptoms at baseline</p> </li> </ul> </p> </section> <section id="CD001395-sec-0053"> <h4 class="title">Types of interventions</h4> <p>All food products or dietary supplements containing high levels of phytoestrogens (&gt; 30 mg/d of isoflavones, &gt; 100 µg 8‐prenylnaringenin or &gt; 10,000 µg total lignans) versus placebo, hormone therapy, no treatment or food products with low levels of phytoestrogens given as perimenopausal or postmenopausal therapy for the alleviation of vasomotor menopausal symptoms for a period of at least 12 weeks. Studies in which phytoestrogens were combined with other therapies were excluded. </p> </section> <section id="CD001395-sec-0054"> <h4 class="title">Types of outcome measures</h4> <section id="CD001395-sec-0055"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD001395-list-0003"> <li> <p>Efficacy</p> </li> </ul> <ul class="plain" id="CD001395-list-0004"> <li> <ul id="CD001395-list-0005"> <li> <p>Change in vasomotor menopausal symptom scores (without distinction between types of vasomotor symptoms) </p> </li> <li> <p>Change in frequency of individual vasomotor symptoms or severity of individual vasomotor symptom scores (e.g. hot flushes and night sweats) </p> </li> <li> <p>Incidence of vasomotor symptoms (hot flushes and night sweats) after treatment</p> </li> </ul> </li> </ul> </p> <p>Studies were included if they measured vasomotor symptoms on a subscale of a compendium score, for example, Greene Score, Kupperman Index, Nordin Score, MacLennan Score or any other general menopausal symptom score that derives numerical results from a combination of vasomotor menopausal symptoms. </p> <p>In addition, studies were included that measured individual vasomotor symptoms, for example, severity or frequency, or both, of hot flushes and night sweats (evaluated subjectively by participants, usually in daily diaries). </p> </section> <section id="CD001395-sec-0056"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD001395-list-0006"> <li> <p>Safety</p> </li> </ul> <ul class="plain" id="CD001395-list-0007"> <li> <ul id="CD001395-list-0008"> <li> <p>Stimulation of the endometrium (endometrial thickness, rates of atrophic endometrium)</p> </li> </ul> </li> </ul> <ul class="plain" id="CD001395-list-0009"> <li> <ul id="CD001395-list-0010"> <li> <p>Vaginal stimulation (pH, maturation value)</p> </li> <li> <p>Adverse events</p> </li> </ul> </li> </ul> <ul id="CD001395-list-0011"> <li> <p>Acceptability</p> </li> </ul> <ul class="plain" id="CD001395-list-0012"> <li> <ul id="CD001395-list-0013"> <li> <p>Acceptability of therapy (withdrawal due to adverse events or satisfaction rates)</p> </li> </ul> </li> </ul> </p> <p>Studies were included if they measured specific safety outcomes, such as measures of physiological oestrogenicity of the endometrium and vagina. Other possible safety outcomes could be measured that are related to the effects of oestrogen action on other tissue and organs, but these will be assessed in future reviews if evidence of a beneficial effect on symptoms is noted. </p> </section> </section> </section> <section id="CD001395-sec-0057"> <h3 class="title">Search methods for identification of studies</h3> <p>The Trials Search Co‐ordinator designed the search strategy for use with the electronic databases. The complete search strategies are listed in the Appendices of this review. </p> <section id="CD001395-sec-0058"> <h4 class="title">Electronic searches</h4> <p>The Trials Search Co‐ordinator of the Menstrual Disorders and Subfertility Group (MDSG) searched for all published and unpublished randomised controlled trials (RCTs) of phytoestrogens for vasomotor symptoms, with no language restriction, using the following electronic databases. </p> <p> <ul id="CD001395-list-0014"> <li> <p>MEDLINE (see <a href="./appendices#CD001395-sec-0138">Appendix 1</a>). </p> </li> <li> <p>EMBASE (see <a href="./appendices#CD001395-sec-0139">Appendix 2</a>). </p> </li> <li> <p>PsycInfo (see <a href="./appendices#CD001395-sec-0140">Appendix 3</a>). </p> </li> <li> <p>AMED (see <a href="./appendices#CD001395-sec-0141">Appendix 4</a>). </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (see <a href="./appendices#CD001395-sec-0142">Appendix 5</a>). </p> </li> <li> <p>MDSG Specialised Register of Controlled Trials (see <a href="./appendices#CD001395-sec-0143">Appendix 6</a>). </p> </li> </ul> </p> <p>The principal author of the review (AL) searched the following trial registers and websites. </p> <p> <ul id="CD001395-list-0015"> <li> <p>Trial registers for ongoing and registered trials: http://www.controlled‐trials.com</p> </li> <li> <p>Citation indexes: http://scientific.thomson.com/products/sci</p> </li> <li> <p>Conference abstracts in the Web of Knowledge: http://www.wokinfo.com/</p> </li> <li> <p>LILACS database, for trials from the Portuguese‐ and Spanish‐speaking world: http://bases.bireme.br/cgibin/wxislind.exe/iah/online/?IsisScript=iah/iah.xis&amp;base=LILACS&amp;lang=i&amp;form=F</p> </li> <li> <p>Results from clinical trials of marketed pharmaceuticals: http://www.clinicalstudyresults.org</p> </li> <li> <p>PubMed: http://www.ncbi.nlm.nih.gov/pubmed/</p> </li> <li> <p>OpenSIGLE database: http://opensigle.inist.fr/</p> </li> <li> <p>Google</p> </li> </ul> </p> </section> <section id="CD001395-sec-0059"> <h4 class="title">Searching other resources</h4> <p>The reference lists of retrieved potentially eligible studies and relevant reviews were also searched. Novogen, manufacturer of a standardised extract of phytoestrogens (Promensil), was contacted for details of unpublished trials. </p> </section> </section> <section id="CD001395-sec-0060"> <h3 class="title" id="CD001395-sec-0060">Data collection and analysis</h3> <section id="CD001395-sec-0061"> <h4 class="title">Selection of studies</h4> <p>Trials for inclusion in the review were selected at different times by two review authors (AL and FK, JM or JB) after the search strategy described previously was employed. First, titles and abstracts were scanned, and full‐text copies of those that appeared relevant were retrieved to determine whether they met the inclusion criteria for the review. If necessary, authors of potential trials for inclusion were contacted to clarify study eligibility. Disagreements over selection were resolved by consensus. The selection process for the 2013 update has been documented on a flow chart (<a href="#CD001395-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD001395-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD001395-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD001395-sec-0062"> <h4 class="title">Data extraction and management</h4> <p>Data were extracted independently by at least two review authors (AL and FK, JM or JB), who used a specially designed data extraction form. Any discrepancies in data extraction were resolved by consensus. When necessary, additional information on trial methodology or original trial data were sought from the principal or corresponding author of any trials that met the eligibility criteria (see Acknowledgements for details of the authors who provided additional clarification of data beyond that reported in the publications). </p> <p>Data extracted included details on study characteristics (participants, interventions and comparison groups) and outcome data. When necessary, missing data were imputed from data in other, similar trials or were calculated by using formulas suggested in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD001395-bbs2-0146" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> </section> <section id="CD001395-sec-0063"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>All assessments of risk of bias were performed independently by at least two review authors (AL and FK, JM or JB), who used the Cochrane 'Risk of bias assessment tool' (<a href="./references#CD001395-bbs2-0146" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>); results were compared. Any discrepancies were resolved by consensus. Criteria assessed included randomisation method, allocation concealment, blinding of participants and investigators, blinding of assessors, incomplete outcome data and selective outcome reporting. Summary assessments of risk of bias are presented in <a href="#CD001395-fig-0002">Figure 2</a> and <a href="#CD001395-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD001395-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001395-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD001395-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001395-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <p>Risk of bias assessments have been incorporated into sensitivity analyses (see below).</p> </section> <section id="CD001395-sec-0064"> <h4 class="title">Measures of treatment effect</h4> <p>When trials were combined in a meta‐analysis, summary effect measures were calculated. For dichotomous data, the numbers of events in the intervention and control groups were used to calculate risk ratios (RRs), together with their 95% confidence intervals (CIs). For continuous data, the weighted mean difference (MD) between groups, together with 95% CIs, was calculated. For all other studies, findings in the individual study publications were reported in narrative format and compared. </p> </section> <section id="CD001395-sec-0065"> <h4 class="title">Unit of analysis issues</h4> <p>The primary unit of analysis was per woman randomised. Only first‐phase data from cross‐over trials were analysed. </p> </section> <section id="CD001395-sec-0066"> <h4 class="title">Dealing with missing data</h4> <p>When data were missing, attempts were made to obtain these data from the authors of relevant included studies. Clarifications of data and details from the publications were received from a number of study authors (see <a href="#CD001395-sec-0135">Acknowledgements</a>). </p> </section> <section id="CD001395-sec-0067"> <h4 class="title">Assessment of heterogeneity</h4> <p>We considered whether the clinical and methodological characteristics of included studies were sufficiently similar to warrant meta‐analysis. When meta‐analyses were performed, statistical heterogeneity was assessed by the Chi<sup>2</sup> test (with P &lt; 0.10 considered evidence of statistical heterogeneity) and the I<sup>2</sup> metric. An I<sup>2</sup> value &gt; 50% was considered to represent substantial heterogeneity. </p> </section> <section id="CD001395-sec-0068"> <h4 class="title">Assessment of reporting biases</h4> <p>In view of the difficulty of detecting and correcting for publication bias and other reporting biases, the review authors have attempted to minimise their potential impact by ensuring a comprehensive search for eligible studies and by being alert to duplication of data. No funnel plot was generated, as most of the studies were synthesised narratively because of substantial heterogeneity. </p> </section> <section id="CD001395-sec-0069"> <h4 class="title">Data synthesis</h4> <p>A priori, it was decided that results from the included studies would be combined in meta‐analysis only if similarities were noted in the baseline experience of hot flushes among participants: the composition, type and dosage of the phytoestrogen interventions; the duration of the studies; and the outcomes measured. Significant heterogeneity was seen in the isoflavone concentration of foods and extracts used in the trials that were considered to contain high levels of phytoestrogens. Because of this variation in isoflavone concentration and the variation in the general mix of constituents of each phytoestrogen intervention, pooling of different food products, tablets and extracts was not considered appropriate, and results were reported separately for each trial in table format (see <a href="#CD001395-tbl-0001">Table 1</a><a href="#CD001395-tbl-0002">Table 2</a> and <a href="#CD001395-tbl-0003">Table 3</a>). </p> <div class="table" id="CD001395-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of findings: efficacy outcomes</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No.</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Results (between‐group comparison)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Overall risk of bias</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SOY DIETARY SUPPLEMENTS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0001" title="AlbertazziP , PansiniF , BonaccorsiG , ZanottiL , ForiniE , DeAloysioD . The effect of dietary soy supplementation on hot flushes. Obstetrics and Gynecology1998;91:6‐11. AlbertazziP , PansiniF , BottazziM , BonaccorsiG , deAloysioD , MortonS . Dietary soy suplementation and phytooestrogen levels. Obstetrics and Gynecology1999;94(2):229‐31. PansiniF , AlbertazziP , BonaccorsiG , ZanottiC , CampobassoC , NegriC , et al. Soy and Hot Flushes. 8th International Congress on the Menopause, Sydney, Australia. 3‐7 November 1996. ">Albertazzi 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 g soy powder (76 mg isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (60 g casein)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes/d after treatment; percentage decrease in number of flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At end of study, significant difference between placebo and soy: ‐1.59 (‐1.95 to ‐1.2; P &lt; 0.01), representing mean reduction of 1.6 flushes/d in soy group compared with placebo. 45% reduction in flushes with soy versus 30% reduction with placebo (P &lt; 0.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0004" title="BalkJL , WhitesideDA , NausG , DeFerrariE , RobertsJM . A pilot study of the effects of phytoestrogen supplementation on the postmenopausal endometrium. Journal of the Society for Gynecologic Investigation2002;9:238‐42. ">Balk 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy and corn flour cereal (100 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (wheat cereal)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flush and night sweat symptom score after Rx (1 to 4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS all outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0006" title="BrzezinskiA , AdlercreutzH , ShaoulR , RoslerA , ShmueliA , TanosV , SchenkerJG . Short‐term effects of phytoestrogen‐rich diet on postmenopausal women. Menopause1997;4(2):89‐94. ">Brzezinski 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Phytoestrogen‐enriched diet (individualised by dietician) (isoflavone amount not given)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control—regular diet (avoiding phytoestrogens)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MSQ hot flush severity reduction subscore (0 to 3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Greater reduction with PE‐rich diet (P = 0.004; no CI given)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0007" title="BurkeGL , LegaultC , AnthonyM , BlandDR , MorganTM , NaughtonMJ , et al. Soy protein and isoflavone effects on vasomotor symptoms in peri‐ and postmenopausal women: the Soy Estrogen Alternative Study. Menopause2003;10(2):147‐53. ">Burke 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) soy drink 1 (42 mg/d isoflavones);</p> <p>(2) soy drink 2 (58 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (soy drink with isoflavones removed)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number and severity of flushes/sweats per day after Rx (symptom diary); also subgroup analysis in women with 4+ symptoms/d at baseline </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS all outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0009" title="CarmigianiLO , PedroAO , Cost‐PaivaLH , Pinto‐NetoAM . The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomised controlled trial. Maturitas2010;67:262‐9. ">Carmigiani 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) oestradiol 1 mg + 0.5 mg norethisterone acetate;</p> <p>(2) dietary soy supplementation (90 mg isoflavone) in powder form + placebo tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (identical powder and placebo tablets)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Somatic score (hot flushes, heart discomfort, sleeping problems and muscle and joint problems) on the Menopause Rating Scale </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reduction in somatic symptoms was ‐45.6% with HT and ‐49.8% with dietary soy compared with ‐28.6% with placebo </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0010" title="ChengG , WilczekB , WarnerM , GustafssonJ‐A , LandgrenB‐L . Isoflavone treatment for acute menopausal symptoms. Menopause2007;14(3, Part 1):468‐73. ">Cheng 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) isoflavones 60 mg daily in fruit drink</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (oatmeal drink)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flush and night sweat scores</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant reduction in hot flush score with isoflavones compared with placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0014" title="DalaisFS , RiceGE , WahlqvistML , GrehanM , MurkiesAL , MedleyG , et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric1998;1:124‐9. ">Dalais 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) soy diet (53 mg/d isoflavones);</p> <p>(2) linseed diet (high in isoflavones—quantity not given)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (wheat diet (low isoflavones))</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage decrease in number of hot flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS: 22% reduction with soy; 41% reduction with linseed; 51% reduction with wheat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0021" title="HanachiP , GolkhoS . Assessment of soy phytoestrogens and exercise on lipid profiles and menopause symptoms in menopausal women. Journal of Biological Sciences2008;8(4):789‐93. ">Hanachi 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) soy milk product (12.5 g soy protein with 13 mg genistein and 4.13 mg daidzein);</p> <p>(2) soy milk product + exercise</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flush score on Kupperman Index</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flushes significantly improved with both soy interventions compared with control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0031" title="KnightDC , HowesJB , EdenJA , HowesLG . Effects on menopausal symptoms and acceptability of isoflavone‐containing soy powder dietary supplementation. Climacteric2001;4:13‐8. ">Knight 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy powder 60 g/d for beverage (134.4 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (casein powder for beverage)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per week after Rx</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS: 29 flushes/wk in soy group; 46 flushes/wk in placebo group (reduction in both from baseline) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0032" title="KotsopoulosD , DalaisFS , LiangY‐L , McGrathBP , TeedeHJ . The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric2000;3:161‐7. ">Kotsopoulos 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy powder for beverage (118 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (casein powder for beverage)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flush symptom score (severity) (0 to 3) after Rx</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS: 0.77 score with soy; 0.83 score with placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0034" title="LewisJE , NickellLA , ThompsonLU , SzalaiJP , KissA , HilditchJR . A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause. Menopause2006;13(4):631‐42. ">Lewis 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) soy flour muffins (42 mg/d isoflavones);</p> <p>(2) flaxseed muffins (50 mg/d lignans)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (wheat flour muffins (low lignans and no isoflavones))</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Menoquol vasomotor score; number of flushes per day; severity of flushes (1 to 7 scale) after Rx </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS: all outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0037" title="RadhakrishnanG , AgarwalN , VaidN . Evaluation of isoflavone rich soy protein supplementation for postmenopausal therapy. Pakistan Journal of Nutrition2009;8(7):1009‐17. ">Radhakrishnan 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) soy sachets (25 mg isoflavone soy protein isolate containing 75 mg isoflavones in powder form) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo powder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of daily hot flushes; karyopyknotic index; maturation value; endometrial thickness; acceptability of treatment; adverse events </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significantly greater proportion of women had reduction in hot flushes with soy (84%) when compared with placebo (60%) but no significant difference in hot flush score between groups </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0039" title="StGermainA , PetersonCT , RobinsonJG , AlekelDL . Isoflavone‐rich or isoflavone‐poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause2002;8(1):17‐26. ">St Germain 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) soy protein + (80.4 mg/d isoflavones); (2) soy protein – (4.4 mg/d isoflavones) in muffins and powder for cooking </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (whey protein)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage of participants perceiving a decrease in (1) frequency, (2) duration and (3) severity of flushes; number of flushes per week after Rx; number of sweats per week after Rx </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SOY EXTRACT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0005" title="Bicca ML deO , HortaBL , LethabyAE . Double‐blind randomized clinical trial to assess the effectiveness of soy isoflavones in the relief of climacteric symptoms. ">Bicca 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract (33 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Greene Vasomotor Subscale (intensity); percentage who experienced a decrease in frequency of flushes and sweats from baseline </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS: Greene Vasomotor Scale; 74% with soy versus 43% with placebo had decrease in number of hot flushes (P = 0.007); 68% with soy versus 46% with placebo had decrease in number of night sweats (P = 0.049). NS: severity of symptoms </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0008" title="CampagnoliC , AbbaC , AmbroggioS , PerisC , PeronaM , SanseverinoP . Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement. Maturitas2005;51:127‐34. ">Campagnoli 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract (soy select) (60 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per week after Rx</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0017" title="FaureED , ChantreP , MaresP . Effects of a standardised soy extract on hot flushes: a multicentre, double‐blind, randomised placebo‐controlled study. Menopause2002;9(5):329‐34. ">Faure 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract capsules (70 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage decrease in flushes per day; percentage of 'responders' (participants who had reduction of at least 50%) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61% decrease with soy versus 21% reduction with placebo (P value not reported); 66% of soy group were responders versus 34% in placebo group (P &lt; 0.005). Repeated measures analysis confirmed the soy‐placebo treatment effect </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0020" title="HanKK , SoaresJM , HaidarMA , deLimaGR , BaracatEC . Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstetrics and Gynecology2002;99:389‐94. ">Han 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy capsules (100 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kupperman Vasomotor Symptom Score (severity)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor score 8.2 in soy group versus 9.9 in placebo group (P &lt; 0.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0027" title="JouH‐J , WuS‐C , ChangF‐W , LingP‐Y , ChuKS , WuW‐H . Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones. International Journal of Gynecology and Obstetrics2008;102:44‐9. ">Jou 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy germ extract powder (3 g) twice per day (135 mg isoflavones – 1 g = 10.9 mg daidzein and 2.85 mg genistein) in equol producers and non‐producers </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (roasted wheat powder)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flushes as measured by Kupperman Index</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reduction in hot flush score of 79% in equol producers, 35% in non‐equol producers and 78% in placebo group. Results from equol producers significantly different from placebo by repeated measures analysis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0028" title="KaariC , HaidarMA , Soares JuniorJM , NunesMG , deAzevedo QuadrosLG , KempC , et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas2006;53:49‐58. ">Kaari 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy extract capsules (S40/Ach‐1) (120 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oestrogen + placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage of participants reporting reduction (subgroup)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0029" title="KhaodhiarL , RicciottiHA , LiL , PanW , SchickelM , ZhouJ , et al. Daidzein‐rich isoflavone‐aglycones are effective in reducing hot flashes in menopausal women. Menopause2008;15(1):125‐32. ">Khaodhiar 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy extract capsule (isoflavone quantity not known) (1) 40 mg/d; (2) 60 mg/d</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage reduction in frequency of hot flushes (from daily diary), percentage reduction in severity of hot flushes (daily diary) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52% and 51% reduction in hot flush frequency in 40‐mg and 60‐mg soy groups at 12 weeks compared with 39% reduction with placebo (NS). When both treatment groups were combined, an average reduction of 52% was seen in hot flush frequency per day in women taking soy compared with women taking placebo (P = 0.048) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0033" title="LevisS , Strickman‐SteinN , Ganjei‐AzarP , XuP , DoergeD , KrischerJ . Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms. Archives of Internal Medicine2011;171(15):1363‐8. ">Levis 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Isoflavone tablets 200 mg from soy protein (each tablet 91 mg genistein, 103 mg daidzein)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Menopausal symptoms (hot flushes and night sweats) were secondary outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy isoflavone group: 48.4% had hot flushes; 31.7% in placebo group had hot flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0035" title="NahasE , Nahas‐NetoJ , OrsattiF , CarvalhoE , OliveiraM , DiasR . Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized double‐blind, and placebo controlled study. Maturitas2007;58:249‐58. ">Nahas 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy extract (isoflavones 100 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in daily hot flush number; change in hot flush severity score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant reduction from baseline in number of daily hot flushes in both groups and significantly greater in soy versus placebo. Hot flush severity significantly reduced in soy extract group when compared with placebo </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0036" title="PenottiM , FabioE , ModenaAB , RinaldiM , OmodeiU , ViganoP . Effect of soy‐derived isoflavones on hot flushes, endometrial thickness and the pulsatility index of the uterine and cerebral arteries. Fertility and Sterility2003;79(5):1112‐7. PenottiM , FabioE , RinaldiM , OmodeiU , BacchiM . Effects of soy‐derived isoflavones on hot flushes and vascular reactivity. The 10th World Congress on the Menopause, Berlin, Germany. 10‐14 June 2002:Abstract F‐27‐01. ">Penotti 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy tablets (72 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per day after Rx</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0041" title="UpmalisDH , LoboR , BradleyL , WarrenM , ConeFL , LamiaCA . Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter double‐blind randomized placebo‐controlled study. Menopause2000;7(4):236‐42. ">Upmalis 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract tablets (50 mg/d of genistein and daidzin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage change in flush severity per week; percentage change in flush frequency per week; percentage change in sweat frequency per week </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34% change in severity with soy versus 21% change in severity with placebo (P = 0.01); NS for percentage change in frequency (P = 0.078 repeated measures analysis); NS for change in reduction of night sweats </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0043" title="YeY‐B , WangZ‐L , ZhuoS‐Y , LuW , LiaoH‐F , VerbruggenMA , et al. Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomised placebo‐controlled trial. Menopause2012;19(7):791‐8. ">Ye 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy germ isoflavone extract powder in capsules in two doses (84 mg and 126 mg of isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flush frequency and percentage change per week</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44.3% and 48.5% change in hot flushes from baseline in the 84‐mg and 126‐mg isoflavone groups, respectively, compared with 27.8% change in placebo group (P &lt; 0.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RED CLOVER EXTRACTS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0003" title="BaberRJ , TemplemanC , MortonT , KellyGE , WestL . Randomized placebo‐controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric1999;2:85‐92. ">Baber 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Promensil (standardised red clover extract) (40 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per day after Rx; percentage flush reduction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0015" title="DelGiornoC , Maggio da FonsecaA , BagnoliVR , Serrano de AssisJ , SoaresJM , BaracatEC . Effects of trifolium pratense on climacteric and sexual symptoms in postmenopausal women. Revista da Associacao Medica Brasileira2010;56(5):558‐62. ">Del Giorno 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Trifolium pratense</i> (red clover) 40 mg </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor symptoms (Kupperman Index)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0019" title="GellerSE , ShulmanLP , vanBreemenRB , BanuvarS , ZhouY , EpsteinG , et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomised controlled trial. Menopause2009;16(6):1156‐66. ">Geller 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) 0.625 mg CEE + 2.5 mg MPA;</p> <p>(2) Black cohosh (128 mg/d);</p> <p>(3) Red clover (398 mg/d including 120 mg isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor symptoms (hot flushes and night sweats); frequency of hot flushes; intensity of hot flushes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS: black cohosh and red clover versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0024" title="HidalgoLA , ChedrauiPA , MorochoN , RossS , San MiguelG . The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double‐blind, placebo‐controlled study. Gynecological Endocrinology2005;21(5):257‐64. ">Hidalgo 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Red clover supplement capsules (80 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kupperman Index score for hot flushes and sweats (severity) (expressed as percentage)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flushes: 15% with red clover versus 98% with placebo; night sweats: 30% with red clover versus 93% with placebo; P value not given </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0025" title="ImhofM , GocanA , ReithmayerF , LipovacM , SchimitzekC , ChedrauiP , et al. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas2006;55:76‐81. LipovacM , ChedrauiP , GruenhutC , GocanA , KurzC , NeuberB , et al. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women. Gynecological Endocrinology2012;28(3):203‐7. ">Imhof 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Red clover extract capsules (80 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90 days + 7 days washout + 90 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flush daily frequency, night sweats daily frequency</p> <p>Mean percentage decrease in hot flushes and night sweats</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean (SD) daily frequency (hot flushes) in red clover group (3.1 (3.5)); in placebo group (10.1 (5.5)) </p> <p>Mean (SD) daily frequency (night sweats) in red clover group (1.5 (2.1)); in placebo group (5.0 (2.6)) </p> <p>Mean percentage decrease in hot flushes in red clover group 73.5%; in placebo group 8.2% </p> <p>Mean percentage decrease in night sweats in red clover group 72.2%; in placebo group 0.9% </p> <p>All differences significant (P = 0.0001)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0026" title="JeriA . The use of an isoflavone supplement to relieve hot flushes. The Female Patient2002;27:47‐9. ">Jeri 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Promensil (standardised red clover extract) (40 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage reduction in number of flushes per day; severity of flushes per day (scale)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Frequency: 49% reduction with red clover versus 11% reduction with placebo (P &lt; 0.001); severity: reduction from 2.53 to 1.33 with red clover versus no reduction with placebo (P &lt; 0.001) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0030" title="KnightDC , HowesJB , EdenJA . The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric1999;2:79‐84. ">Knight 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Promensil (standardised red clover extract) (40 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0040" title="TiceJA , EttingerB , EnsrudK , WallaceR , BlackwellT , CummingsSR . Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. JAMA2003;290(2):207‐14. ">Tice 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) Promensil (standardised red clover extract) (82 mg/d isoflavones—two tablets);</p> <p>(2) Rimostil (standardised red clover extract) (57 mg/d isoflavones—two tablets)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per day; percentage reduction in flushes; rate of reduction over time </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per day NS; percentage reductions NS; Promensil had faster reduction over time versus placebo (P = 0.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0042" title="van deWeijerPHM , BarentsenR . Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas2002;42:187‐93. ">van de Weijer 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Promensil (standardised red clover extract) (80 mg/d isoflavones—two tablets)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per day; median percentage change in number of flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.4 flushes/d with Promensil versus 6 flushes/d with placebo (P value not reported); 44% reduction with Promensil versus 0% reduction with placebo (P = 0.01; variation not reported) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GENISTEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0012" title="CrisafulliA , MariniH , BittoA , AltavillaD , SquadritoG , RomeoA , et al. Effects of genistein on hot flushes in early postmenopausal women: a randomized, double‐blind EPT‐ and placebo‐ controlled study. Menopause2004;11:400‐4. ">Crisafulli 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) genistein extract (54 mg/d isoflavones);</p> <p>(2) continuous HT (17B‐ostradiol 1 mg/d + norethisterone acetate)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage change in number of flushes per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24% reduction with genistein when compared with placebo (P &lt; 0.01); 30% reduction with HT when compared with genistein (P &lt; 0.05) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0013" title="D'AnnaR , CannataM , AtteritanoM , CancellieriF , CorradoF , BavieraG , et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1 year randomized, double‐blind, placebo controlled study. Menopause2007;14(4):648‐55. D'AnnaR , CannataML , MariniH , AtteritanoM , CancellieriF , CorradoF , et al. Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2‐year randomised, double‐blind, placebo‐controlled study. Menopause2009;16(2):301‐6. ">D'Anna 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Genistein extract twice per day (each tablet containing 27 mg total isoflavone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number and severity of hot flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant reduction in frequency (56.4%) and severity (37.5%) of hot flushes compared with placebo </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0016" title="EvansM , EllitoJG , SharmaP , BermanR , GuthrieN . The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi‐center, randomised, placebo‐controlled study. Maturitas2011;68:189‐96. ">Evans 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Genistein (geniVida) 30 mg once daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage change in number of daily hot flushes; duration and severity of daily hot flushes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant reduction in frequency (51.2% vs 27.2%) and duration of hot flushes (12 minutes/d vs 23 minutes/d) at the end of treatment compared with placebo. NS severity of hot flushes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0018" title="FerrariA . Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. Journal of Obstetric and Gynaecological Research2009;35(6):1083‐90. ">Ferrari 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy isoflavone extract (80 mg) with high dose of genistein (60 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in daily frequency of hot flushes; improvement (as assessed by investigator)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant reduction in number of hot flushes in genistein group (41.2%) when compared with placebo (29.3%); improvement in genistein group 56.7% and in placebo group 53.1% (P value not reported) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OTHER PHYTOESTROGENS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0002" title="AsoT . Equol improves menopausal symptoms in Japanese women. Journal of Nutrition2010;140:1386S‐9S. AsoT , UchiyamaS , MatsumuraY , TaguchiM , NozakiM , TakamatsuK , et al. A natural S‐Equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women. Journal of Women's Health2012;21(1):92‐100. ">Aso 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Natural S‐(‐)equol supplement twice per day (5.0 mg equol, 1.2 mg daidzein, 1.4 mg genistein) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in frequency and severity of hot flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant reduction in frequency of hot flushes with equol supplement (62.8%) compared with placebo (23.6%) in women with more than three hot flushes per day. Significant improvement in severity of hot flushes with equol supplement (61.2%) when compared with placebo (45%) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0011" title="ColliMC , BrachtA , SoaresAA , deOliveiraAL , BoerCG , deSouzaCGM , et al. Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. Journal of Medicinal Food2012;15(9):840‐5. ">Colli 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Flaxseed extract (1 g/d) (at least 100 mg secoisolariciresinol diglucoside (SDG)) and flaxseed meal (90 g/d) (at least 270 mg SDG) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (1 g/d collagen)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intensity of hot flush score (Kupperman Index)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In both flaxseed groups, hot flush intensity score was reduced significantly from baseline, but no significant difference was seen in the placebo group. Comparison of groups by ANOVA showed no significant difference between groups at end of study </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0014" title="DalaisFS , RiceGE , WahlqvistML , GrehanM , MurkiesAL , MedleyG , et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric1998;1:124‐9. ">Dalais 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See above for results in the flaxseed arm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0022" title="HegerM , VentskovskiyBM , BorzenkoI , KneisKC , RettenbergerR , Kaszkin‐BettagM , et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12‐week randomised double‐blind placebo‐controlled trial. Menopause2006;13(5):744‐59. ">Heger 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Extract of ERr 731, an extract of the roots of <i>Rheum rhaponticum</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Changes in number and severity of hot flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number and frequency of hot flushes significantly reduced with ERr 731 compared with placebo (P &lt; 0.0001) (average of 5.5 fewer per day compared with 0 fewer per day) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0023" title="HeyerickA , VervarckeS , DepypereH , BrackeM , DeKeukeleireD . A first prospective, randomized, double‐blind, placebo‐controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas2006;54:164‐75. ">Heyerick 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) Hop extract 1 (100 μg 8‐prenylnaringenin);</p> <p>(2) Hop extract 2 (250 μg 8‐prenylnaringenin) (Menohop)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kupperman hot flush score (severity)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS at the end of the study period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0034" title="LewisJE , NickellLA , ThompsonLU , SzalaiJP , KissA , HilditchJR . A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause. Menopause2006;13(4):631‐42. ">Lewis 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See above for results in the flaxseed arm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CEE: conjugated equine oestrogen.</p> <p>MPA: medroxyprogesterone acetate.</p> </div> </div> <div class="table" id="CD001395-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of findings: safety outcomes</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No.</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Safety outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Results (between‐group comparison)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Overall risk of bias</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SOY DIETARY SUPPLEMENTS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0001" title="AlbertazziP , PansiniF , BonaccorsiG , ZanottiL , ForiniE , DeAloysioD . The effect of dietary soy supplementation on hot flushes. Obstetrics and Gynecology1998;91:6‐11. AlbertazziP , PansiniF , BottazziM , BonaccorsiG , deAloysioD , MortonS . Dietary soy suplementation and phytooestrogen levels. Obstetrics and Gynecology1999;94(2):229‐31. PansiniF , AlbertazziP , BonaccorsiG , ZanottiC , CampobassoC , NegriC , et al. Soy and Hot Flushes. 8th International Congress on the Menopause, Sydney, Australia. 3‐7 November 1996. ">Albertazzi 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 g soy powder (76 mg isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (60 g casein)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0004" title="BalkJL , WhitesideDA , NausG , DeFerrariE , RobertsJM . A pilot study of the effects of phytoestrogen supplementation on the postmenopausal endometrium. Journal of the Society for Gynecologic Investigation2002;9:238‐42. ">Balk 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy and corn flour cereal (100 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (wheat cereal)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial stimulation; adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial stimulation: NS (all participants had atrophic endometrium). Adverse events: NS </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0009" title="CarmigianiLO , PedroAO , Cost‐PaivaLH , Pinto‐NetoAM . The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomised controlled trial. Maturitas2010;67:262‐9. ">Carmigiani 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) oestradiol 1 mg + 0.5 mg norethisterone acetate;</p> <p>(2) dietary soy supplementation (90 mg isoflavone) in powder form + placebo tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (identical powder and placebo tablets)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness, vaginal maturation value; side effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS: side effects, endometrial thickness or vaginal maturation value with soy compared with placebo </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0010" title="ChengG , WilczekB , WarnerM , GustafssonJ‐A , LandgrenB‐L . Isoflavone treatment for acute menopausal symptoms. Menopause2007;14(3, Part 1):468‐73. ">Cheng 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) isoflavones 60 mg daily in fruit drink</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (oatmeal drink)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference in endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0014" title="DalaisFS , RiceGE , WahlqvistML , GrehanM , MurkiesAL , MedleyG , et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric1998;1:124‐9. ">Dalais 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) soy diet (53 mg/d isoflavones);</p> <p>(2) linseed diet (high in isoflavones— quantity not given)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (wheat diet—low isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal maturation index (percentage increase from baseline)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increase of 103% with soy diet (P = 0.03), 6% increase with linseed (NS), 11% increase with placebo (NS) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0031" title="KnightDC , HowesJB , EdenJA , HowesLG . Effects on menopausal symptoms and acceptability of isoflavone‐containing soy powder dietary supplementation. Climacteric2001;4:13‐8. ">Knight 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy powder 60 g/d for beverage (134.4 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (casein powder for beverage)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events; vaginal maturation index</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total adverse events: 75% with soy versus 17% with placebo (P &lt; 0.001); vaginal maturation index NS </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0032" title="KotsopoulosD , DalaisFS , LiangY‐L , McGrathBP , TeedeHJ . The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric2000;3:161‐7. ">Kotsopoulos 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy powder for beverage (118 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (casein powder for beverage)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total adverse events: NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0037" title="RadhakrishnanG , AgarwalN , VaidN . Evaluation of isoflavone rich soy protein supplementation for postmenopausal therapy. Pakistan Journal of Nutrition2009;8(7):1009‐17. ">Radhakrishnan 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) Soy sachets (25 mg isoflavone soy protein isolate containing 75 mg isoflavones in powder form) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo powder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Karyopyknotic index; maturation value; endometrial thickness; adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference in vaginal cytology, endometrial thickness or adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SOY EXTRACTS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0005" title="Bicca ML deO , HortaBL , LethabyAE . Double‐blind randomized clinical trial to assess the effectiveness of soy isoflavones in the relief of climacteric symptoms. ">Bicca 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract (33 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal maturation index; vaginal pH (percentage with improvement)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maturation: NS; pH: 21% with soy versus 11% with placebo had improvement in pH (P = 0.008) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0008" title="CampagnoliC , AbbaC , AmbroggioS , PerisC , PeronaM , SanseverinoP . Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement. Maturitas2005;51:127‐34. ">Campagnoli 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract (Soyselect) (60 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal maturation index</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0017" title="FaureED , ChantreP , MaresP . Effects of a standardised soy extract on hot flushes: a multicentre, double‐blind, randomised placebo‐controlled study. Menopause2002;9(5):329‐34. ">Faure 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract capsules (7 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0020" title="HanKK , SoaresJM , HaidarMA , deLimaGR , BaracatEC . Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstetrics and Gynecology2002;99:389‐94. ">Han 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy capsules (100 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0028" title="KaariC , HaidarMA , Soares JuniorJM , NunesMG , deAzevedo QuadrosLG , KempC , et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas2006;53:49‐58. ">Kaari 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy extract capsules (S40/Ach‐1) (120 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oestrogen + placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal pH; vaginal maturation index; endometrial thickness; endometrial stimulation; adverse events </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>pH: 5.5 in soy group versus 4.8 in HT group (P = 0.0012); maturation index: significant difference in intermediate and superficial cell frequency in ET group when compared with soy group (P value not given); endometrial thickness: 5.9 mm in HT group versus 3.0 mm in soy group (significant; P value not given); non‐atrophic endometrium: 54% in HT group versus 88% in soy group (P &lt; 0.01); adverse events: 17% genital bleeding in HT group versus 0% in soy group </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0029" title="KhaodhiarL , RicciottiHA , LiL , PanW , SchickelM , ZhouJ , et al. Daidzein‐rich isoflavone‐aglycones are effective in reducing hot flashes in menopausal women. Menopause2008;15(1):125‐32. ">Khaodhiar 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy extract capsules (isoflavone quantity not known)—two different doses:</p> <p>(1) 40 mg/d;</p> <p>(2) 60 mg/d</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very few events reported—no group comparisons reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0033" title="LevisS , Strickman‐SteinN , Ganjei‐AzarP , XuP , DoergeD , KrischerJ . Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms. Archives of Internal Medicine2011;171(15):1363‐8. ">Levis 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Isoflavone tablets 200 mg from soy protein (each tablet 91 mg genistein, 103 mg daidzein)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7/99 had fractures in soy group compared with 1/83 in placebo group (P = 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0035" title="NahasE , Nahas‐NetoJ , OrsattiF , CarvalhoE , OliveiraM , DiasR . Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized double‐blind, and placebo controlled study. Maturitas2007;58:249‐58. ">Nahas 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy extract (isoflavones 100 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median endometrial thickness (mm); maturation value; vaginal pH; adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4 mm in intervention group and 2.8 mm in placebo group (NS)</p> <p>NS in vaginal outcomes and adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0036" title="PenottiM , FabioE , ModenaAB , RinaldiM , OmodeiU , ViganoP . Effect of soy‐derived isoflavones on hot flushes, endometrial thickness and the pulsatility index of the uterine and cerebral arteries. Fertility and Sterility2003;79(5):1112‐7. PenottiM , FabioE , RinaldiM , OmodeiU , BacchiM . Effects of soy‐derived isoflavones on hot flushes and vascular reactivity. The 10th World Congress on the Menopause, Berlin, Germany. 10‐14 June 2002:Abstract F‐27‐01. ">Penotti 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy tablets (72 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0041" title="UpmalisDH , LoboR , BradleyL , WarrenM , ConeFL , LamiaCA . Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter double‐blind randomized placebo‐controlled study. Menopause2000;7(4):236‐42. ">Upmalis 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract tablets (50 mg/d of genistin and daidzin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse effects; vaginal pH; vaginal maturation index; endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events: 34% (30/89) of soy group reported 70 events versus 45% (39/86) in placebo group reported 79 events (no P value); pH: NS; maturation index NS; endometrial thickness: NS </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RED CLOVER EXTRACTS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0003" title="BaberRJ , TemplemanC , MortonT , KellyGE , WestL . Randomized placebo‐controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric1999;2:85‐92. ">Baber 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Promensil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0019" title="GellerSE , ShulmanLP , vanBreemenRB , BanuvarS , ZhouY , EpsteinG , et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomised controlled trial. Menopause2009;16(6):1156‐66. ">Geller 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) 0.625 mg CEE + 2.5 mg MPA;</p> <p>(2) black cohosh (128 mg/d);</p> <p>(3) red clover (398 mg/d including 120 mg isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness; adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0024" title="HidalgoLA , ChedrauiPA , MorochoN , RossS , San MiguelG . The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double‐blind, placebo‐controlled study. Gynecological Endocrinology2005;21(5):257‐64. ">Hidalgo 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Red clover supplement capsules (80 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal cytology (karyopyknotic index, cornification index, maturation index)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant changes (P &lt; 0.05) in all indexes when compared with placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0025" title="ImhofM , GocanA , ReithmayerF , LipovacM , SchimitzekC , ChedrauiP , et al. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas2006;55:76‐81. LipovacM , ChedrauiP , GruenhutC , GocanA , KurzC , NeuberB , et al. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women. Gynecological Endocrinology2012;28(3):203‐7. ">Imhof 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Red clover extract capsules (80 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant decrease in thickness with red clover (15%) but not with placebo (placebo values not given) (P &lt; 0.001) </p> <p>No side effects reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0040" title="TiceJA , EttingerB , EnsrudK , WallaceR , BlackwellT , CummingsSR . Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. JAMA2003;290(2):207‐14. ">Tice 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) Promensil (standardised red clover extract) (82 mg/d isoflavones— two tablets);</p> <p>(2) Rimostil (standardised red clover extract) (57 mg/d isoflavones—two tablets)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GENISTEIN EXTRACTS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0012" title="CrisafulliA , MariniH , BittoA , AltavillaD , SquadritoG , RomeoA , et al. Effects of genistein on hot flushes in early postmenopausal women: a randomized, double‐blind EPT‐ and placebo‐ controlled study. Menopause2004;11:400‐4. ">Crisafulli 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) genistein extract (54 mg/d isoflavones);</p> <p>(2) continuous HT (17B‐oestradiol 1 mg/d + norethisterone acetate)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0013" title="D'AnnaR , CannataM , AtteritanoM , CancellieriF , CorradoF , BavieraG , et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1 year randomized, double‐blind, placebo controlled study. Menopause2007;14(4):648‐55. D'AnnaR , CannataML , MariniH , AtteritanoM , CancellieriF , CorradoF , et al. Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2‐year randomised, double‐blind, placebo‐controlled study. Menopause2009;16(2):301‐6. ">D'Anna 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Genistein extract twice per day (each tablet containing 27 mg total isoflavone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness; vaginal maturation values</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0016" title="EvansM , EllitoJG , SharmaP , BermanR , GuthrieN . The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi‐center, randomised, placebo‐controlled study. Maturitas2011;68:189‐96. ">Evans 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Genistein (geniVida) 30 mg once daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness; adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0018" title="FerrariA . Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. Journal of Obstetric and Gynaecological Research2009;35(6):1083‐90. ">Ferrari 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy isoflavone extract (80 mg) with high dose of genistein (60 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0038" title="SammartinoA , DiCarloC , MandatoVD , BifulcoG , DeStefanoM , NappiC . Effects of genistein on the endometrium: ultrasonographic evaluation. Gynecological Endocrinology2003;17(1):45‐9. ">Sammartino 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Genistein extract tablets (quantity of isoflavones not given)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OTHER PHYTOESTROGENS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0011" title="ColliMC , BrachtA , SoaresAA , deOliveiraAL , BoerCG , deSouzaCGM , et al. Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. Journal of Medicinal Food2012;15(9):840‐5. ">Colli 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Flaxseed extract (1 g per day) (at least 100 mg secoisolariciresinol diglucoside (SDG)) and flaxseed meal (90 g per day) (at least 270 mg SDG) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (1 g per day collagen)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness; vaginal epithelial maturation value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0014" title="DalaisFS , RiceGE , WahlqvistML , GrehanM , MurkiesAL , MedleyG , et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric1998;1:124‐9. ">Dalais 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See above for results in the linseed arm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0022" title="HegerM , VentskovskiyBM , BorzenkoI , KneisKC , RettenbergerR , Kaszkin‐BettagM , et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12‐week randomised double‐blind placebo‐controlled trial. Menopause2006;13(5):744‐59. ">Heger 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Extract of ERr 731, an extract of the roots of <i>Rheum rhaponticum</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness; adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0038" title="SammartinoA , DiCarloC , MandatoVD , BifulcoG , DeStefanoM , NappiC . Effects of genistein on the endometrium: ultrasonographic evaluation. Gynecological Endocrinology2003;17(1):45‐9. ">Sammartino 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Genistein extract tablets (quantity of isoflavones not given)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>HT: Hormone therapy.</p> </div> </div> <div class="table" id="CD001395-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Summary of findings: acceptability outcomes</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No.</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Results (between‐group comparison)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0001" title="AlbertazziP , PansiniF , BonaccorsiG , ZanottiL , ForiniE , DeAloysioD . The effect of dietary soy supplementation on hot flushes. Obstetrics and Gynecology1998;91:6‐11. AlbertazziP , PansiniF , BottazziM , BonaccorsiG , deAloysioD , MortonS . Dietary soy suplementation and phytooestrogen levels. Obstetrics and Gynecology1999;94(2):229‐31. PansiniF , AlbertazziP , BonaccorsiG , ZanottiC , CampobassoC , NegriC , et al. Soy and Hot Flushes. 8th International Congress on the Menopause, Sydney, Australia. 3‐7 November 1996. ">Albertazzi 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 g soy powder (76 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Withdrawal due to adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20% in soy group versus 23% in placebo group (P value not reported)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0018" title="FerrariA . Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. Journal of Obstetric and Gynaecological Research2009;35(6):1083‐90. ">Ferrari 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy isoflavone extract (80 mg) with high dose of genistein (60 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Satisfaction rates</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79.1% in genistein group; 69.1% in placebo group (P value not reported)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0022" title="HegerM , VentskovskiyBM , BorzenkoI , KneisKC , RettenbergerR , Kaszkin‐BettagM , et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12‐week randomised double‐blind placebo‐controlled trial. Menopause2006;13(5):744‐59. ">Heger 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Extract of ERr 731, an extract of the roots of <i>Rheum rhaponticum</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Satisfaction rates</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63% in ERr 731 group satisfied at end of treatment; 32% in placebo group (P value not reported) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0031" title="KnightDC , HowesJB , EdenJA , HowesLG . Effects on menopausal symptoms and acceptability of isoflavone‐containing soy powder dietary supplementation. Climacteric2001;4:13‐8. ">Knight 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy powder 60 g/d for beverage (134.4 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Withdrawal due to adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25% in soy group versus 8% in placebo group (P value not reported)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0032" title="KotsopoulosD , DalaisFS , LiangY‐L , McGrathBP , TeedeHJ . The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric2000;3:161‐7. ">Kotsopoulos 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy powder for beverage (118 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Withdrawal due to adverse events or inability to tolerate treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20% in soy group versus 18% in placebo group (P value not given)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0037" title="RadhakrishnanG , AgarwalN , VaidN . Evaluation of isoflavone rich soy protein supplementation for postmenopausal therapy. Pakistan Journal of Nutrition2009;8(7):1009‐17. ">Radhakrishnan 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy sachets (25 mg isoflavone soy protein isolate containing 75 mg isoflavones in powder form) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo powder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acceptability of treatment according to taste, odor or bulk of preparation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> </tbody> </table> </div> <p>Data from five trials were combined in meta‐analyses because the intervention was a standardised dose of Promensil (<a href="./references#CD001395-bbs2-0003" title="BaberRJ , TemplemanC , MortonT , KellyGE , WestL . Randomized placebo‐controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric1999;2:85‐92. ">Baber 1999</a>; <a href="./references#CD001395-bbs2-0026" title="JeriA . The use of an isoflavone supplement to relieve hot flushes. The Female Patient2002;27:47‐9. ">Jeri 2002</a>; <a href="./references#CD001395-bbs2-0030" title="KnightDC , HowesJB , EdenJA . The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric1999;2:79‐84. ">Knight 1999</a>; <a href="./references#CD001395-bbs2-0040" title="TiceJA , EttingerB , EnsrudK , WallaceR , BlackwellT , CummingsSR . Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. JAMA2003;290(2):207‐14. ">Tice 2003</a>; <a href="./references#CD001395-bbs2-0042" title="van deWeijerPHM , BarentsenR . Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas2002;42:187‐93. ">van de Weijer 2002</a>). It was planned that a fixed‐effect model would be used to combine studies in the meta‐analyses, although both fixed‐effect and random‐effects estimates were calculated initially and results compared. </p> <p>In the forest plots, an increase in the risk of a particular binary outcome that may be beneficial (e.g. improvement in hot flush severity) or detrimental (e.g. proportion with adverse events) is displayed graphically in the meta‐analyses to the right of the centre line, and a decrease in the risk of an outcome to the left of the centre line. Similarly, for continuous data, for some outcomes a higher value for an outcome may be considered beneficial (e.g. greater change in vasomotor symptom score) or detrimental (e.g. number of hot flushes per day), and interpretation will be guided by considering the graph labels that are reversed for benefit as opposed to detriment. </p> </section> <section id="CD001395-sec-0070"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>For most trials, when results were reported in tabular form, subgroup analysis was undertaken because of variation in the phytoestrogen interventions. Trials were grouped a priori according to the type of phytoestrogen given in the experimental arms. Subgroups included the following. </p> <p> <ul id="CD001395-list-0016"> <li> <p>Trials in which the phytoestrogen given was in the form of dietary soy, such as flour, beverage or powder containing isoflavones. </p> </li> <li> <p>Trials in which the phytoestrogen given was in the form of a soy isoflavone extract.</p> </li> <li> <p>Trials in which the phytoestrogen given was in the form of a red clover extract.</p> </li> <li> <p>Trials in which the phytoestrogen given was in the form of a predominantly genistein extract. </p> </li> <li> <p>All other trials.</p> </li> </ul> </p> <p>Statistical heterogeneity between the results of studies pooled in meta‐analyses was examined by inspecting the scatter in the data points and the overlap in their confidence intervals and, more formally, by checking results of the Chi<sup>2</sup> test and the I<sup>2</sup> quantity. A priori, it was planned to look at the possible contribution of differences in trial design to any heterogeneity identified in this manner. When substantial heterogeneity was indicated that could not be explained, a random‐effects model was reported as a more appropriate method for estimating an average treatment effect. </p> </section> <section id="CD001395-sec-0071"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analysis was conducted to compare differences among participants, interventions, outcomes and methodological quality of included studies. </p> <p> <ul id="CD001395-list-0017"> <li> <p>Comparison of trial results of all included studies with those studies at low risk of bias (with at least double blinding, adequate concealment, intention‐to‐treat analyses). </p> </li> <li> <p>Comparison of trial results of all included studies with those studies in which a power calculation was performed for sample size. </p> </li> <li> <p>Comparison of trial results of all included studies with those studies in which women were required to have at least five moderate to severe hot flushes per day before they were eligible to participate. </p> </li> <li> <p>Comparison of trial results of all included studies with those studies using more than 50 mg/d of isoflavones in the treatment group. </p> </li> </ul> </p> <section id="CD001395-sec-0072"> <h5 class="title">Overall summaries: 'Summary of results' tables</h5> <p>As few of the studies could be combined in meta‐analyses, separate 'Summary of results' tables were generated to display efficacy, safety and acceptability outcomes for each trial (<a href="#CD001395-tbl-0001">Table 1</a>, <a href="#CD001395-tbl-0002">Table 2</a> and <a href="#CD001395-tbl-0003">Table 3</a>). Study results in these tables should be considered by referring to the quality of the individual study (<a href="#CD001395-fig-0003">Figure 3</a>) to aid in interpretation of overall results. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001395-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001395-sec-0073"></div> <section id="CD001395-sec-0074"> <h3 class="title">Description of studies</h3> <section id="CD001395-sec-0075"> <h4 class="title">Results of the search</h4> <p>For earlier versions of this review, 30 studies (2,730 participants) were included, 31 were excluded and 11 were awaiting classification (further details on the total number of potentially eligible trials are not available). </p> <p>For the 2013 update of the review, the search retrieved 51 potentially eligible additional studies through inspection of titles and abstracts (<a href="#CD001395-fig-0001">Figure 1</a>). </p> </section> <section id="CD001395-sec-0076"> <h4 class="title">Included studies</h4> <p>Of 51 potentially eligible studies in the 2013 update, a further 16 new studies met the inclusion, criteria together with two additional studies, which were later publications of studies already included in the review, with longer follow‐up or additional results. A total of 43 RCTs (with 4,364 participants) is included in the review (<a href="#CD001395-fig-0001">Figure 1</a>). Full details of the included studies are displayed in an additional table (<a href="./references#CD001395-sec-0152" title="">Characteristics of included studies</a>). </p> <section id="CD001395-sec-0077"> <h5 class="title">Study design and setting</h5> <p>A total of 38 studies used a parallel‐group design, and the remaining five used a cross‐over design. One cross‐over trial had no washout period, and in the remaining four trials, the washout period ranged from seven days to one month. One cross‐over trial was combined with parallel‐group trials in forest plots; only data from the first phase of the trial before cross‐over were used in these analyses. </p> </section> <section id="CD001395-sec-0078"> <h5 class="title">Participants</h5> <p>Most participants were recruited solely from menopause clinics or through a mixture of advertisements and flyers placed in medical practices or in the community; the source of recruitment was not specified in 14 trials. Participants in these trials were experiencing vasomotor symptoms (hot flushes or night sweats) ranging from at least one flush per day to up to 15 flushes per day. Fifteen other trials were included in which vasomotor symptoms or scores on menopausal symptom indices were measured at baseline, although specification of the level of these symptoms was not a requirement for inclusion in the trial. Two of the trials measured the effects of treatment in subgroups (only those women with symptoms at baseline) of randomly assigned participants. One trial excluded women with severe menopausal symptoms who required medical treatment. Menopausal status was most often confirmed by follicle‐stimulating hormone (FSH), luteinising hormone (LH) and plasma oestradiol measurements and/or by amenorrhoea ranging from two months to up to 10 years. Elderly women were not included; participants usually ranged in age from 40 to 65 years, although one trial included women up to 75 years of age. Because the minimum threshold of the last menstrual period ranged from two to 12 months or longer, many trials included a mix of perimenopausal and postmenopausal women. Three trials explicitly recruited perimenopausal women; women were required to have no more than one menstrual period during the three months before recruitment (ages ranged from 45 to 55 years) in one trial; in another, women were required to have had at least one period over the past 12 months (average time since last menstrual period was 16 weeks), and in another, women were 45 to 55 years of age and showed cycle irregularity over the previous 12 months or last menstruation at least three but no longer than 12 months previously. In most of the trials, women using HT, currently or recently, were excluded. Other exclusion criteria included women on a vegetarian diet or on a soy‐rich diet, malignancy, comorbidities and taking medication that might interfere with assessment of vasomotor symptoms. It was not clear in most trials whether participants had a natural or surgical menopause, but nine trials specifically excluded women with a surgical menopause. Women in five trials were from Australia, seven trials were performed in Italy, eight in the USA, seven in Brazil and the remainder in Israel, Japan, Canada, Sweden, France, Ukraine, Belgium, Ecuador, Peru, Austria, Taiwan, the Netherlands, India, China and Iran. </p> </section> <section id="CD001395-sec-0079"> <h5 class="title">Interventions</h5> <p>Interventions used in the trials varied substantially.</p> <p><i>Type and method of delivery of phytoestrogen</i> <br/> Trials were grouped into broad categories according to method of delivery and type of phytoestrogen. </p> <p> <ul id="CD001395-list-0018"> <li> <p>Thirteen trials assessed the effects of dietary substances in the form of flour, powder or beverages derived from soy isoflavones with varying amounts of phytoestrogen enrichment. </p> </li> <li> <p>Twelve trials assessed the effects of varying types of soy isoflavone extracts, usually in tablet form. </p> </li> <li> <p>Nine trials assessed the effects of red clover extracts (five of the nine used a standardised extract manufactured by Novogen under the brand name Promensil). </p> </li> <li> <p>Five trials assessed the effects of mainly genistein extracts on hot flushes.</p> </li> <li> <p>The remaining trials (n = 6) assessed other types of phytoestrogen supplements: Three trials investigated the effects of flaxseed dietary supplements (two of which had soy dietary supplement arms and were included in the first category and the other trial also assessed the effects of a flaxseed extract in addition to the flaxseed dietary supplement); one looked at two doses of a hop extract (<i>Humulus luputus</i> L.), one investigated the effects of a standardised natural S‐(‐)equol containing supplement (SE5‐OH) (a metabolite of isoflavones) and another investigated the effects of an extract taken from the roots of <i>Rheum rhaponticum</i> (ERr 731) (which is considered a phytoestrogen supplement). The authors of this trial noted that ERr 731 has been used by perimeopausal and postmenopausal women in Germany since 1993. </p> </li> </ul> </p> <p><i>Duration</i> <br/> Duration of the interventions provided was three months in most of the trials (or three months for the first phase of cross‐over trials). Five trials had a duration of 16 weeks, nine trials had a duration of 24 weeks, one trial had a duration of 10 months, four trials had a duration of one year and three trials had a duration of two years. </p> <p><i>Comparison groups</i> <br/> The phytoestrogen interventions were mostly placebo controlled, although three open studies compared phytoestrogens with other types of control, either different diet with no phytoestrogens or calcium tablets. One other study included a blinded arm that compared flaxseed extract capsules with placebo capsules and another unblinded arm in which flaxseed dietary powder was used. Six placebo‐controlled studies compared different doses of the phytoestrogen intervention, and two other placebo‐controlled studies compared different types of phytoestrogens (e.g. comparison of a soy diet with a linseed diet or flaxseed muffins with soy muffins). Three studies compared phytoestrogens with HT and placebo, and another compared phytoestrogens solely with HT without a control group. </p> </section> <section id="CD001395-sec-0080"> <h5 class="title">Outcomes</h5> <p>Most of the trials were pilot studies that did not use power calculations. The effect of the interventions provided in the included studies on total menopausal scores derived from general menopausal symptom questionnaires (such as that of Kupperman and Greene) was not an outcome of this review, although studies were included if they measured vasomotor symptoms on a subscale of a compendium score. Most included studies assessed the effectiveness of the intervention as the primary outcome, although effectiveness was measured in different ways (number of hot flushes per day after treatment, percentage decrease in frequency of hot flushes, severity score after treatment, proportion that reported any reduction in frequency). A few studies separately reported on the frequency and severity of night sweats. Frequency of hot flushes or night sweats was generally reported by participants themselves in a daily diary. Severity was recorded usually in the scales or subscales of general menopause symptom rating scales in different categories, but a few studies required that women record severity in prespecified categories in their daily diaries. Menopause symptom scales included Menopause Symptoms Questionnaire, Menopause Rating Scale, Kupperman Index, Greene Climacteric Scale, Menopause‐Specific Quality of Life Questionnaire, Women's Health Questionnaire and the modified Climacteric Symptom Evaluation Checklist. These instruments commonly used a 4‐point scale from 0 (no symptoms) to 3 (severe symptoms) to categorise severity, but a few scales used a larger number of categories. </p> <p>Two studies specifically assessed the safety of the intervention (as measured by effects on endometrial stimulation) as the primary outcome, and 14 others assessed these measures as secondary outcomes. A few studies also assessed the effects of the intervention on the vaginal epithelium or on pH—each of which is a surrogate outcome that is a biological indicator of oestrogenic activity. Adverse events were reported in a few trials but generally were collected as spontaneous reports. Most trials provided details of withdrawals before the study was completed, and a few indicated whether these occurred because of adverse effects or because of problems with acceptability of the intervention. </p> </section> </section> <section id="CD001395-sec-0081"> <h4 class="title">Excluded studies</h4> <p>Of 51 potentially eligible studies for the 2013 update, 28 were excluded because women were not symptomatic at baseline, the studies were not randomised, the duration of the study was less than 12 weeks, the interventions assessed were not included in the review, women had breast cancer, the intervention was a combination treatment, the study was a dose‐finding study that did not include a control group or the interventions were not considered phytoestrogens. A further three studies, originally included in the review, were also excluded because the participants had minimal vasomotor symptoms at baseline (<a href="./references#CD001395-bbs2-0060" title="DodinS , LemayA , JacquesH , LegareF , ForestJ‐C , MasseB . The effects of flaxseed dietary supplement on lipid profile, bone mineral density and symptoms in menopausal women: a randomized, double‐blind, wheat germ placebo‐controlled clinical trial. Journal of Clinical Endocrinology and Metabolism2004;90(3):1390‐7. ">Dodin 2005</a>; <a href="./references#CD001395-bbs2-0061" title="DuffyR , WisemanH , FileSE . Improved cognitive function in postmenopausal women after 12 weeks of consumption of a soya extract containing isoflavones. Pharmacology, Biochemistry and Behaviour2003;75:721‐9. ">Duffy 2003</a>; <a href="./references#CD001395-bbs2-0103" title="WooJ , LauE , HoSC , ChengF , ChanC , ChanAS , et al. Comparison of Pueraria lobata with hormone replacement therapy in treating the adverse health consequences of menopause. Menopause2003;10(4):352‐61. ">Woo 2003</a>). A total of 60 studies have been excluded from the review (<a href="./references#CD001395-sec-0153" title="">Characteristics of excluded studies</a>). Five studies were considered potentially eligible in the 2013 update and are awaiting classification; a total of eight studies are now awaiting classification. </p> </section> </section> <section id="CD001395-sec-0082"> <h3 class="title">Risk of bias in included studies</h3> <p>Risk of bias in the included studies is summarised in chart format (<a href="#CD001395-fig-0002">Figure 2</a> and <a href="#CD001395-fig-0003">Figure 3</a>). However, given that the results are mostly presented in narrative format in subgroups to reduce the variability of the intervention, the overall risk of bias of each study is also included in the 'Additional tables' summarising the results, so that the reader can judge the quality of the trial evidence for each subgroup separately. </p> <section id="CD001395-sec-0083"> <h4 class="title">Allocation</h4> <p>In all, 32 of the studies gave full descriptions of an adequate randomisation procedure and were considered at low risk of bias. The remaining 11 trials claimed that randomisation was the method of allocation, but the method was not described; these trials were considered at unclear risk of bias. Less than half of the studies (n = 19) reported methods to conceal allocation and were considered at low risk of bias; the remaining trials reported no details and were considered at unclear risk of bias. </p> </section> <section id="CD001395-sec-0084"> <h4 class="title">Blinding</h4> <p>Nearly all of the trials reported that treatments were blind to participants, investigators and outcome assessors, but the procedures used to ensure that this occurred were not always described. In many studies, the outcome assessors were the participants, as they evaluated their own experience of hot flushes through questionnaires. In four studies, blinding was not possible because the interventions were different types of diets or because phytoestrogens were compared with calcium (although for this latter study, lack of blinding was not likely to affect measurement of the primary outcome—endometrial stimulation). </p> </section> <section id="CD001395-sec-0085"> <h4 class="title">Incomplete outcome data</h4> <p>For 20 studies, no dropouts or withdrawals were discussed, numbers were balanced between groups or missing data were imputed; these studies were considered at low risk of bias for incomplete outcome data. Eighteen studies were considered at high risk of bias; in these studies, dropouts and withdrawals ranged from 16% to 31%. Five studies were considered at unclear risk of bias, as the percentage of dropouts ranged from 10% to 15% and/or dropouts were unbalanced between randomly assigned groups. </p> </section> <section id="CD001395-sec-0086"> <h4 class="title">Selective reporting</h4> <p>Eighteen studies had low risk of bias, as all prespecified and potential outcomes were reported; seven had unclear risk of bias and 18 had high risk of bias because adverse events were not reported or because outcomes that had been prespecified were not reported. </p> </section> </section> <section id="CD001395-sec-0087"> <h3 class="title" id="CD001395-sec-0087">Effects of interventions</h3> <p>Five of the included studies assessed the effects of Promensil, which is a standardised product, and their data were combined in a meta‐analysis. Because of the heterogeneity of the phytoestrogen interventions provided in the other included studies (dose, composition, type), these data could not be pooled but were synthesised in narrative format and displayed in separate tables for efficacy, safety and acceptability outcomes (<i>see</i><a href="#CD001395-tbl-0001">Table 1</a>, <a href="#CD001395-tbl-0002">Table 2</a> and <a href="#CD001395-tbl-0003">Table 3</a>). </p> <section id="CD001395-sec-0088"> <h4 class="title">Dietary soy</h4> <section id="CD001395-sec-0089"> <h5 class="title">Primary outcome: efficacy</h5> <p>Of the 13 included studies that used some type of substance containing dietary soy and that had efficacy analyses of any kind, seven studies indicated that no significant differences in primary efficacy outcomes were noted between the soy intervention and control groups. </p> <p>Of the remaining six studies, one study assessed vasomotor symptoms specified as "somatic" symptoms on the Menopause Rating Scale. The Carmigiani study reported that both women on hormone therapy and women taking dietary soy supplementation (90 mg isoflavone) had significantly improved somatic symptoms (hot flushes and muscle/joint problems) (46% and 50%, respectively) when compared with placebo (29%) (<a href="./references#CD001395-bbs2-0009" title="CarmigianiLO , PedroAO , Cost‐PaivaLH , Pinto‐NetoAM . The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomised controlled trial. Maturitas2010;67:262‐9. ">Carmigiani 2010</a>). This study found a significant difference in the frequency of hot flushes. The Albertazzi study of 104 women compared soy powder containing 76 mg/d of isoflavones with casein powder over 12 weeks (<a href="./references#CD001395-bbs2-0001" title="AlbertazziP , PansiniF , BonaccorsiG , ZanottiL , ForiniE , DeAloysioD . The effect of dietary soy supplementation on hot flushes. Obstetrics and Gynecology1998;91:6‐11. AlbertazziP , PansiniF , BottazziM , BonaccorsiG , deAloysioD , MortonS . Dietary soy suplementation and phytooestrogen levels. Obstetrics and Gynecology1999;94(2):229‐31. PansiniF , AlbertazziP , BonaccorsiG , ZanottiC , CampobassoC , NegriC , et al. Soy and Hot Flushes. 8th International Congress on the Menopause, Sydney, Australia. 3‐7 November 1996. ">Albertazzi 1998</a>). Investigators reported a mean reduction of 1.6 flushes per day (95% CI ‐1.95 to ‐1.2) for participants consuming soy powder compared with placebo. This was also expressed as a 45% reduction in the number of hot flushes with soy powder compared with a 30% reduction with placebo powder. Two studies found that severity or intensity of hot flushes was significantly reduced by the intervention. Brezinski compared a phytoestrogen‐enriched diet that was individualised for each participant by a dietician (exceeding the cutoff point of &gt; 30 mg/d of isoflavones) versus a regular diet that avoided phytoestrogen‐containing foods consumed by a control group (<a href="./references#CD001395-bbs2-0006" title="BrzezinskiA , AdlercreutzH , ShaoulR , RoslerA , ShmueliA , TanosV , SchenkerJG . Short‐term effects of phytoestrogen‐rich diet on postmenopausal women. Menopause1997;4(2):89‐94. ">Brzezinski 1997</a>). Hot flushes (rated in a menopause symptoms questionnaire) were reduced in severity in both arms of the study but to a significantly greater extent in the phytoestrogen diet group. This study was one of the few that was not blinded, and knowledge of treatment could have affected participants' assessments. In the Radhakrishnan study, a significantly higher proportion of women (84%) reported improvement in hot flush symptoms (severity) with soy protein when compared with placebo (60%), but no evidence was found of a significant difference in the hot flush score (mean hot flushes per day) after six months (<a href="./references#CD001395-bbs2-0037" title="RadhakrishnanG , AgarwalN , VaidN . Evaluation of isoflavone rich soy protein supplementation for postmenopausal therapy. Pakistan Journal of Nutrition2009;8(7):1009‐17. ">Radhakrishnan 2009</a>). Two studies reported other significant differences, but it is unclear whether the scores represented frequency or severity or a combination of the two. The Cheng study reported that women taking 60 mg isoflavones daily had a significantly lower hot flush score (57%) than those taking placebo, but details on what the score represented are not clear (both number of daily hot flushes and intensity were recorded) (<a href="./references#CD001395-bbs2-0010" title="ChengG , WilczekB , WarnerM , GustafssonJ‐A , LandgrenB‐L . Isoflavone treatment for acute menopausal symptoms. Menopause2007;14(3, Part 1):468‐73. ">Cheng 2007</a>). The Hanachi study reported that soy milk significantly reduced hot flushes by 72% compared with control after three months, but no details were given of the actual values for each group (<a href="./references#CD001395-bbs2-0021" title="HanachiP , GolkhoS . Assessment of soy phytoestrogens and exercise on lipid profiles and menopause symptoms in menopausal women. Journal of Biological Sciences2008;8(4):789‐93. ">Hanachi 2008</a>). </p> </section> <section id="CD001395-sec-0090"> <h5 class="title">Secondary outcomes: safety</h5> <p>Of the six studies that assessed adverse events, five were negative (no significant differences between randomised groups) and one was positive. The positive study (<a href="./references#CD001395-bbs2-0031" title="KnightDC , HowesJB , EdenJA , HowesLG . Effects on menopausal symptoms and acceptability of isoflavone‐containing soy powder dietary supplementation. Climacteric2001;4:13‐8. ">Knight 2001</a>) found that 75% of participants in the soy group had adverse events compared with 17% of the placebo group. Side effects included bloating, nausea, weight gain and concerns about bowel function. </p> <p>In all three studies that assessed the effects of phytoestrogens on the endometrium, no evidence of a significant difference between groups was found. </p> <p>Of four studies that assessed the effects of a soy diet on the vaginal maturation index, three found no evidence of a significant difference between phytoestogen and control groups, but one study reported that this index increased by 103% from baseline with a soy diet compared with a 6% increase with linseed and an 11% increase with placebo (<a href="./references#CD001395-bbs2-0014" title="DalaisFS , RiceGE , WahlqvistML , GrehanM , MurkiesAL , MedleyG , et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric1998;1:124‐9. ">Dalais 1998</a>). </p> </section> <section id="CD001395-sec-0091"> <h5 class="title">Secondary outcomes: acceptability</h5> <p>Of the four studies that assessed the acceptability of the phytoestrogen intervention compared with control, one study reported a difference in the rate of withdrawal due to adverse events (<a href="./references#CD001395-bbs2-0031" title="KnightDC , HowesJB , EdenJA , HowesLG . Effects on menopausal symptoms and acceptability of isoflavone‐containing soy powder dietary supplementation. Climacteric2001;4:13‐8. ">Knight 2001</a>) (P value not reported). This small study reported that 25% of participants who consumed a beverage containing soy powder withdrew from the study because of dislike of the taste compared with 8% in the placebo group. </p> <section id="CD001395-sec-0092"> <h6 class="title">Sensitivity analyses</h6> <p>Dietary food supplements varied enormously in the type of product used in the trials, the formulation and the isoflavone content (42 mg/d to 134 mg/d). Sensitivity analysis was undertaken to attempt to explain differences in efficacy outcomes between the six positive studies and the seven negative studies. In particular, the difference between positive and negative trials was not explained by the level of isoflavones in the food product. Variability in trial results could have been caused by other factors for which no controls could be applied. Intestinal florae convert soy isoflavone to equol—a more potent oestrogenic isoflavone that is absorbed along with unconverted genistein and daidzein; this conversion is variable (<a href="./references#CD001395-bbs2-0115" title="AdlercreutzH . Western diet and western diseases: some hormonal and biochemical mechanisms and associations. Scandinavian Journal of Clinical Laboratory Investigations1990;50(Suppl):3‐23. ">Adlercreutz 1990</a>) and may have influenced the heterogeneity of the results. The severity of hot flushes at baseline could also explain the differences. In the six positive studies, severity of hot flushes among participants was variable; two trials required that women have at least five or eight moderate to severe flushes per day, but in the other trials, hot flushes were mild or were unspecified. </p> <p>Quality of the trials in this subgroup was variable; only one positive trial had low risk of bias. Of the six trials with positive findings, two trials had very high dropout rates (24% and 21%) and two trials were unblinded and were thus considered at high risk of bias. </p> </section> </section> </section> <section id="CD001395-sec-0093"> <h4 class="title">Soy extracts</h4> <section id="CD001395-sec-0094"> <h5 class="title">Primary outcome: efficacy</h5> <p>Of the 12 studies that compared various types of soy extract in capsule or tablet form (11 vs placebo and one vs HT), nine studies (all vs placebo) reported significant differences in efficacy outcomes (frequency or severity). Five trials (<a href="./references#CD001395-bbs2-0005" title="Bicca ML deO , HortaBL , LethabyAE . Double‐blind randomized clinical trial to assess the effectiveness of soy isoflavones in the relief of climacteric symptoms. ">Bicca 2004</a>; <a href="./references#CD001395-bbs2-0017" title="FaureED , ChantreP , MaresP . Effects of a standardised soy extract on hot flushes: a multicentre, double‐blind, randomised placebo‐controlled study. Menopause2002;9(5):329‐34. ">Faure 2002</a>; <a href="./references#CD001395-bbs2-0029" title="KhaodhiarL , RicciottiHA , LiL , PanW , SchickelM , ZhouJ , et al. Daidzein‐rich isoflavone‐aglycones are effective in reducing hot flashes in menopausal women. Menopause2008;15(1):125‐32. ">Khaodhiar 2008</a>; <a href="./references#CD001395-bbs2-0035" title="NahasE , Nahas‐NetoJ , OrsattiF , CarvalhoE , OliveiraM , DiasR . Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized double‐blind, and placebo controlled study. Maturitas2007;58:249‐58. ">Nahas 2007</a>; <a href="./references#CD001395-bbs2-0043" title="YeY‐B , WangZ‐L , ZhuoS‐Y , LuW , LiaoH‐F , VerbruggenMA , et al. Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomised placebo‐controlled trial. Menopause2012;19(7):791‐8. ">Ye 2012</a>) reported a reduction in the frequency of flushes (one also found a reduction in the frequency of night sweats); four trials found a reduction in severity of flushes as measured by the Kupperman vasomotor symptom score (<a href="./references#CD001395-bbs2-0020" title="HanKK , SoaresJM , HaidarMA , deLimaGR , BaracatEC . Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstetrics and Gynecology2002;99:389‐94. ">Han 2002</a>; <a href="./references#CD001395-bbs2-0027" title="JouH‐J , WuS‐C , ChangF‐W , LingP‐Y , ChuKS , WuW‐H . Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones. International Journal of Gynecology and Obstetrics2008;102:44‐9. ">Jou 2008</a>; <a href="./references#CD001395-bbs2-0035" title="NahasE , Nahas‐NetoJ , OrsattiF , CarvalhoE , OliveiraM , DiasR . Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized double‐blind, and placebo controlled study. Maturitas2007;58:249‐58. ">Nahas 2007</a>) or by a subjective rating by participants on a scale of 1 to 3 (<a href="./references#CD001395-bbs2-0041" title="UpmalisDH , LoboR , BradleyL , WarrenM , ConeFL , LamiaCA . Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter double‐blind randomized placebo‐controlled study. Menopause2000;7(4):236‐42. ">Upmalis 2000</a>). This latter trial reported that severity of night sweats did not differ at the end of the study according to group. Not all of the positive studies described benefit from soy extracts; one trial found that women were significantly MORE likely to have hot flushes after isoflavone treatment (48.4%) than after placebo (31.7%), although this was a secondary outcome in the trial (<a href="./references#CD001395-bbs2-0033" title="LevisS , Strickman‐SteinN , Ganjei‐AzarP , XuP , DoergeD , KrischerJ . Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms. Archives of Internal Medicine2011;171(15):1363‐8. ">Levis 2011</a>). The trial that compared soy extract with oestrogen therapy (ET; <a href="./references#CD001395-bbs2-0028" title="KaariC , HaidarMA , Soares JuniorJM , NunesMG , deAzevedo QuadrosLG , KempC , et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas2006;53:49‐58. ">Kaari 2006</a>) reported no differences between them in the percentage of participants reporting any reduction in hot flushes (at six months, P = 0.74; Student's <i>t</i> test). </p> </section> <section id="CD001395-sec-0095"> <h5 class="title">Secondary outcomes: safety</h5> <p>Of the eight studies that assessed safety outcomes, one assessed effects on endometrial stimulation, four on vaginal pH, five on endometrial thickness, six on vaginal maturation index and six on adverse events. The trial that compared soy extract with ET (unopposed oestrogen therapy) (<a href="./references#CD001395-bbs2-0028" title="KaariC , HaidarMA , Soares JuniorJM , NunesMG , deAzevedo QuadrosLG , KempC , et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas2006;53:49‐58. ">Kaari 2006</a>) reported significant improvement in vaginal pH and maturation index in the ET group. The soy extract group had a significantly thinner endometrium, less endometrial stimulation and fewer adverse events (all of which were genital bleeding in the ET group). One of the three other trials that compared soy extract with placebo found significantly greater improvement in vaginal pH in the soy group (<a href="./references#CD001395-bbs2-0005" title="Bicca ML deO , HortaBL , LethabyAE . Double‐blind randomized clinical trial to assess the effectiveness of soy isoflavones in the relief of climacteric symptoms. ">Bicca 2004</a>). One of the six studies that assessed adverse events reported that women taking soy extracts had a significant increase in rate of constipation and in fractures compared with women taking placebo (although this latter outcome was not considered to be related to treatment) (<a href="./references#CD001395-bbs2-0033" title="LevisS , Strickman‐SteinN , Ganjei‐AzarP , XuP , DoergeD , KrischerJ . Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms. Archives of Internal Medicine2011;171(15):1363‐8. ">Levis 2011</a>). For all other studies, no evidence was found of differences in endometrial thickness, vaginal maturation index or incidence of adverse events. </p> </section> <section id="CD001395-sec-0096"> <h5 class="title">Secondary outcomes: acceptability</h5> <p>Two studies assessed the acceptability of the interventions as measured by withdrawal due to adverse events; no evidence of a difference between groups was found. </p> <section id="CD001395-sec-0097"> <h6 class="title">Sensitivity analyses</h6> <p>Sensitivity analyses exploring the effects of quality issues, levels of isoflavones in the active arm (ranging from 33 mg/d to 200 mg/d) or severity of flushes at baseline did not explain the differences in results. The five placebo‐controlled trials that found a difference in flush frequency (<a href="./references#CD001395-bbs2-0005" title="Bicca ML deO , HortaBL , LethabyAE . Double‐blind randomized clinical trial to assess the effectiveness of soy isoflavones in the relief of climacteric symptoms. ">Bicca 2004</a>; <a href="./references#CD001395-bbs2-0017" title="FaureED , ChantreP , MaresP . Effects of a standardised soy extract on hot flushes: a multicentre, double‐blind, randomised placebo‐controlled study. Menopause2002;9(5):329‐34. ">Faure 2002</a>; <a href="./references#CD001395-bbs2-0029" title="KhaodhiarL , RicciottiHA , LiL , PanW , SchickelM , ZhouJ , et al. Daidzein‐rich isoflavone‐aglycones are effective in reducing hot flashes in menopausal women. Menopause2008;15(1):125‐32. ">Khaodhiar 2008</a>; <a href="./references#CD001395-bbs2-0035" title="NahasE , Nahas‐NetoJ , OrsattiF , CarvalhoE , OliveiraM , DiasR . Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized double‐blind, and placebo controlled study. Maturitas2007;58:249‐58. ">Nahas 2007</a>; <a href="./references#CD001395-bbs2-0043" title="YeY‐B , WangZ‐L , ZhuoS‐Y , LuW , LiaoH‐F , VerbruggenMA , et al. Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomised placebo‐controlled trial. Menopause2012;19(7):791‐8. ">Ye 2012</a>) out of the nine that measured this outcome reported reduction ranging from 50% to 74% with soy extract compared with reduction ranging from 21% to 43% with placebo. In contradiction to these findings, one trial actually reported a greater proportion of hot flushes after treatment with soy extracts versus placebo. Six trials had a longer duration than the more usual 12 weeks, ranging from 16 weeks to two years. The trial that compared soy extract versus ET (<a href="./references#CD001395-bbs2-0028" title="KaariC , HaidarMA , Soares JuniorJM , NunesMG , deAzevedo QuadrosLG , KempC , et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas2006;53:49‐58. ">Kaari 2006</a>) found no difference in the percentage of participants reporting a reduction in hot flush frequency, but participants had only mild symptoms at baseline (55% and 72% had hot flushes at baseline in the soy and ET groups, respectively). Although no placebo group was included in the study, the authors concluded that their results suggest that the soy isoflavone extract at 120 mg/d was effective in relieving the frequency of hot flushes; however, the trial was considered at high risk of bias. </p> <p>Severity scores were significantly different in four of the seven trials that measured this outcome; three trials used the Kupperman vasomotor scale (rating severity from 0 to 3; <a href="./references#CD001395-bbs2-0020" title="HanKK , SoaresJM , HaidarMA , deLimaGR , BaracatEC . Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstetrics and Gynecology2002;99:389‐94. ">Han 2002</a>; <a href="./references#CD001395-bbs2-0070" title="JouHJ , LingPY , WuSC . Comparison of 70mg and 35mg isoflavone soya supplement for menopause symptoms. International Journal of Gynaecology and Obstetrics2005;90(2):156‐60. ">Jou 2005</a>; <a href="./references#CD001395-bbs2-0080" title="NahasEP , NetoJN , deLucaL , TraimanP , PontesA , DalbenI . Benefits of soy germ isoflavones in postmenopausal women with contraindication for conventional hormone replacement therapy. Maturitas2004;48(4):372‐80. ">Nahas 2004</a>), and the other used a simple severity scale (with scores of 1 to 3 representing mild, moderate and severe symptoms) scored daily by participants (<a href="./references#CD001395-bbs2-0041" title="UpmalisDH , LoboR , BradleyL , WarrenM , ConeFL , LamiaCA . Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter double‐blind randomized placebo‐controlled study. Menopause2000;7(4):236‐42. ">Upmalis 2000</a>). Variability in the results of included trials was not explained by sensitivity analyses of quality and other aspects of the studies. </p> </section> </section> </section> <section id="CD001395-sec-0098"> <h4 class="title">Red clover extracts</h4> <p>Nine trials assessed the effects of red clover extracts on outcomes. Five of these used Promensil, and data from these trials were included in meta‐analyses. The other trials used MF11RCE (80‐mg isoflavones), a red clover supplement with 40 mg isoflavones or a red clover extract with 120 mg isoflavones. We used data from the first phase of the Baber and Imhof cross‐over trials. </p> <section id="CD001395-sec-0099"> <h5 class="title">Primary outcome: efficacy</h5> <p>Promensil: Five studies reported on the incidence of daily hot flushes after treatment with two different doses of Promensil (40 mg/d and 80 mg/d) (<a href="./references#CD001395-bbs2-0003" title="BaberRJ , TemplemanC , MortonT , KellyGE , WestL . Randomized placebo‐controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric1999;2:85‐92. ">Baber 1999</a>; <a href="./references#CD001395-bbs2-0026" title="JeriA . The use of an isoflavone supplement to relieve hot flushes. The Female Patient2002;27:47‐9. ">Jeri 2002</a>; <a href="./references#CD001395-bbs2-0030" title="KnightDC , HowesJB , EdenJA . The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric1999;2:79‐84. ">Knight 1999</a>; <a href="./references#CD001395-bbs2-0040" title="TiceJA , EttingerB , EnsrudK , WallaceR , BlackwellT , CummingsSR . Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. JAMA2003;290(2):207‐14. ">Tice 2003</a>; <a href="./references#CD001395-bbs2-0042" title="van deWeijerPHM , BarentsenR . Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas2002;42:187‐93. ">van de Weijer 2002</a>). No significant differences were reported between groups in the overall incidence of hot flushes (MD ‐0.93, 95% CI ‐1.95 to 0.10, I<sup>2</sup> = 31%; <a href="#CD001395-fig-0004">Figure 4</a>). Although subgroup analysis suggested benefit for a dose of 40 mg daily of Promensil, this finding should be viewed with caution, as two of the three trials had substantial risk of bias. One moderately sized trial of good quality and one small trial at high risk of bias assessed the percentage reduction in the number of hot flushes from baseline, resulting in a very imprecise pooled estimate (MD 20.15, 95% CI ‐12.08 to 52.38, I<sup>2</sup> = 82%; <a href="./references#CD001395-bbs2-0026" title="JeriA . The use of an isoflavone supplement to relieve hot flushes. The Female Patient2002;27:47‐9. ">Jeri 2002</a>; <a href="./references#CD001395-bbs2-0040" title="TiceJA , EttingerB , EnsrudK , WallaceR , BlackwellT , CummingsSR . Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. JAMA2003;290(2):207‐14. ">Tice 2003</a>; <a href="./references#CD001395-fig-0006" title="">Analysis 1.2</a>). A small trial (<a href="./references#CD001395-bbs2-0026" title="JeriA . The use of an isoflavone supplement to relieve hot flushes. The Female Patient2002;27:47‐9. ">Jeri 2002</a>) reported that a significantly greater proportion of women described hot flush severity ranging from moderate to severe to none or light in the Promensil group (RR 17.06, 95% CI 1.1 to 264.5; <a href="./references#CD001395-fig-0007" title="">Analysis 1.3</a>). One trial found no difference in the change in vasomotor score from baseline to end of study (MD 0.02, 95% CI ‐0.29 to 0.32; <a href="./references#CD001395-bbs2-0040" title="TiceJA , EttingerB , EnsrudK , WallaceR , BlackwellT , CummingsSR . Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. JAMA2003;290(2):207‐14. ">Tice 2003</a>; <a href="./references#CD001395-fig-0008" title="">Analysis 1.4</a>). </p> <div class="figure" id="CD001395-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Promensil versus placebo, outcome: 1.1 Incidence of hot flushes (number/d)." data-id="CD001395-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Promensil versus placebo, outcome: 1.1 Incidence of hot flushes (number/d). </p> </div> </div> </div> <p>Other red clover extracts (not included in the meta‐analyses): One trial using a dose of 80 mg of red clover (<a href="./references#CD001395-bbs2-0025" title="ImhofM , GocanA , ReithmayerF , LipovacM , SchimitzekC , ChedrauiP , et al. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas2006;55:76‐81. LipovacM , ChedrauiP , GruenhutC , GocanA , KurzC , NeuberB , et al. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women. Gynecological Endocrinology2012;28(3):203‐7. ">Imhof 2006</a>) found significant benefit for daily frequency of hot flushes and night sweats and for the mean percentage of decrease in these symptoms (P = 0.0001). Another study that assessed an unspecified red clover extract (same dose) reported benefits for hot flush and night sweat severity (as assessed by the Kupperman Index; <a href="./references#CD001395-bbs2-0024" title="HidalgoLA , ChedrauiPA , MorochoN , RossS , San MiguelG . The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double‐blind, placebo‐controlled study. Gynecological Endocrinology2005;21(5):257‐64. ">Hidalgo 2005</a>). After treatment, 15% of women taking 80 mg of red clover reported hot flushes compared with 98.1% of women taking placebo; values for night sweats were 30.2% and 92.5% for red clover and placebo, respectively (P &lt; 0.05). The authors claimed that these values represented severity "as expressed as a percentage," but it is not clear what they meant. The other two studies assessing the efficacy of red clover (<a href="./references#CD001395-bbs2-0015" title="DelGiornoC , Maggio da FonsecaA , BagnoliVR , Serrano de AssisJ , SoaresJM , BaracatEC . Effects of trifolium pratense on climacteric and sexual symptoms in postmenopausal women. Revista da Associacao Medica Brasileira2010;56(5):558‐62. ">Del Giorno 2010</a>; <a href="./references#CD001395-bbs2-0019" title="GellerSE , ShulmanLP , vanBreemenRB , BanuvarS , ZhouY , EpsteinG , et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomised controlled trial. Menopause2009;16(6):1156‐66. ">Geller 2009</a>) found no difference between groups when treatment was given for 12 months. </p> </section> <section id="CD001395-sec-0100"> <h5 class="title">Secondary outcomes: safety</h5> <p>Results are reported separately for Promensil and other red clover extracts.</p> <p>One large trial of Promensil versus placebo assessed adverse events (<a href="./references#CD001395-bbs2-0040" title="TiceJA , EttingerB , EnsrudK , WallaceR , BlackwellT , CummingsSR . Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. JAMA2003;290(2):207‐14. ">Tice 2003</a>). It reported no differences in the proportions of women who experienced any adverse event (RR 0.95, 95% CI 0.65 to 1.40). Also, no differences were found between groups in rates of specific adverse events, such as respiratory tract infection, headache, myalgia, nausea, arthralgia, diarrhoea and vaginal spotting. Two other studies (not included in the meta‐analysis) also did not find differences between groups with respect to adverse events. </p> <p>Three trials assessed the effects of treatment on endometrial thickness (<a href="./references#CD001395-bbs2-0003" title="BaberRJ , TemplemanC , MortonT , KellyGE , WestL . Randomized placebo‐controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric1999;2:85‐92. ">Baber 1999</a>; <a href="./references#CD001395-bbs2-0019" title="GellerSE , ShulmanLP , vanBreemenRB , BanuvarS , ZhouY , EpsteinG , et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomised controlled trial. Menopause2009;16(6):1156‐66. ">Geller 2009</a>; <a href="./references#CD001395-bbs2-0025" title="ImhofM , GocanA , ReithmayerF , LipovacM , SchimitzekC , ChedrauiP , et al. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas2006;55:76‐81. LipovacM , ChedrauiP , GruenhutC , GocanA , KurzC , NeuberB , et al. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women. Gynecological Endocrinology2012;28(3):203‐7. ">Imhof 2006</a>). One trial (included in the meta‐analysis) found no difference in endometrial thickness after 12 weeks of treatment with Promensil. The other two trials reported different findings: One reported a significant decrease of 15% in endometrial thickness in women treated with red clover compared with zero change in women treated with placebo (SD of change not given, P &lt; 0.001; <a href="./references#CD001395-bbs2-0025" title="ImhofM , GocanA , ReithmayerF , LipovacM , SchimitzekC , ChedrauiP , et al. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas2006;55:76‐81. LipovacM , ChedrauiP , GruenhutC , GocanA , KurzC , NeuberB , et al. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women. Gynecological Endocrinology2012;28(3):203‐7. ">Imhof 2006</a>), and the other found no evidence of a significant difference between groups (<a href="./references#CD001395-bbs2-0019" title="GellerSE , ShulmanLP , vanBreemenRB , BanuvarS , ZhouY , EpsteinG , et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomised controlled trial. Menopause2009;16(6):1156‐66. ">Geller 2009</a>). </p> <p>One study that assessed an unspecified red clover extract reported significant changes in all vaginal cytology indexes (karyopyknotic index, cornification index, maturation index) when compared with placebo (P &lt; 0.05) (<a href="./references#CD001395-bbs2-0024" title="HidalgoLA , ChedrauiPA , MorochoN , RossS , San MiguelG . The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double‐blind, placebo‐controlled study. Gynecological Endocrinology2005;21(5):257‐64. ">Hidalgo 2005</a>). </p> </section> <section id="CD001395-sec-0101"> <h5 class="title">Secondary outcomes: acceptability</h5> <p>No trials assessed the acceptability of treatment.</p> <section id="CD001395-sec-0102"> <h6 class="title">Sensitivity analyses</h6> <p>Variability in study results appeared to be explained in part by trial quality. One small Peruvian study (n = 30) of poor quality (<a href="./references#CD001395-bbs2-0026" title="JeriA . The use of an isoflavone supplement to relieve hot flushes. The Female Patient2002;27:47‐9. ">Jeri 2002</a>) reported highly significant effects for both frequency and severity but gave no details on randomisation method, allocation concealment or baseline comparability. Inclusion of this study in the meta‐analyses, combined with findings of other, larger trials of better quality, caused highly significant heterogeneity, and a random‐effects model was chosen for presentation of results. Exclusion of this small trial of poor quality from the meta‐analyses reduced heterogeneity and the summary effect estimate, suggesting that benefit derived from a dose of 40 mg of Promensil per day was no longer significant. Another study (<a href="./references#CD001395-bbs2-0042" title="van deWeijerPHM , BarentsenR . Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas2002;42:187‐93. ">van de Weijer 2002</a>) reported a significant benefit of Promensil (at a dose of two tablets per day) but did not provide an indication of the variability around the estimate so could not be included in the meta‐analysis. A large trial of good quality (n = 252) (<a href="./references#CD001395-bbs2-0040" title="TiceJA , EttingerB , EnsrudK , WallaceR , BlackwellT , CummingsSR . Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. JAMA2003;290(2):207‐14. ">Tice 2003</a>) that compared two types of red clover extract—Promensil (two tablets per day) and Rimostil—versus placebo reported no significant change in the frequency of hot flushes between groups and no significant difference in the change in vasomotor score over the period of the study. One of these studies also compared a higher dose of Promensil (160 mg/d) with placebo, but substitution of these values in the meta‐analysis did not alter the results. </p> <p>Four studies compared other types of red clover extract (<a href="./references#CD001395-bbs2-0015" title="DelGiornoC , Maggio da FonsecaA , BagnoliVR , Serrano de AssisJ , SoaresJM , BaracatEC . Effects of trifolium pratense on climacteric and sexual symptoms in postmenopausal women. Revista da Associacao Medica Brasileira2010;56(5):558‐62. ">Del Giorno 2010</a>; <a href="./references#CD001395-bbs2-0019" title="GellerSE , ShulmanLP , vanBreemenRB , BanuvarS , ZhouY , EpsteinG , et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomised controlled trial. Menopause2009;16(6):1156‐66. ">Geller 2009</a>; <a href="./references#CD001395-bbs2-0024" title="HidalgoLA , ChedrauiPA , MorochoN , RossS , San MiguelG . The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double‐blind, placebo‐controlled study. Gynecological Endocrinology2005;21(5):257‐64. ">Hidalgo 2005</a>; <a href="./references#CD001395-bbs2-0025" title="ImhofM , GocanA , ReithmayerF , LipovacM , SchimitzekC , ChedrauiP , et al. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas2006;55:76‐81. LipovacM , ChedrauiP , GruenhutC , GocanA , KurzC , NeuberB , et al. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women. Gynecological Endocrinology2012;28(3):203‐7. ">Imhof 2006</a>), but findings were inconclusive regarding efficacy. Two of these studies found benefit for 80 mg of red clover, but two others reported no evidence of significant differences associated with a dose of 40 mg or 120 mg of red clover at the end of 12 months of treatment. Variation in the findings was explained to some extent by differing quality of the trials. Results from larger studies of better quality appeared to conflict with those from smaller studies of poorer quality. </p> </section> </section> </section> <section id="CD001395-sec-0103"> <h4 class="title">Genistein</h4> <p>Five studies assessed the effects of predominantly genistein extracts on outcomes (<a href="./references#CD001395-bbs2-0012" title="CrisafulliA , MariniH , BittoA , AltavillaD , SquadritoG , RomeoA , et al. Effects of genistein on hot flushes in early postmenopausal women: a randomized, double‐blind EPT‐ and placebo‐ controlled study. Menopause2004;11:400‐4. ">Crisafulli 2004</a>; <a href="./references#CD001395-bbs2-0013" title="D'AnnaR , CannataM , AtteritanoM , CancellieriF , CorradoF , BavieraG , et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1 year randomized, double‐blind, placebo controlled study. Menopause2007;14(4):648‐55. D'AnnaR , CannataML , MariniH , AtteritanoM , CancellieriF , CorradoF , et al. Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2‐year randomised, double‐blind, placebo‐controlled study. Menopause2009;16(2):301‐6. ">D'Anna 2007</a>; <a href="./references#CD001395-bbs2-0016" title="EvansM , EllitoJG , SharmaP , BermanR , GuthrieN . The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi‐center, randomised, placebo‐controlled study. Maturitas2011;68:189‐96. ">Evans 2011</a>; <a href="./references#CD001395-bbs2-0018" title="FerrariA . Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. Journal of Obstetric and Gynaecological Research2009;35(6):1083‐90. ">Ferrari 2009</a>; <a href="./references#CD001395-bbs2-0038" title="SammartinoA , DiCarloC , MandatoVD , BifulcoG , DeStefanoM , NappiC . Effects of genistein on the endometrium: ultrasonographic evaluation. Gynecological Endocrinology2003;17(1):45‐9. ">Sammartino 2003</a>). Genistein doses ranged from 30 mg to 60 mg per day. Duration of treatment with genistein ranged from 12 weeks to two years. </p> <section id="CD001395-sec-0104"> <h5 class="title">Primary outcome: efficacy</h5> <p>All four studies assessing primary efficacy—two with unclear risk of bias and two with low risk of bias—reported that genistein significantly improved the frequency of hot flushes when compared with placebo (<a href="./references#CD001395-bbs2-0012" title="CrisafulliA , MariniH , BittoA , AltavillaD , SquadritoG , RomeoA , et al. Effects of genistein on hot flushes in early postmenopausal women: a randomized, double‐blind EPT‐ and placebo‐ controlled study. Menopause2004;11:400‐4. ">Crisafulli 2004</a>; <a href="./references#CD001395-bbs2-0013" title="D'AnnaR , CannataM , AtteritanoM , CancellieriF , CorradoF , BavieraG , et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1 year randomized, double‐blind, placebo controlled study. Menopause2007;14(4):648‐55. D'AnnaR , CannataML , MariniH , AtteritanoM , CancellieriF , CorradoF , et al. Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2‐year randomised, double‐blind, placebo‐controlled study. Menopause2009;16(2):301‐6. ">D'Anna 2007</a>; <a href="./references#CD001395-bbs2-0016" title="EvansM , EllitoJG , SharmaP , BermanR , GuthrieN . The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi‐center, randomised, placebo‐controlled study. Maturitas2011;68:189‐96. ">Evans 2011</a>; <a href="./references#CD001395-bbs2-0018" title="FerrariA . Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. Journal of Obstetric and Gynaecological Research2009;35(6):1083‐90. ">Ferrari 2009</a>). One study also found that the duration of hot flushes was reduced compared with placebo (although this is not an outcome of this review). The Crisafulli study also compared genistein with continuous hormone therapy; it reported a 24% mean reduction in daily hot flushes with genistein compared with placebo (P &lt; 0.05) and a 30% reduction in daily hot flushes with HT compared with genistein (P &lt; 0.05). The other three studies reported a mean percentage reduction in daily hot flushes from baseline ranging from 41% to 61% with genistein in comparison with a mean reduction ranging from 7% to 29% with placebo. Two studies of 12 weeks' duration found no evidence that the severity or intensity of hot flushes differed between genistein and placebo groups (<a href="./references#CD001395-bbs2-0016" title="EvansM , EllitoJG , SharmaP , BermanR , GuthrieN . The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi‐center, randomised, placebo‐controlled study. Maturitas2011;68:189‐96. ">Evans 2011</a>; <a href="./references#CD001395-bbs2-0018" title="FerrariA . Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. Journal of Obstetric and Gynaecological Research2009;35(6):1083‐90. ">Ferrari 2009</a>), but a study of longer duration reported that hot flush severity declined significantly when compared with placebo over two years (<a href="./references#CD001395-bbs2-0013" title="D'AnnaR , CannataM , AtteritanoM , CancellieriF , CorradoF , BavieraG , et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1 year randomized, double‐blind, placebo controlled study. Menopause2007;14(4):648‐55. D'AnnaR , CannataML , MariniH , AtteritanoM , CancellieriF , CorradoF , et al. Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2‐year randomised, double‐blind, placebo‐controlled study. Menopause2009;16(2):301‐6. ">D'Anna 2007</a>). </p> </section> <section id="CD001395-sec-0105"> <h5 class="title">Secondary outcomes: safety</h5> <p>Four studies did not find a significant difference between groups in endometrial thickness after genistein treatment, and one study found no evidence of a significant difference in the vaginal maturation value. </p> <p>Two studies found no evidence of a significant difference in adverse events between randomly assigned groups. In one study, most of these adverse events were gastrointestinal. No severe adverse events were experienced by participants. </p> </section> <section id="CD001395-sec-0106"> <h5 class="title">Secondary outcomes: acceptability</h5> <p>The proportion of participants who were satisfied with treatment was similar in both groups in one study (79% with genistein compared with 69% with placebo; <a href="./references#CD001395-bbs2-0022" title="HegerM , VentskovskiyBM , BorzenkoI , KneisKC , RettenbergerR , Kaszkin‐BettagM , et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12‐week randomised double‐blind placebo‐controlled trial. Menopause2006;13(5):744‐59. ">Heger 2006</a>). </p> <section id="CD001395-sec-0107"> <h6 class="title">Sensitivity analyses</h6> <p>The four studies had low or unclear risk of bias. All studies evaluating efficacy consistently reported significant reductions in the frequency of hot flushes at the end of treatment ranging from 12 weeks to two years. Individual trial characteristics were generally fairly similar. Doses of genistein ranged from 56 mg to 60 mg of genistein per day, with one trial using a 30‐mg dose. Women generally had at least four hot flushes per day, and two studies reported average numbers of eight and nine hot flushes per day. Reductions in the number of hot flushes with genistein ranged from 24% to 56% against placebo. Placebo response, when reported, was variable; the two‐year study reported a reduction from baseline of 7.2%, but two shorter studies of 12 weeks' duration reported reductions of 27% and 29%. Results of the effects of genistein on the severity of hot flushes were more mixed and could not be explained by trial characteristics or quality. </p> </section> </section> </section> <section id="CD001395-sec-0108"> <h4 class="title">Other phytoestrogens</h4> <p>Three studies compared flaxseed dietary supplement or flaxseed extract versus placebo or control (<a href="./references#CD001395-bbs2-0011" title="ColliMC , BrachtA , SoaresAA , deOliveiraAL , BoerCG , deSouzaCGM , et al. Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. Journal of Medicinal Food2012;15(9):840‐5. ">Colli 2012</a>; <a href="./references#CD001395-bbs2-0014" title="DalaisFS , RiceGE , WahlqvistML , GrehanM , MurkiesAL , MedleyG , et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric1998;1:124‐9. ">Dalais 1998</a>; <a href="./references#CD001395-bbs2-0034" title="LewisJE , NickellLA , ThompsonLU , SzalaiJP , KissA , HilditchJR . A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause. Menopause2006;13(4):631‐42. ">Lewis 2006</a>); one compared two strengths of hop extract with placebo (<a href="./references#CD001395-bbs2-0023" title="HeyerickA , VervarckeS , DepypereH , BrackeM , DeKeukeleireD . A first prospective, randomized, double‐blind, placebo‐controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas2006;54:164‐75. ">Heyerick 2006</a>), one compared a natural supplement containing S‐(‐)equol, a daidzein metabolite, with placebo in women who were equol nonproducers (<a href="./references#CD001395-bbs2-0002" title="AsoT . Equol improves menopausal symptoms in Japanese women. Journal of Nutrition2010;140:1386S‐9S. AsoT , UchiyamaS , MatsumuraY , TaguchiM , NozakiM , TakamatsuK , et al. A natural S‐Equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women. Journal of Women's Health2012;21(1):92‐100. ">Aso 2012</a>) and one compared an extract of <i>Rheum rhaponticum</i> (ERr 731) with placebo in perimenopausal women (<a href="./references#CD001395-bbs2-0022" title="HegerM , VentskovskiyBM , BorzenkoI , KneisKC , RettenbergerR , Kaszkin‐BettagM , et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12‐week randomised double‐blind placebo‐controlled trial. Menopause2006;13(5):744‐59. ">Heger 2006</a>). Duration of treatment was 12 weeks in most of the studies, but one trial had a duration of 16 weeks and another had a duration of 24 weeks. </p> <section id="CD001395-sec-0109"> <h5 class="title">Primary outcome: efficacy</h5> <p>All six trials assessed efficacy outcomes. Two trials found no evidence of a difference between groups in frequency or intensity of hot flushes after flaxseed treatment (<a href="./references#CD001395-bbs2-0014" title="DalaisFS , RiceGE , WahlqvistML , GrehanM , MurkiesAL , MedleyG , et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric1998;1:124‐9. ">Dalais 1998</a>; <a href="./references#CD001395-bbs2-0034" title="LewisJE , NickellLA , ThompsonLU , SzalaiJP , KissA , HilditchJR . A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause. Menopause2006;13(4):631‐42. ">Lewis 2006</a>), and both Lewis and Colli did not find evidence of a time by interaction effect of hot flush severity or intensity between groups. The study evaluating hop extracts did not find evidence of a significant difference in the Kupperman Index hot flush severity score, although a non‐significant trend favoured both hop extract doses (<a href="./references#CD001395-bbs2-0023" title="HeyerickA , VervarckeS , DepypereH , BrackeM , DeKeukeleireD . A first prospective, randomized, double‐blind, placebo‐controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas2006;54:164‐75. ">Heyerick 2006</a>). The study comparing S‐Equol with placebo found that S‐Equol was associated with a significantly larger decrease in hot flush frequency from baseline (62.8%) compared with placebo (23.6%) in women with three or more hot flushes per day and a significant improvement in hot flush severity with S‐Equol (61%) compared with placebo (45%) (<a href="./references#CD001395-bbs2-0002" title="AsoT . Equol improves menopausal symptoms in Japanese women. Journal of Nutrition2010;140:1386S‐9S. AsoT , UchiyamaS , MatsumuraY , TaguchiM , NozakiM , TakamatsuK , et al. A natural S‐Equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women. Journal of Women's Health2012;21(1):92‐100. ">Aso 2012</a>). Results of the trial were assessed in postmenopausal women with at least one hot flush per day and low rates of equol excretion, as this was considered to reduce the possibility of confounding by background isoflavone intake. Another trial investigating the effects of an extract from the roots of <i>Rheum rhaponticum</i> (ERr 731) in perimenopausal women in the Ukraine reported that both the frequency and the severity of moderate to severe hot flushes and sweats (Menopause Rating Scale II and Menoqol vasomotor score) were significantly reduced with ERr 731 compared with placebo (mean decrease of 2.5 points compared with mean decrease of 1.2 points) at week 12 (<a href="./references#CD001395-bbs2-0022" title="HegerM , VentskovskiyBM , BorzenkoI , KneisKC , RettenbergerR , Kaszkin‐BettagM , et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12‐week randomised double‐blind placebo‐controlled trial. Menopause2006;13(5):744‐59. ">Heger 2006</a>). Effects were assessed blindly by both participants and investigators. </p> </section> <section id="CD001395-sec-0110"> <h5 class="title">Secondary outcomes: safety</h5> <p>Three trials assessed endometrial thickness after six months or one year and reported no significant difference between groups (<a href="./references#CD001395-bbs2-0011" title="ColliMC , BrachtA , SoaresAA , deOliveiraAL , BoerCG , deSouzaCGM , et al. Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. Journal of Medicinal Food2012;15(9):840‐5. ">Colli 2012</a>; <a href="./references#CD001395-bbs2-0012" title="CrisafulliA , MariniH , BittoA , AltavillaD , SquadritoG , RomeoA , et al. Effects of genistein on hot flushes in early postmenopausal women: a randomized, double‐blind EPT‐ and placebo‐ controlled study. Menopause2004;11:400‐4. ">Crisafulli 2004</a>; <a href="./references#CD001395-bbs2-0022" title="HegerM , VentskovskiyBM , BorzenkoI , KneisKC , RettenbergerR , Kaszkin‐BettagM , et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12‐week randomised double‐blind placebo‐controlled trial. Menopause2006;13(5):744‐59. ">Heger 2006</a>). Also no evidence of a change in vaginal maturation index was noted with flaxseed compared with placebo or control (<a href="./references#CD001395-bbs2-0011" title="ColliMC , BrachtA , SoaresAA , deOliveiraAL , BoerCG , deSouzaCGM , et al. Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. Journal of Medicinal Food2012;15(9):840‐5. ">Colli 2012</a>; <a href="./references#CD001395-bbs2-0014" title="DalaisFS , RiceGE , WahlqvistML , GrehanM , MurkiesAL , MedleyG , et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric1998;1:124‐9. ">Dalais 1998</a>). In one trial, women ingesting flaxseed meal withdrew from treatment in greater numbers than those taking flaxseed extract or placebo because of gastrointestinal complaints (<a href="./references#CD001395-bbs2-0011" title="ColliMC , BrachtA , SoaresAA , deOliveiraAL , BoerCG , deSouzaCGM , et al. Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. Journal of Medicinal Food2012;15(9):840‐5. ">Colli 2012</a>), but these differences were not tested statistically. </p> </section> <section id="CD001395-sec-0111"> <h5 class="title">Secondary outcomes: acceptability</h5> <p>One trial (<a href="./references#CD001395-bbs2-0022" title="HegerM , VentskovskiyBM , BorzenkoI , KneisKC , RettenbergerR , Kaszkin‐BettagM , et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12‐week randomised double‐blind placebo‐controlled trial. Menopause2006;13(5):744‐59. ">Heger 2006</a>) reported that 63% of women taking ERr 731 were satisfied with their treatment compared with 32% of women taking placebo (no P value reported). </p> <section id="CD001395-sec-0112"> <h6 class="title">Sensitivity analyses</h6> <p>Studies using similar interventions in this subgroup were too few for sensitivity analyses to be undertaken. </p> </section> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001395-sec-0113" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001395-sec-0113"></div> <section id="CD001395-sec-0114"> <h3 class="title" id="CD001395-sec-0114">Summary of main results</h3> <p>This review has assessed the effectiveness, safety and acceptability of foods, supplements or extracts containing phytoestrogens when compared with placebo, no treatment and HT in randomised studies completed by the end of July 2013. It has been able to pool only the studies that used Promensil in meta‐analyses because of the heterogeneity of the other phytoestrogen interventions. </p> <section id="CD001395-sec-0115"> <h4 class="title">Primary outcome: efficacy</h4> <section id="CD001395-sec-0116"> <h5 class="title">Dietary soy</h5> <p>Of the 13 included studies that used some type of substance containing dietary soy and had efficacy analyses of any kind, seven studies indicated that no significant differences were seen between the soy intervention group and the control group in terms of primary efficacy outcomes. In studies that reported significant findings, interventions included phytoestrogen‐enriched diets, soy milk, fruit drinks with isoflavones and soy powders. Only one trial had low risk of bias, and participants varied in the severity of their flushes at baseline. Sensitivity analyses could not explain the variable results. Thus, the findings from these trials must be considered only tentative, as variability and significant bias influencing the findings cannot be excluded. </p> <p>Overall, no evidence suggested that a diet with high levels of soy phytoestrogens had a positive effect on hot flush frequency or severity. </p> </section> <section id="CD001395-sec-0117"> <h5 class="title">Soy extracts</h5> <p>Of the 11 trials that compared soy extracts with placebo, nine had some positive results and two were negative. Five of nine studies found significant improvement in hot flush frequency with soy extract, but one found that soy extract was associated with more hot flushes than were seen with placebo. Four of seven studies found that hot flush severity was significantly reduced with soy extract, but most of these studies were at high risk of bias. One other study at high risk of bias found no difference in the effect of soy extract or hormone therapy on hot flush symptoms (as measured by the Kupperman Index). </p> <p>Given the variability in the interventions, the severity of hot flushes at baseline and the potential for risk of bias, no overall conclusive evidence showed that soy extracts had a positive effect on hot flush frequency or severity. </p> </section> <section id="CD001395-sec-0118"> <h5 class="title">Red clover extracts</h5> <p>Five studies assessed the effects of Promensil, and four studies assessed the effects of other red clover extracts. Findings were inconclusive and could largely be explained by risk of bias. The two larger studies at low risk of bias found no evidence of benefit with red clover extracts. </p> <p>Overall, no evidence suggested that red clover extracts had a positive effect on hot flush frequency or severity. </p> </section> <section id="CD001395-sec-0119"> <h5 class="title">Genistein</h5> <p>All four studies found consistent benefit for hot flush frequency with doses of genistein ranging from 30 to 60 mg per day in women with moderate to severe hot flushes, although benefits for hot flush severity were more mixed. Although benefits were found with genistein, they were significantly less than those associated with continuous hormone therapy in one study. These positive findings should be considered tentative as, in two of the four studies, effects on hot flushes were secondary outcomes, and in one study, measurements were made in a subgroup from the total study population, which may have introduced bias (<a href="./references#CD001395-bbs2-0172" title="SchulzKF , GrimesDA . Multiplicity in randomised trials II: subgroup and interim analyses. Lancet2005;365:1657‐61. ">Schulz 2005</a>). </p> <p>Overall, genistein extracts appeared to significantly reduce the numbers of hot flushes experienced by symptomatic postmenopausal women but to a lesser extent than hormone therapy. </p> </section> <section id="CD001395-sec-0120"> <h5 class="title">Other phytoestrogens</h5> <p>Among six trials that assessed the effects of other types of phytoestrogens, no evidence of an efficacy difference was noted between flaxseed or linseed diets or extracts and placebo or control in three trials (two of which also contained soy diet arms) or in one trial that assessed a phytoestrogen preparation derived from hops in two different doses in women who had two to five daily flushes. In one trial, ERr 731 was associated with a significant reduction in hot flush and sweating severity symptoms (Menopause Rating Scale II) and in Menoqol vasomotor score compared with placebo. Another trial reported that hot flush frequency and severity were significantly reduced with the S‐Equol supplement (a daidzein metabolite) when compared with placebo. </p> <p>Overall, although benefits were reported from single trials investigating a phytoestrogen extract from the rhubarb plant (ERr 731) and an equol supplement (SE5‐OH), data were insufficient to permit determination of whether any other type of phytoestrogen product had significant effects on vasomotor symptoms. </p> </section> </section> <section id="CD001395-sec-0121"> <h4 class="title">Secondary outcomes</h4> <section id="CD001395-sec-0122"> <h5 class="title">Safety</h5> <p>Data on oestrogenic effects on the endometrium and the vagina and rates of adverse effects were collected in only a few trials and were considered together rather than in subgroups. </p> </section> <section id="CD001395-sec-0123"> <h5 class="title">Endometrial outcomes</h5> <p>Phytoestrogen products do not appear to have an oestrogen agonistic effect on the endometrium when given for up to one year, in contrast to hormone replacement therapy. No evidence was derived from two studies in the review to suggest that phytoestrogens promote a proliferative endometrium (<a href="./references#CD001395-bbs2-0004" title="BalkJL , WhitesideDA , NausG , DeFerrariE , RobertsJM . A pilot study of the effects of phytoestrogen supplementation on the postmenopausal endometrium. Journal of the Society for Gynecologic Investigation2002;9:238‐42. ">Balk 2002</a>; <a href="./references#CD001395-bbs2-0028" title="KaariC , HaidarMA , Soares JuniorJM , NunesMG , deAzevedo QuadrosLG , KempC , et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas2006;53:49‐58. ">Kaari 2006</a>). Most studies reported no difference in endometrial thickness between phytoestrogens and placebo. One study actually found a significant reduction in endometrial thickness from baseline (<a href="./references#CD001395-bbs2-0025" title="ImhofM , GocanA , ReithmayerF , LipovacM , SchimitzekC , ChedrauiP , et al. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas2006;55:76‐81. LipovacM , ChedrauiP , GruenhutC , GocanA , KurzC , NeuberB , et al. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women. Gynecological Endocrinology2012;28(3):203‐7. ">Imhof 2006</a>). The lack of an oestrogenic effect on the endometrium was further supported by a study comparing phytoestrogens with HT; endometrial thickness significantly changed from baseline with HT, but no change was seen with phytoestrogens (<a href="./references#CD001395-bbs2-0028" title="KaariC , HaidarMA , Soares JuniorJM , NunesMG , deAzevedo QuadrosLG , KempC , et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas2006;53:49‐58. ">Kaari 2006</a>). </p> </section> <section id="CD001395-sec-0124"> <h5 class="title">Vaginal outcomes</h5> <p>Evidence of the effects of phytoestrogens on the vaginal maturation index and on pH is mixed. Five placebo‐controlled trials found no evidence of a stimulatory effect, but two other studies described a positive oestrogenic effect of increasing cellular mitotic activity, as evidenced by improvement in maturation indices—one with a soy diet versus a wheat diet and the other with a red clover extract (<a href="./references#CD001395-bbs2-0014" title="DalaisFS , RiceGE , WahlqvistML , GrehanM , MurkiesAL , MedleyG , et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric1998;1:124‐9. ">Dalais 1998</a>; <a href="./references#CD001395-bbs2-0024" title="HidalgoLA , ChedrauiPA , MorochoN , RossS , San MiguelG . The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double‐blind, placebo‐controlled study. Gynecological Endocrinology2005;21(5):257‐64. ">Hidalgo 2005</a>). In two studies with a hormone therapy comparator, vaginal cytology values with HT were significantly different from those obtained with soy (<a href="./references#CD001395-bbs2-0009" title="CarmigianiLO , PedroAO , Cost‐PaivaLH , Pinto‐NetoAM . The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomised controlled trial. Maturitas2010;67:262‐9. ">Carmigiani 2010</a>; <a href="./references#CD001395-bbs2-0028" title="KaariC , HaidarMA , Soares JuniorJM , NunesMG , deAzevedo QuadrosLG , KempC , et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas2006;53:49‐58. ">Kaari 2006</a>). Other studies not included in this review, wherein participants were asymptomatic or had breast cancer, have also produced conflicting data. Three studies found evidence of improvement in maturation values (<a href="./references#CD001395-bbs2-0050" title="BairdDB , UmbachDM , LansdellL , HughesCL , SetchellKDR , WeinbergCR , et al. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women. Journal of Clinical Endocrinology and Metabolism1995;80(5):1685‐90. ">Baird 1995</a>; <a href="./references#CD001395-bbs2-0056" title="ChiechiLM , PutignanoG , GuerraV , SchiavelliMP , CisterninoAM , CarrieroC . The effect of a soy rich diet on the vaginal epithelium in postmenopause: a randomized double blind trial. Maturitas2003;45:241‐6. ">Chiechi 2003</a>; <a href="./references#CD001395-bbs2-0097" title="UesugiS , WatanabeS , IshiwataN , UeharaM , OuchiK . Effects of isoflavone supplements on bone metabolic markers and climacteric symptoms in Japanese women. BioFactors2004;22:221‐8. ">Uesugi 2004</a>), but three others have not confirmed these results (<a href="./references#CD001395-bbs2-0062" title="DuncanAM , UnderhillKEW , XuX , LaValleurJ , PhippsWR , KurzerMS . Modest hormonal effects of soy isoflavones in postmenopausal women. Journal of Clinical Endocrinology and Metabolism1999;84(10):3479‐84. ">Duncan 1999</a>; <a href="./references#CD001395-bbs2-0076" title="ManonaiJ , SongchitsomboonS , ChandaK , HongJH , KomindrS . The effect of a soy‐rich diet on urogenital atrophy: a randomized crossover trial. Maturitas2006;54:135‐40. ">Manonai 2006</a>; <a href="./references#CD001395-bbs2-0083" title="NikanderE , RutanenE‐M , NieminenP , WahlstromT , YlikorkalaO , TiitinenA . Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women. Fertility and Sterility2005;83(1):137‐42. ">Nikander 2005</a>). Characteristics of the individual trials provided no clues that could explain these mixed results. Similarly, one unpublished study described improvement in vaginal pH with a soy extract when compared with placebo (<a href="./references#CD001395-bbs2-0005" title="Bicca ML deO , HortaBL , LethabyAE . Double‐blind randomized clinical trial to assess the effectiveness of soy isoflavones in the relief of climacteric symptoms. ">Bicca 2004</a>), and another, much larger study did not find evidence of a difference (<a href="./references#CD001395-bbs2-0041" title="UpmalisDH , LoboR , BradleyL , WarrenM , ConeFL , LamiaCA . Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter double‐blind randomized placebo‐controlled study. Menopause2000;7(4):236‐42. ">Upmalis 2000</a>). In the study that compared soy extract versus HT, vaginal pH improved significantly more with HT than with soy (<a href="./references#CD001395-bbs2-0028" title="KaariC , HaidarMA , Soares JuniorJM , NunesMG , deAzevedo QuadrosLG , KempC , et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas2006;53:49‐58. ">Kaari 2006</a>). It is hoped that a Cochrane systematic review will be prepared to specifically assess the effects of phytoestrogens on urogenital menopausal symptoms to provide further clarification. </p> </section> <section id="CD001395-sec-0125"> <h5 class="title">Adverse events</h5> <p>Only three of 17 trials found a significant difference in adverse event rates (<a href="./references#CD001395-bbs2-0011" title="ColliMC , BrachtA , SoaresAA , deOliveiraAL , BoerCG , deSouzaCGM , et al. Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. Journal of Medicinal Food2012;15(9):840‐5. ">Colli 2012</a>; <a href="./references#CD001395-bbs2-0031" title="KnightDC , HowesJB , EdenJA , HowesLG . Effects on menopausal symptoms and acceptability of isoflavone‐containing soy powder dietary supplementation. Climacteric2001;4:13‐8. ">Knight 2001</a>; <a href="./references#CD001395-bbs2-0033" title="LevisS , Strickman‐SteinN , Ganjei‐AzarP , XuP , DoergeD , KrischerJ . Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms. Archives of Internal Medicine2011;171(15):1363‐8. ">Levis 2011</a>). The phytoestrogen supplement in the first small trial was give in the form of a powder, and the authors included data on the dislike of the taste of soy powder in the total incidence of adverse events. In this case, the adverse event rate was linked to the type of product used in the soy diet and was more appropriate as a measure of acceptability. Data on the total incidence of adverse effects, with dislike of taste excluded, were not available. The Levis trial, which investigated the effects of soy on bone loss and on vasomotor symptoms, reported that fracture rates were significantly higher in the group of women consuming soy, but this is likely to be a chance event, as all fractures were associated with a traumatic event rather than with osteoporosis. Women ingesting flaxseed meal as a dietary supplement in another trial were more likely to withdraw from treatment because of gastrointestinal complaints when compared with those given flaxseed extract or placebo (<a href="./references#CD001395-bbs2-0011" title="ColliMC , BrachtA , SoaresAA , deOliveiraAL , BoerCG , deSouzaCGM , et al. Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. Journal of Medicinal Food2012;15(9):840‐5. ">Colli 2012</a>). In a trial that compared soy extract with combined HT (<a href="./references#CD001395-bbs2-0028" title="KaariC , HaidarMA , Soares JuniorJM , NunesMG , deAzevedo QuadrosLG , KempC , et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas2006;53:49‐58. ">Kaari 2006</a>), women in the latter arm were more likely to experience genital bleeding, which is a common symptom of HT in perimenopausal women. This symptom was not experienced by women who took phytoestrogen supplements. Adverse events were most often collected incidentally during the trials. </p> </section> <section id="CD001395-sec-0126"> <h5 class="title">Acceptability</h5> <p>Few trials specifically assessed this outcome in spite of the high dropout rate in many of the studies. No evidence was found of a difference in acceptability of any of the phytoestrogen products used when compared with placebo, except for one trial; 63% of those taking ERr 731 were satisfied with their treatment compared with 38% taking placebo. </p> </section> </section> <section id="CD001395-sec-0127"> <h4 class="title">Summary</h4> <p>In summary, generally no conclusive evidence showed a benefit of phytoestrogen‐enriched or ‐derived products for menopausal vasomotor symptoms, with the exception of products containing a minimum of 30 mg per day of genistein, which have been evaluated for up to two years in four studies. Also, no evidence indicated that products derived from phytoestrogens were associated with stimulation of the endometrium and/or vagina of women with vasomotor symptoms. No evidence suggested an increase in adverse events, and limited data suggest that phytoestrogen supplements were well tolerated. </p> </section> </section> <section id="CD001395-sec-0128"> <h3 class="title" id="CD001395-sec-0128">Overall completeness and applicability of evidence</h3> <p>The review included 43 studies, but variation in components and duration of the intervention and in types of participants and severity of their hot flushes, as well as potential variation in metabolism and absorption among individuals and a high placebo response rate, generally resulted in inconclusive findings. Although some trials reported a significant beneficial effect of phytoestrogen treatment on symptoms, strong evidence was found of a placebo effect, with improvements in frequency ranging from ‐1% to ‐59%—similar to the placebo effect found in the Cochrane review of hormone replacement for vasomotor symptoms (<a href="./references#CD001395-bbs2-0157" title="MacLennanA . The four harms of harmless therapies (editorial). Climacteric1999;2:73‐4. ">MacLennan 1999</a>). When some of the included studies reported significant differences between groups, it was not possible to tease out which of the many variables that differed between included studies might have explained the results. </p> <p>Studies varied according to the total amount or 'dose' of isoflavone given in the active treatment arm. The rationale for a role for isoflavones is supported by epidemiological evidence from a community‐based study, which found that the incidence of hot flushes was inversely related to the quantity of soy foods consumed and the daily intake of isoflavones (<a href="./references#CD001395-bbs2-0163" title="NagataC , TakatsukaN , KawakamiN , ShimizuH . Soy product intake and hot flashes in Japanese women: results from a community‐based prospective study. American Journal of Epidemiology2001;153:790‐3. ">Nagata 2001</a>). Studies of Japanese women claim a typical daily consumption of 20 to 54 mg of isoflavones (<a href="./references#CD001395-bbs2-0163" title="NagataC , TakatsukaN , KawakamiN , ShimizuH . Soy product intake and hot flashes in Japanese women: results from a community‐based prospective study. American Journal of Epidemiology2001;153:790‐3. ">Nagata 2001</a>; <a href="./references#CD001395-bbs2-0180" title="SomekawaY , ChiguchiM , IshibashiT , AsoT . Soy intake related to menopausal symptoms, serum lipids and bone mineral density in postmenopausal Japanese women. Obstetrics and Gynecology2001;97:109‐15. ">Somekawa 2001</a>). Most of the studies in this review provided treatments with at least 50 mg per day of isoflavones; some used more than 100 mg of isoflavones per day. Examination of the pattern of results within each subgroup did not indicate that trials were more likely to be positive if they used higher doses of isoflavones. Comparison of total isoflavone levels in treatments may not be useful, as the isoflavone profiles of different supplements and extracts differ considerably. Broad groupings in this review into 'types' of phytoestrogens provided no clues as to the best way that phytoestrogens can be delivered for therapeutic effect. </p> <p>In addition to the heterogeneity of interventions used in the included studies, good evidence of variability was noted in the metabolism and absorption of isoflavones by individuals, which can lead to variations in serum concentrations of parent isoflavones and their metabolites (<a href="./references#CD001395-bbs2-0171" title="RowlandI , FaughnanM , HoeyL , WahalaK , WilliamsonG , CassidyA . Bioavailability of phyto‐oestrogens. British Journal of Nutrition2003;(Suppl):45‐8. ">Rowland 2003</a>; <a href="./references#CD001395-bbs2-0191" title="WisemanH , CaseyK , BoweyEA , et al. Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. American Journal of Clinical Nutrition2004;80(3):692‐9. ">Wiseman 2004</a>). It has been claimed that only 20% to 30% of the general population in the United States possess gut microflorae that convert the isoflavone daidzein to the more oestrogenic dihydroxy isoflavan equol (<a href="./references#CD001395-bbs2-0177" title="SetchellKD , BrownNM , Lydeking‐OlsenE . The clinical importance of the metabolite equol—a clue to the effectiveness of soy and its isoflavones. Journal of Nutrition2002;132:3577‐84. ">Setchell 2002</a>) in comparison with 50% to 60% of Asians (<a href="./references#CD001395-bbs2-0165" title="North American Menopause Society. The role of soy isoflavones in menopausal health: report of the North American Menopause Society. Menopause2011;18(7):732‐53. ">NAMS 2011</a>). It has been suggested that 'equol producers' make up a distinct subpopulation that may be associated with the greatest benefit from soy isoflavones for relief of hot flushes, and they may explain anecdotal reports by many women of phytoestrogen effectiveness in relieving hot flushes. The studies included in this review generally did not control or stratify for this added potential source of variation in response to treatment with phytoestrogens, although investigators in one trial stated that isoflavone supplementation improved symptoms only in women with the ability to produce equol. Another recent trial found a significant benefit associated with use of a supplement of S‐(‐)equol in equol‐nonproducing postmenopausal Japanese women. Further research should consider the role of equol production. </p> <p>In spite of variation in doses, duration and components of phytoestrogen products, extracts containing at least 30 mg of genistein, a type of isoflavone, appeared to reduce both frequency and severity of hot flushes in women, but less so than hormone therapy. A possible rationale is the suggestion that genistein is the most potent isoflavone with regard to receptor binding and transactivation (<a href="./references#CD001395-bbs2-0162" title="MuthyalaRS , JuYH , ShengS . Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R‐ and S‐equols and their differing binding and biological activity through estrogen receptors alpha and beta. Bioorganic and Medicinal Chemistry Letters2004;12:1559‐67. ">Muthyala 2004</a>). No evidence of safety concerns in the short term was found. Further research is needed to confirm the efficacy of high doses of genistein in menopausal women. </p> </section> <section id="CD001395-sec-0129"> <h3 class="title" id="CD001395-sec-0129">Quality of the evidence</h3> <p>The quality of the trials was variable. Although most studies blinded both participants and assessors, less than half reported adequate allocation concealment to protect against selection bias, and high rates of attrition and potential selective outcome reporting in half of the trials suggest that they were at high risk of attrition and reporting bias. Substantial variation in the included studies precluded combining findings in forest plots, and this has limited any definitive conclusions. </p> <p>Four trials have suggested benefit for the reduction of hot flush frequency and severity from high doses of genistein, but these findings should be considered tentative because of methodological shortcomings in some of the trials. The effect of genistein on menopausal vasomotor symptoms requires verification. </p> </section> <section id="CD001395-sec-0130"> <h3 class="title" id="CD001395-sec-0130">Potential biases in the review process</h3> <p>This review has the following limitations. Because we were unable to pool most of the studies and in many cases had no access to the original data, we accepted the statistical methods used in each study and reported study results in tabular form. Many studies did not use an appropriate statistical method to measure changes in frequency or severity over time; endpoint analysis may have obscured different patterns of response. Some trials used unvalidated menopausal symptom questionnaires to assess severity, and not all scales were similar. For example, the Greene Vasomotor Scale includes hot flushes and night sweats, whereas the vasomotor scale used by Kotospoulos includes hot flushes, lightheadedness and headache. </p> <p>A second weakness of the review is the potential for publication bias. The search for relevant studies was very comprehensive, and attempts were made to access the grey literature. However, several of the studies waiting assessment are positive studies in abstract form, and their inclusion may paint a different picture. Publication bias usually operates in a differential manner, leading to a higher probability of publication of studies that indicate positive results. </p> <p>Also, some potential for bias may be associated with the need for the review authors to determine which interventions would be considered as phytoestrogens, given the wide variety of sources and doses of phytoestrogenic compounds. </p> </section> <section id="CD001395-sec-0131"> <h3 class="title" id="CD001395-sec-0131">Agreements and disagreements with other studies or reviews</h3> <p>One review has suggested that phytoestrogen products might be more effective in women with more severe flushes at baseline (<a href="./references#CD001395-bbs2-0149" title="HuntleyAL , ErnstE . Soy for the treatment of perimenopausal symptoms—a systematic review. Maturitas2004;47:1‐9. ">Huntley 2004</a>). This hypothesis has been supported by another study, which proposed that the effectiveness of phytoestrogens for hot flush relief is seen only in those with five or more hot flushes per day (<a href="./references#CD001395-bbs2-0160" title="MessinaM , HughesC . Efficacy of soy foods and soybean isoflavone supplements for alleviating menopausal symptoms is positively related to initial hot flush frequency. Journal of Medicinal Food2003;6:1‐11. ">Messina 2003</a>). Another systematic review and meta‐analysis (<a href="./references#CD001395-bbs2-0147" title="HowesLG , HowesJB , KnightDC . Isoflavone therapy for menopausal flushes: a systematic review and meta‐analysis. Maturitas2006;55:203‐11. ">Howes 2006</a>) also came to the conclusion that women more severely affected by vasomotor symptoms derived a small benefit from isoflavone supplementation and suggested a cut point of around four flushes per day. However, the authors of that review pooled highly variable studies, causing significant statistical heterogeneity, which affects the credibility of effect estimates. These suggestions have not been confirmed by the sensitivity analyses performed in this review, which compared the overall pattern of results with studies that required women to have at least five hot flushes per day. In addition, the North American Menopause Society (NAMS) position paper on isoflavones, which used strict criteria for evaluation of isoflavones, concluded that no linear dose‐response relationship was observed (<a href="./references#CD001395-bbs2-0165" title="North American Menopause Society. The role of soy isoflavones in menopausal health: report of the North American Menopause Society. Menopause2011;18(7):732‐53. ">NAMS 2011</a>), and a recent systematic review (<a href="./references#CD001395-bbs2-0181" title="TakuK , MelbyMK , KronenbergF , KurzerMS , MessinaM . Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta‐analysis of randomised controlled trials. Menopause2012;19(7):776‐90. ">Taku 2012</a>) concluded that the effect of baseline frequency of hot flushes is unclear. When included trials show huge variation in characteristics of participants, types of intervention and outcomes measured, it is important to consider the quality of the trials. One of the largest trials (<a href="./references#CD001395-bbs2-0040" title="TiceJA , EttingerB , EnsrudK , WallaceR , BlackwellT , CummingsSR . Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. JAMA2003;290(2):207‐14. ">Tice 2003</a>) was a study of good quality with high compliance, a low dropout rate and good generalisability (including a broad cross section of the population). It required that women have at least 35 hot flushes per week to participate, and investigators found no evidence of benefit for Promensil or Rimostil. </p> <p>The efficacy findings of this review are broadly in accord with those of most systematic reviews assessing the effects of phytoestrogens on menopausal symptoms published over the past decade (<a href="./references#CD001395-bbs2-0126" title="BolanosR , DelCastilloA , FranciaJ . Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta‐analysis. Menopause2010;17(3):660‐6. ">Bolanos 2010</a>; <a href="./references#CD001395-bbs2-0132" title="CoonJT , PittlerMH , ErnstE . Trifolium pratense isoflavones in the treatment of menopausal hot flushes: a systematic review and meta‐analysis. Phytomedicine2007;14:153‐9. ">Coon 2007</a>; <a href="./references#CD001395-bbs2-0138" title="GellerSE , StudeeL . Botanical and dietary supplements for menopausal symptoms: what works, what does not. Journal of Women's Health2005;14(7):634‐49. ">Geller 2005</a>; <a href="./references#CD001395-bbs2-0139" title="GlazierMG , BowmanMA . A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy. Archives of Internal Medicine2001;161:1161‐72. ">Glazier 2001</a>; <a href="./references#CD001395-bbs2-0144" title="Haimov‐KochmanR , Hchner‐CelnikierD . Hot flashes revisited: pharmacological and herbal options for hot flush management. What does the evidence tell us?. Acta Obstetrica Gynecologica Scandinavica2005;84:972‐9. ">Haimov‐Kochman 2005</a>; <a href="./references#CD001395-bbs2-0147" title="HowesLG , HowesJB , KnightDC . Isoflavone therapy for menopausal flushes: a systematic review and meta‐analysis. Maturitas2006;55:203‐11. ">Howes 2006</a>; <a href="./references#CD001395-bbs2-0149" title="HuntleyAL , ErnstE . Soy for the treatment of perimenopausal symptoms—a systematic review. Maturitas2004;47:1‐9. ">Huntley 2004</a>; <a href="./references#CD001395-bbs2-0150" title="JacobsA , WegewitzU , SommerfeldC , GrossklausR , LampenA . Efficacy of isoflavones in relieving vasomotor menopausal symptoms—a systematic review. Molecular Nutrition and Food Research2009;53:1084‐97. ">Jacobs 2009</a>; <a href="./references#CD001395-bbs2-0152" title="KrebsEE , EnsrudKE , MacDonaldR , WiltTJ . Phytoestrogens for treatment of menopausal symptoms: a systematic review. Obstetrics and Gynecology2004;104(4):824‐36. ">Krebs 2004</a>; <a href="./references#CD001395-bbs2-0156" title="Low DogT . Menopause: a review of botanical dietary supplements. American Journal of Medicine2005;118(12B):98‐108. ">Low Dog 2005</a>; <a href="./references#CD001395-bbs2-0167" title="NedrowA , MillerJ , WalkerM , NygrenP , HuffmanLH , NelsonHD . Complementary and alternative therapies for the management of menopause‐related symptoms. Archives of Internal Medicine2006;166:1453‐65. ">Nedrow 2006</a>; <a href="./references#CD001395-bbs2-0186" title="VillasecaP . Non‐estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice. Climacteric2012;15:115‐24. ">Villaseca 2012</a>; <a href="./references#CD001395-bbs2-0190" title="Williamson‐HughesPS , FlickingerBD , MessinaMJ , EmpieMW . Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause2006;13(5):831‐9. ">Williamson‐H 2006</a>), and this review has included several more recently published studies. In general, most reviews have concluded that phytoestrogen supplementation has no effect or a very mild effect on vasomotor symptoms. However, NAMS, using strict criteria for selection of relevant trials, concluded that soy‐based isoflavones are modestly effective in relieving menopausal symptoms, and that their use in women with distressing symptoms is 'reasonable' (<a href="./references#CD001395-bbs2-0165" title="North American Menopause Society. The role of soy isoflavones in menopausal health: report of the North American Menopause Society. Menopause2011;18(7):732‐53. ">NAMS 2011</a>). A recent systematic review reported that soy isoflavone supplements derived by extraction or chemical synthesis were significantly more effective than placebo in reducing the frequency and severity of hot flushes (<a href="./references#CD001395-bbs2-0181" title="TakuK , MelbyMK , KronenbergF , KurzerMS , MessinaM . Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta‐analysis of randomised controlled trials. Menopause2012;19(7):776‐90. ">Taku 2012</a>). This review included trials with a shorter duration of treatment (six weeks) and women with previous breast cancer; these types of studies were excluded from this review. The Taku review authors also acknowledged substantial heterogeneity in their findings and have noted that further research is warranted to clarify the influence of additional factors, such as dose, isoflavone form, baseline hot flush frequency and duration of treatment. </p> <p>The Taku review has also confirmed the findings of <a href="./references#CD001395-bbs2-0190" title="Williamson‐HughesPS , FlickingerBD , MessinaMJ , EmpieMW . Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies. Menopause2006;13(5):831‐9. ">Williamson‐H 2006</a>, which focused specifically on soy isoflavone extracts and stratified studies according to the amount of genistein included in the extract. Findings of this review suggest that supplements that provide at least 15 mg of genistein per day are effective, whereas those providing less genistein are not, and this hypothesis has been supported by the findings of this review. However, this hypothesis has not been supported by the longitudinal Study of Women's Health Across the Nation, which assessed the association between vasomotor symptoms and ethnicity during the menopausal transition in 3,198 women (<a href="./references#CD001395-bbs2-0140" title="GoldEB , ColvinA , AvisN , BrombergerJ , GreendateGA , PowellL , et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women's health across the nation. American Journal of Public Health2006;96(7):1226‐35. ">Gold 2006</a>). Investigators in this study reported that genistein intake in their sample was not related to vasomotor symptoms, and that it did not account for the reduced symptom reporting that they found among Asian women after adjusting for covariates. This hypothesis needs to be further investigated in randomised trials for inclusion in future updates of this review. </p> <p>The safety of phytoestrogen products has been investigated in another systematic review and assessed in separate subgroups: gynecological or urinary, gastrointestinal, musculoskeletal, neurological or sensory and nonspecific (<a href="./references#CD001395-bbs2-0182" title="TempferCB , FroeseG , HeinzeG , BentzEK , HeflerLA , HuberJC . Side effects of phytoestrogens: a meta‐analysis of randomised trials. American Journal of Medicine2009;122:939‐46. ">Tempfer 2009</a>). The review authors concluded that phytoestrogen supplements had a safe side effect profile, along with moderately elevated rates of gastrointestinal side effects. Use of phytoestrogens was not associated with increased risk of endometrial or breast cancer. Most studies in the review were of limited duration. These findings support the conclusion of this review that phytoestrogen‐enriched products appear to be safe when used for up to two years. A study of women without hot flushes at baseline (not eligible for inclusion in this review) (<a href="./references#CD001395-bbs2-0098" title="UnferV , CasiniML , CostabileL , MignosaM , GerliS , DiRenzoGC . Endometrial effects of long‐term treatment with phytoestrogens: a randomized double‐blind placebo‐controlled study. Fertility and Sterility2004;82(1):145‐8. ">Unfer 2004</a>) reported that long‐term treatment (up to five years) with soy (150 mg/d isoflavones) was associated with increased occurrence of simple endometrial hyperplasia compared with placebo. This finding has not been confirmed by other studies, but the long‐term endometrial safety of high doses of phytoestrogen supplements has not been fully established. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001395-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/urn:x-wiley:14651858:media:CD001395:CD001395-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_t/tCD001395-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD001395-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#CD001395-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001395-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/urn:x-wiley:14651858:media:CD001395:CD001395-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_t/tCD001395-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001395-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#CD001395-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001395-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/urn:x-wiley:14651858:media:CD001395:CD001395-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_t/tCD001395-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001395-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#CD001395-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001395-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/urn:x-wiley:14651858:media:CD001395:CD001395-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_t/tCD001395-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Promensil versus placebo, outcome: 1.1 Incidence of hot flushes (number/d)." data-id="CD001395-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Promensil versus placebo, outcome: 1.1 Incidence of hot flushes (number/d). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#CD001395-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001395-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/urn:x-wiley:14651858:media:CD001395:CD001395-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_t/tCD001395-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Promensil versus placebo, Outcome 1 Incidence of hot flushes (number/d)." data-id="CD001395-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Promensil versus placebo, Outcome 1 Incidence of hot flushes (number/d).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/references#CD001395-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001395-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/urn:x-wiley:14651858:media:CD001395:CD001395-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_t/tCD001395-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Promensil versus placebo, Outcome 2 Change in frequency of hot flushes (% reduction)." data-id="CD001395-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Promensil versus placebo, Outcome 2 Change in frequency of hot flushes (% reduction). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/references#CD001395-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001395-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/urn:x-wiley:14651858:media:CD001395:CD001395-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_t/tCD001395-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Promensil versus placebo, Outcome 3 Improvement in hot flush severity rate." data-id="CD001395-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Promensil versus placebo, Outcome 3 Improvement in hot flush severity rate. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/references#CD001395-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001395-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/urn:x-wiley:14651858:media:CD001395:CD001395-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_t/tCD001395-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Promensil versus placebo, Outcome 4 Change in vasomotor score from baseline to end of study/vasomotor severity—Kupperman subscale." data-id="CD001395-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Promensil versus placebo, Outcome 4 Change in vasomotor score from baseline to end of study/vasomotor severity—Kupperman subscale. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/references#CD001395-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001395-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/urn:x-wiley:14651858:media:CD001395:CD001395-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_t/tCD001395-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Promensil versus placebo, Outcome 5 Endometrial thickness (mm) after treatment." data-id="CD001395-fig-0009" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Promensil versus placebo, Outcome 5 Endometrial thickness (mm) after treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/references#CD001395-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001395-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/urn:x-wiley:14651858:media:CD001395:CD001395-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_t/tCD001395-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Promensil versus placebo, Outcome 6 Adverse event rates." data-id="CD001395-fig-0010" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Promensil versus placebo, Outcome 6 Adverse event rates.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/references#CD001395-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001395-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/urn:x-wiley:14651858:media:CD001395:CD001395-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_t/tCD001395-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Promensil versus placebo, Outcome 7 Incidence of specific adverse events." data-id="CD001395-fig-0011" src="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Promensil versus placebo, Outcome 7 Incidence of specific adverse events.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/references#CD001395-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/media/CDSR/CD001395/image_n/nCD001395-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD001395-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of findings: efficacy outcomes</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No.</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Efficacy outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Results (between‐group comparison)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Overall risk of bias</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SOY DIETARY SUPPLEMENTS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0001" title="AlbertazziP , PansiniF , BonaccorsiG , ZanottiL , ForiniE , DeAloysioD . The effect of dietary soy supplementation on hot flushes. Obstetrics and Gynecology1998;91:6‐11. AlbertazziP , PansiniF , BottazziM , BonaccorsiG , deAloysioD , MortonS . Dietary soy suplementation and phytooestrogen levels. Obstetrics and Gynecology1999;94(2):229‐31. PansiniF , AlbertazziP , BonaccorsiG , ZanottiC , CampobassoC , NegriC , et al. Soy and Hot Flushes. 8th International Congress on the Menopause, Sydney, Australia. 3‐7 November 1996. ">Albertazzi 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 g soy powder (76 mg isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (60 g casein)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes/d after treatment; percentage decrease in number of flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>At end of study, significant difference between placebo and soy: ‐1.59 (‐1.95 to ‐1.2; P &lt; 0.01), representing mean reduction of 1.6 flushes/d in soy group compared with placebo. 45% reduction in flushes with soy versus 30% reduction with placebo (P &lt; 0.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0004" title="BalkJL , WhitesideDA , NausG , DeFerrariE , RobertsJM . A pilot study of the effects of phytoestrogen supplementation on the postmenopausal endometrium. Journal of the Society for Gynecologic Investigation2002;9:238‐42. ">Balk 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy and corn flour cereal (100 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (wheat cereal)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flush and night sweat symptom score after Rx (1 to 4)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS all outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0006" title="BrzezinskiA , AdlercreutzH , ShaoulR , RoslerA , ShmueliA , TanosV , SchenkerJG . Short‐term effects of phytoestrogen‐rich diet on postmenopausal women. Menopause1997;4(2):89‐94. ">Brzezinski 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>145</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Phytoestrogen‐enriched diet (individualised by dietician) (isoflavone amount not given)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control—regular diet (avoiding phytoestrogens)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MSQ hot flush severity reduction subscore (0 to 3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Greater reduction with PE‐rich diet (P = 0.004; no CI given)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0007" title="BurkeGL , LegaultC , AnthonyM , BlandDR , MorganTM , NaughtonMJ , et al. Soy protein and isoflavone effects on vasomotor symptoms in peri‐ and postmenopausal women: the Soy Estrogen Alternative Study. Menopause2003;10(2):147‐53. ">Burke 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>241</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) soy drink 1 (42 mg/d isoflavones);</p> <p>(2) soy drink 2 (58 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (soy drink with isoflavones removed)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number and severity of flushes/sweats per day after Rx (symptom diary); also subgroup analysis in women with 4+ symptoms/d at baseline </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS all outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0009" title="CarmigianiLO , PedroAO , Cost‐PaivaLH , Pinto‐NetoAM . The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomised controlled trial. Maturitas2010;67:262‐9. ">Carmigiani 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) oestradiol 1 mg + 0.5 mg norethisterone acetate;</p> <p>(2) dietary soy supplementation (90 mg isoflavone) in powder form + placebo tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (identical powder and placebo tablets)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Somatic score (hot flushes, heart discomfort, sleeping problems and muscle and joint problems) on the Menopause Rating Scale </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reduction in somatic symptoms was ‐45.6% with HT and ‐49.8% with dietary soy compared with ‐28.6% with placebo </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0010" title="ChengG , WilczekB , WarnerM , GustafssonJ‐A , LandgrenB‐L . Isoflavone treatment for acute menopausal symptoms. Menopause2007;14(3, Part 1):468‐73. ">Cheng 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) isoflavones 60 mg daily in fruit drink</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (oatmeal drink)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flush and night sweat scores</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant reduction in hot flush score with isoflavones compared with placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0014" title="DalaisFS , RiceGE , WahlqvistML , GrehanM , MurkiesAL , MedleyG , et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric1998;1:124‐9. ">Dalais 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) soy diet (53 mg/d isoflavones);</p> <p>(2) linseed diet (high in isoflavones—quantity not given)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (wheat diet (low isoflavones))</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage decrease in number of hot flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS: 22% reduction with soy; 41% reduction with linseed; 51% reduction with wheat</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0021" title="HanachiP , GolkhoS . Assessment of soy phytoestrogens and exercise on lipid profiles and menopause symptoms in menopausal women. Journal of Biological Sciences2008;8(4):789‐93. ">Hanachi 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) soy milk product (12.5 g soy protein with 13 mg genistein and 4.13 mg daidzein);</p> <p>(2) soy milk product + exercise</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flush score on Kupperman Index</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flushes significantly improved with both soy interventions compared with control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0031" title="KnightDC , HowesJB , EdenJA , HowesLG . Effects on menopausal symptoms and acceptability of isoflavone‐containing soy powder dietary supplementation. Climacteric2001;4:13‐8. ">Knight 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy powder 60 g/d for beverage (134.4 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (casein powder for beverage)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per week after Rx</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS: 29 flushes/wk in soy group; 46 flushes/wk in placebo group (reduction in both from baseline) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0032" title="KotsopoulosD , DalaisFS , LiangY‐L , McGrathBP , TeedeHJ . The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric2000;3:161‐7. ">Kotsopoulos 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy powder for beverage (118 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (casein powder for beverage)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flush symptom score (severity) (0 to 3) after Rx</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS: 0.77 score with soy; 0.83 score with placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0034" title="LewisJE , NickellLA , ThompsonLU , SzalaiJP , KissA , HilditchJR . A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause. Menopause2006;13(4):631‐42. ">Lewis 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) soy flour muffins (42 mg/d isoflavones);</p> <p>(2) flaxseed muffins (50 mg/d lignans)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (wheat flour muffins (low lignans and no isoflavones))</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Menoquol vasomotor score; number of flushes per day; severity of flushes (1 to 7 scale) after Rx </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS: all outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0037" title="RadhakrishnanG , AgarwalN , VaidN . Evaluation of isoflavone rich soy protein supplementation for postmenopausal therapy. Pakistan Journal of Nutrition2009;8(7):1009‐17. ">Radhakrishnan 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) soy sachets (25 mg isoflavone soy protein isolate containing 75 mg isoflavones in powder form) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo powder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of daily hot flushes; karyopyknotic index; maturation value; endometrial thickness; acceptability of treatment; adverse events </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significantly greater proportion of women had reduction in hot flushes with soy (84%) when compared with placebo (60%) but no significant difference in hot flush score between groups </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0039" title="StGermainA , PetersonCT , RobinsonJG , AlekelDL . Isoflavone‐rich or isoflavone‐poor soy protein does not reduce menopausal symptoms during 24 weeks of treatment. Menopause2002;8(1):17‐26. ">St Germain 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) soy protein + (80.4 mg/d isoflavones); (2) soy protein – (4.4 mg/d isoflavones) in muffins and powder for cooking </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (whey protein)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage of participants perceiving a decrease in (1) frequency, (2) duration and (3) severity of flushes; number of flushes per week after Rx; number of sweats per week after Rx </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SOY EXTRACT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0005" title="Bicca ML deO , HortaBL , LethabyAE . Double‐blind randomized clinical trial to assess the effectiveness of soy isoflavones in the relief of climacteric symptoms. ">Bicca 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract (33 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Greene Vasomotor Subscale (intensity); percentage who experienced a decrease in frequency of flushes and sweats from baseline </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS: Greene Vasomotor Scale; 74% with soy versus 43% with placebo had decrease in number of hot flushes (P = 0.007); 68% with soy versus 46% with placebo had decrease in number of night sweats (P = 0.049). NS: severity of symptoms </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0008" title="CampagnoliC , AbbaC , AmbroggioS , PerisC , PeronaM , SanseverinoP . Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement. Maturitas2005;51:127‐34. ">Campagnoli 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract (soy select) (60 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per week after Rx</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0017" title="FaureED , ChantreP , MaresP . Effects of a standardised soy extract on hot flushes: a multicentre, double‐blind, randomised placebo‐controlled study. Menopause2002;9(5):329‐34. ">Faure 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract capsules (70 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage decrease in flushes per day; percentage of 'responders' (participants who had reduction of at least 50%) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61% decrease with soy versus 21% reduction with placebo (P value not reported); 66% of soy group were responders versus 34% in placebo group (P &lt; 0.005). Repeated measures analysis confirmed the soy‐placebo treatment effect </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0020" title="HanKK , SoaresJM , HaidarMA , deLimaGR , BaracatEC . Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstetrics and Gynecology2002;99:389‐94. ">Han 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy capsules (100 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kupperman Vasomotor Symptom Score (severity)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor score 8.2 in soy group versus 9.9 in placebo group (P &lt; 0.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0027" title="JouH‐J , WuS‐C , ChangF‐W , LingP‐Y , ChuKS , WuW‐H . Effect of intestinal production of equol on menopausal symptoms in women treated with soy isoflavones. International Journal of Gynecology and Obstetrics2008;102:44‐9. ">Jou 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy germ extract powder (3 g) twice per day (135 mg isoflavones – 1 g = 10.9 mg daidzein and 2.85 mg genistein) in equol producers and non‐producers </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (roasted wheat powder)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flushes as measured by Kupperman Index</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Reduction in hot flush score of 79% in equol producers, 35% in non‐equol producers and 78% in placebo group. Results from equol producers significantly different from placebo by repeated measures analysis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0028" title="KaariC , HaidarMA , Soares JuniorJM , NunesMG , deAzevedo QuadrosLG , KempC , et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas2006;53:49‐58. ">Kaari 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy extract capsules (S40/Ach‐1) (120 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oestrogen + placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage of participants reporting reduction (subgroup)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0029" title="KhaodhiarL , RicciottiHA , LiL , PanW , SchickelM , ZhouJ , et al. Daidzein‐rich isoflavone‐aglycones are effective in reducing hot flashes in menopausal women. Menopause2008;15(1):125‐32. ">Khaodhiar 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy extract capsule (isoflavone quantity not known) (1) 40 mg/d; (2) 60 mg/d</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage reduction in frequency of hot flushes (from daily diary), percentage reduction in severity of hot flushes (daily diary) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52% and 51% reduction in hot flush frequency in 40‐mg and 60‐mg soy groups at 12 weeks compared with 39% reduction with placebo (NS). When both treatment groups were combined, an average reduction of 52% was seen in hot flush frequency per day in women taking soy compared with women taking placebo (P = 0.048) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0033" title="LevisS , Strickman‐SteinN , Ganjei‐AzarP , XuP , DoergeD , KrischerJ . Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms. Archives of Internal Medicine2011;171(15):1363‐8. ">Levis 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Isoflavone tablets 200 mg from soy protein (each tablet 91 mg genistein, 103 mg daidzein)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Menopausal symptoms (hot flushes and night sweats) were secondary outcomes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy isoflavone group: 48.4% had hot flushes; 31.7% in placebo group had hot flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0035" title="NahasE , Nahas‐NetoJ , OrsattiF , CarvalhoE , OliveiraM , DiasR . Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized double‐blind, and placebo controlled study. Maturitas2007;58:249‐58. ">Nahas 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy extract (isoflavones 100 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in daily hot flush number; change in hot flush severity score</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant reduction from baseline in number of daily hot flushes in both groups and significantly greater in soy versus placebo. Hot flush severity significantly reduced in soy extract group when compared with placebo </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0036" title="PenottiM , FabioE , ModenaAB , RinaldiM , OmodeiU , ViganoP . Effect of soy‐derived isoflavones on hot flushes, endometrial thickness and the pulsatility index of the uterine and cerebral arteries. Fertility and Sterility2003;79(5):1112‐7. PenottiM , FabioE , RinaldiM , OmodeiU , BacchiM . Effects of soy‐derived isoflavones on hot flushes and vascular reactivity. The 10th World Congress on the Menopause, Berlin, Germany. 10‐14 June 2002:Abstract F‐27‐01. ">Penotti 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy tablets (72 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per day after Rx</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0041" title="UpmalisDH , LoboR , BradleyL , WarrenM , ConeFL , LamiaCA . Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter double‐blind randomized placebo‐controlled study. Menopause2000;7(4):236‐42. ">Upmalis 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract tablets (50 mg/d of genistein and daidzin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage change in flush severity per week; percentage change in flush frequency per week; percentage change in sweat frequency per week </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34% change in severity with soy versus 21% change in severity with placebo (P = 0.01); NS for percentage change in frequency (P = 0.078 repeated measures analysis); NS for change in reduction of night sweats </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0043" title="YeY‐B , WangZ‐L , ZhuoS‐Y , LuW , LiaoH‐F , VerbruggenMA , et al. Soy germ isoflavones improve menopausal symptoms but have no effect on blood lipids in early postmenopausal Chinese women: a randomised placebo‐controlled trial. Menopause2012;19(7):791‐8. ">Ye 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy germ isoflavone extract powder in capsules in two doses (84 mg and 126 mg of isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flush frequency and percentage change per week</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44.3% and 48.5% change in hot flushes from baseline in the 84‐mg and 126‐mg isoflavone groups, respectively, compared with 27.8% change in placebo group (P &lt; 0.01) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RED CLOVER EXTRACTS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0003" title="BaberRJ , TemplemanC , MortonT , KellyGE , WestL . Randomized placebo‐controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric1999;2:85‐92. ">Baber 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Promensil (standardised red clover extract) (40 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per day after Rx; percentage flush reduction</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0015" title="DelGiornoC , Maggio da FonsecaA , BagnoliVR , Serrano de AssisJ , SoaresJM , BaracatEC . Effects of trifolium pratense on climacteric and sexual symptoms in postmenopausal women. Revista da Associacao Medica Brasileira2010;56(5):558‐62. ">Del Giorno 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><i>Trifolium pratense</i> (red clover) 40 mg </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor symptoms (Kupperman Index)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS between groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0019" title="GellerSE , ShulmanLP , vanBreemenRB , BanuvarS , ZhouY , EpsteinG , et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomised controlled trial. Menopause2009;16(6):1156‐66. ">Geller 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) 0.625 mg CEE + 2.5 mg MPA;</p> <p>(2) Black cohosh (128 mg/d);</p> <p>(3) Red clover (398 mg/d including 120 mg isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vasomotor symptoms (hot flushes and night sweats); frequency of hot flushes; intensity of hot flushes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS: black cohosh and red clover versus placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0024" title="HidalgoLA , ChedrauiPA , MorochoN , RossS , San MiguelG . The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double‐blind, placebo‐controlled study. Gynecological Endocrinology2005;21(5):257‐64. ">Hidalgo 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Red clover supplement capsules (80 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kupperman Index score for hot flushes and sweats (severity) (expressed as percentage)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flushes: 15% with red clover versus 98% with placebo; night sweats: 30% with red clover versus 93% with placebo; P value not given </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0025" title="ImhofM , GocanA , ReithmayerF , LipovacM , SchimitzekC , ChedrauiP , et al. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas2006;55:76‐81. LipovacM , ChedrauiP , GruenhutC , GocanA , KurzC , NeuberB , et al. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women. Gynecological Endocrinology2012;28(3):203‐7. ">Imhof 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>109</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Red clover extract capsules (80 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90 days + 7 days washout + 90 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hot flush daily frequency, night sweats daily frequency</p> <p>Mean percentage decrease in hot flushes and night sweats</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mean (SD) daily frequency (hot flushes) in red clover group (3.1 (3.5)); in placebo group (10.1 (5.5)) </p> <p>Mean (SD) daily frequency (night sweats) in red clover group (1.5 (2.1)); in placebo group (5.0 (2.6)) </p> <p>Mean percentage decrease in hot flushes in red clover group 73.5%; in placebo group 8.2% </p> <p>Mean percentage decrease in night sweats in red clover group 72.2%; in placebo group 0.9% </p> <p>All differences significant (P = 0.0001)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0026" title="JeriA . The use of an isoflavone supplement to relieve hot flushes. The Female Patient2002;27:47‐9. ">Jeri 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Promensil (standardised red clover extract) (40 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage reduction in number of flushes per day; severity of flushes per day (scale)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Frequency: 49% reduction with red clover versus 11% reduction with placebo (P &lt; 0.001); severity: reduction from 2.53 to 1.33 with red clover versus no reduction with placebo (P &lt; 0.001) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0030" title="KnightDC , HowesJB , EdenJA . The effect of Promensil, an isoflavone extract, on menopausal symptoms. Climacteric1999;2:79‐84. ">Knight 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Promensil (standardised red clover extract) (40 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0040" title="TiceJA , EttingerB , EnsrudK , WallaceR , BlackwellT , CummingsSR . Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. JAMA2003;290(2):207‐14. ">Tice 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) Promensil (standardised red clover extract) (82 mg/d isoflavones—two tablets);</p> <p>(2) Rimostil (standardised red clover extract) (57 mg/d isoflavones—two tablets)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per day; percentage reduction in flushes; rate of reduction over time </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per day NS; percentage reductions NS; Promensil had faster reduction over time versus placebo (P = 0.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0042" title="van deWeijerPHM , BarentsenR . Isoflavones from red clover (Promensil) significantly reduce menopausal hot flush symptoms compared with placebo. Maturitas2002;42:187‐93. ">van de Weijer 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Promensil (standardised red clover extract) (80 mg/d isoflavones—two tablets)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number of flushes per day; median percentage change in number of flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.4 flushes/d with Promensil versus 6 flushes/d with placebo (P value not reported); 44% reduction with Promensil versus 0% reduction with placebo (P = 0.01; variation not reported) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GENISTEIN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0012" title="CrisafulliA , MariniH , BittoA , AltavillaD , SquadritoG , RomeoA , et al. Effects of genistein on hot flushes in early postmenopausal women: a randomized, double‐blind EPT‐ and placebo‐ controlled study. Menopause2004;11:400‐4. ">Crisafulli 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) genistein extract (54 mg/d isoflavones);</p> <p>(2) continuous HT (17B‐ostradiol 1 mg/d + norethisterone acetate)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage change in number of flushes per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24% reduction with genistein when compared with placebo (P &lt; 0.01); 30% reduction with HT when compared with genistein (P &lt; 0.05) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0013" title="D'AnnaR , CannataM , AtteritanoM , CancellieriF , CorradoF , BavieraG , et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1 year randomized, double‐blind, placebo controlled study. Menopause2007;14(4):648‐55. D'AnnaR , CannataML , MariniH , AtteritanoM , CancellieriF , CorradoF , et al. Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2‐year randomised, double‐blind, placebo‐controlled study. Menopause2009;16(2):301‐6. ">D'Anna 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Genistein extract twice per day (each tablet containing 27 mg total isoflavone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number and severity of hot flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant reduction in frequency (56.4%) and severity (37.5%) of hot flushes compared with placebo </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0016" title="EvansM , EllitoJG , SharmaP , BermanR , GuthrieN . The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi‐center, randomised, placebo‐controlled study. Maturitas2011;68:189‐96. ">Evans 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Genistein (geniVida) 30 mg once daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Percentage change in number of daily hot flushes; duration and severity of daily hot flushes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant reduction in frequency (51.2% vs 27.2%) and duration of hot flushes (12 minutes/d vs 23 minutes/d) at the end of treatment compared with placebo. NS severity of hot flushes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0018" title="FerrariA . Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. Journal of Obstetric and Gynaecological Research2009;35(6):1083‐90. ">Ferrari 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy isoflavone extract (80 mg) with high dose of genistein (60 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in daily frequency of hot flushes; improvement (as assessed by investigator)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant reduction in number of hot flushes in genistein group (41.2%) when compared with placebo (29.3%); improvement in genistein group 56.7% and in placebo group 53.1% (P value not reported) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OTHER PHYTOESTROGENS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0002" title="AsoT . Equol improves menopausal symptoms in Japanese women. Journal of Nutrition2010;140:1386S‐9S. AsoT , UchiyamaS , MatsumuraY , TaguchiM , NozakiM , TakamatsuK , et al. A natural S‐Equol supplement alleviates hot flushes and other menopausal symptoms in equol nonproducing postmenopausal Japanese women. Journal of Women's Health2012;21(1):92‐100. ">Aso 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>160</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Natural S‐(‐)equol supplement twice per day (5.0 mg equol, 1.2 mg daidzein, 1.4 mg genistein) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Change in frequency and severity of hot flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant reduction in frequency of hot flushes with equol supplement (62.8%) compared with placebo (23.6%) in women with more than three hot flushes per day. Significant improvement in severity of hot flushes with equol supplement (61.2%) when compared with placebo (45%) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0011" title="ColliMC , BrachtA , SoaresAA , deOliveiraAL , BoerCG , deSouzaCGM , et al. Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. Journal of Medicinal Food2012;15(9):840‐5. ">Colli 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Flaxseed extract (1 g/d) (at least 100 mg secoisolariciresinol diglucoside (SDG)) and flaxseed meal (90 g/d) (at least 270 mg SDG) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (1 g/d collagen)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Intensity of hot flush score (Kupperman Index)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>In both flaxseed groups, hot flush intensity score was reduced significantly from baseline, but no significant difference was seen in the placebo group. Comparison of groups by ANOVA showed no significant difference between groups at end of study </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0014" title="DalaisFS , RiceGE , WahlqvistML , GrehanM , MurkiesAL , MedleyG , et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric1998;1:124‐9. ">Dalais 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See above for results in the flaxseed arm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0022" title="HegerM , VentskovskiyBM , BorzenkoI , KneisKC , RettenbergerR , Kaszkin‐BettagM , et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12‐week randomised double‐blind placebo‐controlled trial. Menopause2006;13(5):744‐59. ">Heger 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Extract of ERr 731, an extract of the roots of <i>Rheum rhaponticum</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Changes in number and severity of hot flushes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Number and frequency of hot flushes significantly reduced with ERr 731 compared with placebo (P &lt; 0.0001) (average of 5.5 fewer per day compared with 0 fewer per day) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0023" title="HeyerickA , VervarckeS , DepypereH , BrackeM , DeKeukeleireD . A first prospective, randomized, double‐blind, placebo‐controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas2006;54:164‐75. ">Heyerick 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) Hop extract 1 (100 μg 8‐prenylnaringenin);</p> <p>(2) Hop extract 2 (250 μg 8‐prenylnaringenin) (Menohop)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kupperman hot flush score (severity)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS at the end of the study period</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0034" title="LewisJE , NickellLA , ThompsonLU , SzalaiJP , KissA , HilditchJR . A randomized controlled trial of the effect of dietary soy and flaxseed muffins on quality of life and hot flashes during menopause. Menopause2006;13(4):631‐42. ">Lewis 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See above for results in the flaxseed arm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>CEE: conjugated equine oestrogen.</p> <p>MPA: medroxyprogesterone acetate.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Summary of findings: efficacy outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#CD001395-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001395-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of findings: safety outcomes</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No.</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Safety outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Results (between‐group comparison)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b> Overall risk of bias</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SOY DIETARY SUPPLEMENTS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0001" title="AlbertazziP , PansiniF , BonaccorsiG , ZanottiL , ForiniE , DeAloysioD . The effect of dietary soy supplementation on hot flushes. Obstetrics and Gynecology1998;91:6‐11. AlbertazziP , PansiniF , BottazziM , BonaccorsiG , deAloysioD , MortonS . Dietary soy suplementation and phytooestrogen levels. Obstetrics and Gynecology1999;94(2):229‐31. PansiniF , AlbertazziP , BonaccorsiG , ZanottiC , CampobassoC , NegriC , et al. Soy and Hot Flushes. 8th International Congress on the Menopause, Sydney, Australia. 3‐7 November 1996. ">Albertazzi 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 g soy powder (76 mg isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (60 g casein)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0004" title="BalkJL , WhitesideDA , NausG , DeFerrariE , RobertsJM . A pilot study of the effects of phytoestrogen supplementation on the postmenopausal endometrium. Journal of the Society for Gynecologic Investigation2002;9:238‐42. ">Balk 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy and corn flour cereal (100 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (wheat cereal)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial stimulation; adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial stimulation: NS (all participants had atrophic endometrium). Adverse events: NS </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0009" title="CarmigianiLO , PedroAO , Cost‐PaivaLH , Pinto‐NetoAM . The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomised controlled trial. Maturitas2010;67:262‐9. ">Carmigiani 2010</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) oestradiol 1 mg + 0.5 mg norethisterone acetate;</p> <p>(2) dietary soy supplementation (90 mg isoflavone) in powder form + placebo tablet</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (identical powder and placebo tablets)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness, vaginal maturation value; side effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS: side effects, endometrial thickness or vaginal maturation value with soy compared with placebo </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0010" title="ChengG , WilczekB , WarnerM , GustafssonJ‐A , LandgrenB‐L . Isoflavone treatment for acute menopausal symptoms. Menopause2007;14(3, Part 1):468‐73. ">Cheng 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) isoflavones 60 mg daily in fruit drink</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (oatmeal drink)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference in endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0014" title="DalaisFS , RiceGE , WahlqvistML , GrehanM , MurkiesAL , MedleyG , et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric1998;1:124‐9. ">Dalais 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) soy diet (53 mg/d isoflavones);</p> <p>(2) linseed diet (high in isoflavones— quantity not given)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (wheat diet—low isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal maturation index (percentage increase from baseline)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Increase of 103% with soy diet (P = 0.03), 6% increase with linseed (NS), 11% increase with placebo (NS) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0031" title="KnightDC , HowesJB , EdenJA , HowesLG . Effects on menopausal symptoms and acceptability of isoflavone‐containing soy powder dietary supplementation. Climacteric2001;4:13‐8. ">Knight 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy powder 60 g/d for beverage (134.4 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (casein powder for beverage)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events; vaginal maturation index</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total adverse events: 75% with soy versus 17% with placebo (P &lt; 0.001); vaginal maturation index NS </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0032" title="KotsopoulosD , DalaisFS , LiangY‐L , McGrathBP , TeedeHJ . The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric2000;3:161‐7. ">Kotsopoulos 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy powder for beverage (118 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (casein powder for beverage)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Total adverse events: NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0037" title="RadhakrishnanG , AgarwalN , VaidN . Evaluation of isoflavone rich soy protein supplementation for postmenopausal therapy. Pakistan Journal of Nutrition2009;8(7):1009‐17. ">Radhakrishnan 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) Soy sachets (25 mg isoflavone soy protein isolate containing 75 mg isoflavones in powder form) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo powder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Karyopyknotic index; maturation value; endometrial thickness; adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No difference in vaginal cytology, endometrial thickness or adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>SOY EXTRACTS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0005" title="Bicca ML deO , HortaBL , LethabyAE . Double‐blind randomized clinical trial to assess the effectiveness of soy isoflavones in the relief of climacteric symptoms. ">Bicca 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract (33 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal maturation index; vaginal pH (percentage with improvement)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maturation: NS; pH: 21% with soy versus 11% with placebo had improvement in pH (P = 0.008) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0008" title="CampagnoliC , AbbaC , AmbroggioS , PerisC , PeronaM , SanseverinoP . Polyunsaturated fatty acids (PUFAs) might reduce hot flushes: an indication from two controlled trials on soy isoflavones alone and with a PUFA supplement. Maturitas2005;51:127‐34. ">Campagnoli 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract (Soyselect) (60 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal maturation index</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0017" title="FaureED , ChantreP , MaresP . Effects of a standardised soy extract on hot flushes: a multicentre, double‐blind, randomised placebo‐controlled study. Menopause2002;9(5):329‐34. ">Faure 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract capsules (7 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0020" title="HanKK , SoaresJM , HaidarMA , deLimaGR , BaracatEC . Benefits of soy isoflavone therapeutic regimen on menopausal symptoms. Obstetrics and Gynecology2002;99:389‐94. ">Han 2002</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy capsules (100 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0028" title="KaariC , HaidarMA , Soares JuniorJM , NunesMG , deAzevedo QuadrosLG , KempC , et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas2006;53:49‐58. ">Kaari 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy extract capsules (S40/Ach‐1) (120 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Oestrogen + placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal pH; vaginal maturation index; endometrial thickness; endometrial stimulation; adverse events </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>pH: 5.5 in soy group versus 4.8 in HT group (P = 0.0012); maturation index: significant difference in intermediate and superficial cell frequency in ET group when compared with soy group (P value not given); endometrial thickness: 5.9 mm in HT group versus 3.0 mm in soy group (significant; P value not given); non‐atrophic endometrium: 54% in HT group versus 88% in soy group (P &lt; 0.01); adverse events: 17% genital bleeding in HT group versus 0% in soy group </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0029" title="KhaodhiarL , RicciottiHA , LiL , PanW , SchickelM , ZhouJ , et al. Daidzein‐rich isoflavone‐aglycones are effective in reducing hot flashes in menopausal women. Menopause2008;15(1):125‐32. ">Khaodhiar 2008</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>207</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy extract capsules (isoflavone quantity not known)—two different doses:</p> <p>(1) 40 mg/d;</p> <p>(2) 60 mg/d</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Very few events reported—no group comparisons reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0033" title="LevisS , Strickman‐SteinN , Ganjei‐AzarP , XuP , DoergeD , KrischerJ . Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms. Archives of Internal Medicine2011;171(15):1363‐8. ">Levis 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Isoflavone tablets 200 mg from soy protein (each tablet 91 mg genistein, 103 mg daidzein)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7/99 had fractures in soy group compared with 1/83 in placebo group (P = 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0035" title="NahasE , Nahas‐NetoJ , OrsattiF , CarvalhoE , OliveiraM , DiasR . Efficacy and safety of a soy isoflavone extract in postmenopausal women: a randomized double‐blind, and placebo controlled study. Maturitas2007;58:249‐58. ">Nahas 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy extract (isoflavones 100 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Median endometrial thickness (mm); maturation value; vaginal pH; adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4 mm in intervention group and 2.8 mm in placebo group (NS)</p> <p>NS in vaginal outcomes and adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0036" title="PenottiM , FabioE , ModenaAB , RinaldiM , OmodeiU , ViganoP . Effect of soy‐derived isoflavones on hot flushes, endometrial thickness and the pulsatility index of the uterine and cerebral arteries. Fertility and Sterility2003;79(5):1112‐7. PenottiM , FabioE , RinaldiM , OmodeiU , BacchiM . Effects of soy‐derived isoflavones on hot flushes and vascular reactivity. The 10th World Congress on the Menopause, Berlin, Germany. 10‐14 June 2002:Abstract F‐27‐01. ">Penotti 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy tablets (72 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0041" title="UpmalisDH , LoboR , BradleyL , WarrenM , ConeFL , LamiaCA . Vasomotor symptom relief by soy isoflavone extract tablets in postmenopausal women: a multicenter double‐blind randomized placebo‐controlled study. Menopause2000;7(4):236‐42. ">Upmalis 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Standardised soy extract tablets (50 mg/d of genistin and daidzin)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse effects; vaginal pH; vaginal maturation index; endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events: 34% (30/89) of soy group reported 70 events versus 45% (39/86) in placebo group reported 79 events (no P value); pH: NS; maturation index NS; endometrial thickness: NS </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>RED CLOVER EXTRACTS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0003" title="BaberRJ , TemplemanC , MortonT , KellyGE , WestL . Randomized placebo‐controlled trial of an isoflavone supplement and menopausal symptoms in women. Climacteric1999;2:85‐92. ">Baber 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Promensil</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0019" title="GellerSE , ShulmanLP , vanBreemenRB , BanuvarS , ZhouY , EpsteinG , et al. Safety and efficacy of black cohosh and red clover for the management of vasomotor symptoms: a randomised controlled trial. Menopause2009;16(6):1156‐66. ">Geller 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) 0.625 mg CEE + 2.5 mg MPA;</p> <p>(2) black cohosh (128 mg/d);</p> <p>(3) red clover (398 mg/d including 120 mg isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness; adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0024" title="HidalgoLA , ChedrauiPA , MorochoN , RossS , San MiguelG . The effect of red clover isoflavones on menopausal symptoms, lipids and vaginal cytology in menopausal women: a randomized, double‐blind, placebo‐controlled study. Gynecological Endocrinology2005;21(5):257‐64. ">Hidalgo 2005</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Red clover supplement capsules (80 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Vaginal cytology (karyopyknotic index, cornification index, maturation index)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant changes (P &lt; 0.05) in all indexes when compared with placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0025" title="ImhofM , GocanA , ReithmayerF , LipovacM , SchimitzekC , ChedrauiP , et al. Effects of a red clover extract (MF11RCE) on endometrium and sex hormones in postmenopausal women. Maturitas2006;55:76‐81. LipovacM , ChedrauiP , GruenhutC , GocanA , KurzC , NeuberB , et al. The effect of red clover isoflavone supplementation over vasomotor and menopausal symptoms in postmenopausal women. Gynecological Endocrinology2012;28(3):203‐7. ">Imhof 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Red clover extract capsules (80 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks + 12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Significant decrease in thickness with red clover (15%) but not with placebo (placebo values not given) (P &lt; 0.001) </p> <p>No side effects reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0040" title="TiceJA , EttingerB , EnsrudK , WallaceR , BlackwellT , CummingsSR . Phytoestrogen supplements for the treatment of hot flashes: the isoflavone clover extract (ICE) study. JAMA2003;290(2):207‐14. ">Tice 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>252</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) Promensil (standardised red clover extract) (82 mg/d isoflavones— two tablets);</p> <p>(2) Rimostil (standardised red clover extract) (57 mg/d isoflavones—two tablets)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>GENISTEIN EXTRACTS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0012" title="CrisafulliA , MariniH , BittoA , AltavillaD , SquadritoG , RomeoA , et al. Effects of genistein on hot flushes in early postmenopausal women: a randomized, double‐blind EPT‐ and placebo‐ controlled study. Menopause2004;11:400‐4. ">Crisafulli 2004</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(1) genistein extract (54 mg/d isoflavones);</p> <p>(2) continuous HT (17B‐oestradiol 1 mg/d + norethisterone acetate)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0013" title="D'AnnaR , CannataM , AtteritanoM , CancellieriF , CorradoF , BavieraG , et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1 year randomized, double‐blind, placebo controlled study. Menopause2007;14(4):648‐55. D'AnnaR , CannataML , MariniH , AtteritanoM , CancellieriF , CorradoF , et al. Effects of the phytoestrogen genistein on hot flushes, endometrium and vaginal epithelium in postmenopausal women: a 2‐year randomised, double‐blind, placebo‐controlled study. Menopause2009;16(2):301‐6. ">D'Anna 2007</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Genistein extract twice per day (each tablet containing 27 mg total isoflavone)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo twice per day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness; vaginal maturation values</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0016" title="EvansM , EllitoJG , SharmaP , BermanR , GuthrieN . The effect of synthetic genistein on menopause symptom management in healthy postmenopausal women: a multi‐center, randomised, placebo‐controlled study. Maturitas2011;68:189‐96. ">Evans 2011</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Genistein (geniVida) 30 mg once daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness; adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0018" title="FerrariA . Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. Journal of Obstetric and Gynaecological Research2009;35(6):1083‐90. ">Ferrari 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy isoflavone extract (80 mg) with high dose of genistein (60 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0038" title="SammartinoA , DiCarloC , MandatoVD , BifulcoG , DeStefanoM , NappiC . Effects of genistein on the endometrium: ultrasonographic evaluation. Gynecological Endocrinology2003;17(1):45‐9. ">Sammartino 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Genistein extract tablets (quantity of isoflavones not given)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>OTHER PHYTOESTROGENS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0011" title="ColliMC , BrachtA , SoaresAA , deOliveiraAL , BoerCG , deSouzaCGM , et al. Evaluation of the efficacy of flaxseed meal and flaxseed extract in reducing menopausal symptoms. Journal of Medicinal Food2012;15(9):840‐5. ">Colli 2012</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Flaxseed extract (1 g per day) (at least 100 mg secoisolariciresinol diglucoside (SDG)) and flaxseed meal (90 g per day) (at least 270 mg SDG) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo (1 g per day collagen)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness; vaginal epithelial maturation value</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0014" title="DalaisFS , RiceGE , WahlqvistML , GrehanM , MurkiesAL , MedleyG , et al. Effects of dietary phytoestrogens in postmenopausal women. Climacteric1998;1:124‐9. ">Dalais 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>See above for results in the linseed arm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0022" title="HegerM , VentskovskiyBM , BorzenkoI , KneisKC , RettenbergerR , Kaszkin‐BettagM , et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12‐week randomised double‐blind placebo‐controlled trial. Menopause2006;13(5):744‐59. ">Heger 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Extract of ERr 731, an extract of the roots of <i>Rheum rhaponticum</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness; adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0038" title="SammartinoA , DiCarloC , MandatoVD , BifulcoG , DeStefanoM , NappiC . Effects of genistein on the endometrium: ultrasonographic evaluation. Gynecological Endocrinology2003;17(1):45‐9. ">Sammartino 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Genistein extract tablets (quantity of isoflavones not given)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo tablets</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 year</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Endometrial thickness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>NS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>HT: Hormone therapy.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Summary of findings: safety outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#CD001395-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001395-tbl-0003"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Summary of findings: acceptability outcomes</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Trial</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>No.</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Comparison</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Duration</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Results (between‐group comparison)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0001" title="AlbertazziP , PansiniF , BonaccorsiG , ZanottiL , ForiniE , DeAloysioD . The effect of dietary soy supplementation on hot flushes. Obstetrics and Gynecology1998;91:6‐11. AlbertazziP , PansiniF , BottazziM , BonaccorsiG , deAloysioD , MortonS . Dietary soy suplementation and phytooestrogen levels. Obstetrics and Gynecology1999;94(2):229‐31. PansiniF , AlbertazziP , BonaccorsiG , ZanottiC , CampobassoC , NegriC , et al. Soy and Hot Flushes. 8th International Congress on the Menopause, Sydney, Australia. 3‐7 November 1996. ">Albertazzi 1998</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 g soy powder (76 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Withdrawal due to adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20% in soy group versus 23% in placebo group (P value not reported)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0018" title="FerrariA . Soy extract phytoestrogens with high dose of isoflavones for menopausal symptoms. Journal of Obstetric and Gynaecological Research2009;35(6):1083‐90. ">Ferrari 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy isoflavone extract (80 mg) with high dose of genistein (60 mg)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Satisfaction rates</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79.1% in genistein group; 69.1% in placebo group (P value not reported)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0022" title="HegerM , VentskovskiyBM , BorzenkoI , KneisKC , RettenbergerR , Kaszkin‐BettagM , et al. Efficacy and safety of a special extract of Rheum rhaponticum (ERr 731) in perimenopausal women with climacteric complaints: a 12‐week randomised double‐blind placebo‐controlled trial. Menopause2006;13(5):744‐59. ">Heger 2006</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Extract of ERr 731, an extract of the roots of <i>Rheum rhaponticum</i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Satisfaction rates</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63% in ERr 731 group satisfied at end of treatment; 32% in placebo group (P value not reported) </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0031" title="KnightDC , HowesJB , EdenJA , HowesLG . Effects on menopausal symptoms and acceptability of isoflavone‐containing soy powder dietary supplementation. Climacteric2001;4:13‐8. ">Knight 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy powder 60 g/d for beverage (134.4 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Withdrawal due to adverse events</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25% in soy group versus 8% in placebo group (P value not reported)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0032" title="KotsopoulosD , DalaisFS , LiangY‐L , McGrathBP , TeedeHJ . The effects of soy protein containing phytoestrogens on menopausal symptoms in postmenopausal women. Climacteric2000;3:161‐7. ">Kotsopoulos 2000</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy powder for beverage (118 mg/d isoflavones)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Withdrawal due to adverse events or inability to tolerate treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20% in soy group versus 18% in placebo group (P value not given)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001395-bbs2-0037" title="RadhakrishnanG , AgarwalN , VaidN . Evaluation of isoflavone rich soy protein supplementation for postmenopausal therapy. Pakistan Journal of Nutrition2009;8(7):1009‐17. ">Radhakrishnan 2009</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Soy sachets (25 mg isoflavone soy protein isolate containing 75 mg isoflavones in powder form) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo powder</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acceptability of treatment according to taste, odor or bulk of preparation</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Not reported</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Summary of findings: acceptability outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/full#CD001395-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001395-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Promensil versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Incidence of hot flushes (number/d) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.93 [‐1.95, 0.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 40 mg/d</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.45 [‐2.26, ‐0.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 80 mg/d</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.76 [‐3.28, 1.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Change in frequency of hot flushes (% reduction) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>20.15 [‐12.08, 52.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Improvement in hot flush severity rate <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>17.06 [1.10, 264.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Change in vasomotor score from baseline to end of study/vasomotor severity—Kupperman subscale <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>165</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.29, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Endometrial thickness (mm) after treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.06 [‐4.94, 5.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Adverse event rates <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.65, 1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Incidence of specific adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Cold or upper respiratory tract infection (URTI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.30, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Headache</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.46 [0.17, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 Myalgia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.45 [0.58, 3.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 Nausea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.26, 3.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.5 Arthralgia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.27, 2.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.6 Diarrhoea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.12, 3.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.7 Vaginal spotting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>169</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.52 [0.26, 8.85]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Promensil versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001395.pub4/references#CD001395-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001395.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD001395-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD001395-note-0007">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001395-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD001395-note-0006">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD001395-note-0005">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD001395-note-0004">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD001395-note-0003">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD001395-note-0012">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="ru#CD001395-note-0002">Русский</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001395\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001395\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001395\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001395\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001395\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=QzbxnhyM&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001395.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001395.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001395.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001395.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001395.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740717858723"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001395.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740717858727"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001395.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dc230a8a29377',t:'MTc0MDcxNzg1OS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 